<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <roleRef roleURI="http://cumberlandpharma.com/role/CommitmentsAndContingencies" xlink:href="cpix-20161231.xsd#CommitmentsAndContingencies" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/CommitmentsAndContingenciesLegalMattersNarrativeDetails" xlink:href="cpix-20161231.xsd#CommitmentsAndContingenciesLegalMattersNarrativeDetails" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/ConsolidatedBalanceSheets" xlink:href="cpix-20161231.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="cpix-20161231.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="cpix-20161231.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/ConsolidatedStatementsOfEquity" xlink:href="cpix-20161231.xsd#ConsolidatedStatementsOfEquity" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/ConsolidatedStatementsOfIncomeAndComprehensiveIncomeLoss" xlink:href="cpix-20161231.xsd#ConsolidatedStatementsOfIncomeAndComprehensiveIncomeLoss" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/Debt" xlink:href="cpix-20161231.xsd#Debt" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/DebtLineOfCreditDetails" xlink:href="cpix-20161231.xsd#DebtLineOfCreditDetails" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/DocumentAndEntityInformation" xlink:href="cpix-20161231.xsd#DocumentAndEntityInformation" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/EarningsLossPerShare" xlink:href="cpix-20161231.xsd#EarningsLossPerShare" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/EarningsLossPerShareScheduleOfAntiDilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" xlink:href="cpix-20161231.xsd#EarningsLossPerShareScheduleOfAntiDilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/EarningsLossPerShareScheduleOfComputationOfNumeratorAndDenominatorInEarningsPerShareDetails" xlink:href="cpix-20161231.xsd#EarningsLossPerShareScheduleOfComputationOfNumeratorAndDenominatorInEarningsPerShareDetails" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/EarningsLossPerShareTables" xlink:href="cpix-20161231.xsd#EarningsLossPerShareTables" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/EmployeeBenefitPlans" xlink:href="cpix-20161231.xsd#EmployeeBenefitPlans" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/EmployeeBenefitPlansNarrativeDetails" xlink:href="cpix-20161231.xsd#EmployeeBenefitPlansNarrativeDetails" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/EmploymentAgreements" xlink:href="cpix-20161231.xsd#EmploymentAgreements" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/FairValueOfFinancialInstruments" xlink:href="cpix-20161231.xsd#FairValueOfFinancialInstruments" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueOfFinancialInstrumentsByLevelInHierarchyAndNarrativeDetails" xlink:href="cpix-20161231.xsd#FairValueOfFinancialInstrumentsScheduleOfFairValueOfFinancialInstrumentsByLevelInHierarchyAndNarrativeDetails" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/FairValueOfFinancialInstrumentsTables" xlink:href="cpix-20161231.xsd#FairValueOfFinancialInstrumentsTables" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/IncomeTaxes" xlink:href="cpix-20161231.xsd#IncomeTaxes" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/IncomeTaxesOperatingLossCarryforwardsNarrativeDetails" xlink:href="cpix-20161231.xsd#IncomeTaxesOperatingLossCarryforwardsNarrativeDetails" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/IncomeTaxesScheduleOfComponentsOfDeferredIncomeTaxBenefitExpenseDetails" xlink:href="cpix-20161231.xsd#IncomeTaxesScheduleOfComponentsOfDeferredIncomeTaxBenefitExpenseDetails" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxBenefitExpenseDetails" xlink:href="cpix-20161231.xsd#IncomeTaxesScheduleOfComponentsOfIncomeTaxBenefitExpenseDetails" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesNetDetails" xlink:href="cpix-20161231.xsd#IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesNetDetails" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:href="cpix-20161231.xsd#IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/IncomeTaxesScheduleOfNetOperatingLossCarryforwardsDetails" xlink:href="cpix-20161231.xsd#IncomeTaxesScheduleOfNetOperatingLossCarryforwardsDetails" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/IncomeTaxesTables" xlink:href="cpix-20161231.xsd#IncomeTaxesTables" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/IntangibleAssets" xlink:href="cpix-20161231.xsd#IntangibleAssets" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/IntangibleAssetsFutureAmortizationExpenseDetails" xlink:href="cpix-20161231.xsd#IntangibleAssetsFutureAmortizationExpenseDetails" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/IntangibleAssetsNarrativeDetails" xlink:href="cpix-20161231.xsd#IntangibleAssetsNarrativeDetails" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/IntangibleAssetsScheduleOfIntangibleAssetsDetails" xlink:href="cpix-20161231.xsd#IntangibleAssetsScheduleOfIntangibleAssetsDetails" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/IntangibleAssetsTables" xlink:href="cpix-20161231.xsd#IntangibleAssetsTables" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/Inventories" xlink:href="cpix-20161231.xsd#Inventories" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/InventoriesNarrativeDetails" xlink:href="cpix-20161231.xsd#InventoriesNarrativeDetails" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/InventoriesScheduleOfInventoriesCurrentDetails" xlink:href="cpix-20161231.xsd#InventoriesScheduleOfInventoriesCurrentDetails" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/InventoriesTables" xlink:href="cpix-20161231.xsd#InventoriesTables" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/Leases" xlink:href="cpix-20161231.xsd#Leases" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/LeasesNarrativeDetails" xlink:href="cpix-20161231.xsd#LeasesNarrativeDetails" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/LeasesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" xlink:href="cpix-20161231.xsd#LeasesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/LeasesTables" xlink:href="cpix-20161231.xsd#LeasesTables" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/ManufacturingAndSupplyAgreements" xlink:href="cpix-20161231.xsd#ManufacturingAndSupplyAgreements" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/ManufacturingAndSupplyAgreementsManufacturingAndSupplyAgreementsNarrativeDetails" xlink:href="cpix-20161231.xsd#ManufacturingAndSupplyAgreementsManufacturingAndSupplyAgreementsNarrativeDetails" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/MarketConcentrations" xlink:href="cpix-20161231.xsd#MarketConcentrations" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/MarketConcentrationsScheduleOfRevenuesConcentrationFromMajorCustomersAndNarrativeDetails" xlink:href="cpix-20161231.xsd#MarketConcentrationsScheduleOfRevenuesConcentrationFromMajorCustomersAndNarrativeDetails" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/MarketConcentrationsTables" xlink:href="cpix-20161231.xsd#MarketConcentrationsTables" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/Organization" xlink:href="cpix-20161231.xsd#Organization" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/OrganizationNarrativeDetails" xlink:href="cpix-20161231.xsd#OrganizationNarrativeDetails" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/OtherCurrentLiabilities" xlink:href="cpix-20161231.xsd#OtherCurrentLiabilities" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/OtherCurrentLiabilitiesScheduleOfAccruedLiabilitiesDetails" xlink:href="cpix-20161231.xsd#OtherCurrentLiabilitiesScheduleOfAccruedLiabilitiesDetails" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/OtherCurrentLiabilitiesTables" xlink:href="cpix-20161231.xsd#OtherCurrentLiabilitiesTables" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/PropertyAndEquipment" xlink:href="cpix-20161231.xsd#PropertyAndEquipment" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/PropertyAndEquipmentNarrativeDetails" xlink:href="cpix-20161231.xsd#PropertyAndEquipmentNarrativeDetails" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/PropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails" xlink:href="cpix-20161231.xsd#PropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/PropertyAndEquipmentTables" xlink:href="cpix-20161231.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/QuarterlyFinancialInformationScheduleOfQuarterlyFinancialInformationUnauditedDetails" xlink:href="cpix-20161231.xsd#QuarterlyFinancialInformationScheduleOfQuarterlyFinancialInformationUnauditedDetails" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/QuarterlyFinancialInformationUnaudited" xlink:href="cpix-20161231.xsd#QuarterlyFinancialInformationUnaudited" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/QuarterlyFinancialInformationUnauditedTables" xlink:href="cpix-20161231.xsd#QuarterlyFinancialInformationUnauditedTables" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/Revenues" xlink:href="cpix-20161231.xsd#Revenues" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/RevenuesNarrativeDetails" xlink:href="cpix-20161231.xsd#RevenuesNarrativeDetails" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/RevenuesScheduleOfNetProductRevenuesByProductDetails" xlink:href="cpix-20161231.xsd#RevenuesScheduleOfNetProductRevenuesByProductDetails" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/RevenuesTables" xlink:href="cpix-20161231.xsd#RevenuesTables" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/ShareholdersEquity" xlink:href="cpix-20161231.xsd#ShareholdersEquity" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/ShareholdersEquityInitialPublicOfferingPreferredStockAndCommonStockNarrativeDetails" xlink:href="cpix-20161231.xsd#ShareholdersEquityInitialPublicOfferingPreferredStockAndCommonStockNarrativeDetails" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/ShareholdersEquityShareRepurchasesCumberlandEmergingTechnologiesNarrativeDetails" xlink:href="cpix-20161231.xsd#ShareholdersEquityShareRepurchasesCumberlandEmergingTechnologiesNarrativeDetails" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/ShareholdersEquityWarrantsNarrativeDetails" xlink:href="cpix-20161231.xsd#ShareholdersEquityWarrantsNarrativeDetails" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/SignificantAccountingPolicies" xlink:href="cpix-20161231.xsd#SignificantAccountingPolicies" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:href="cpix-20161231.xsd#SignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/SignificantAccountingPoliciesPolicies" xlink:href="cpix-20161231.xsd#SignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/SignificantAccountingPoliciesScheduleOfIntangibleAssetsUsefulLivesDetails" xlink:href="cpix-20161231.xsd#SignificantAccountingPoliciesScheduleOfIntangibleAssetsUsefulLivesDetails" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/SignificantAccountingPoliciesTables" xlink:href="cpix-20161231.xsd#SignificantAccountingPoliciesTables" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/StockBasedCompensationPlans" xlink:href="cpix-20161231.xsd#StockBasedCompensationPlans" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/StockBasedCompensationPlansNarrativeDetails" xlink:href="cpix-20161231.xsd#StockBasedCompensationPlansNarrativeDetails" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/StockBasedCompensationPlansScheduleOfRestrictedStockActivityDetails" xlink:href="cpix-20161231.xsd#StockBasedCompensationPlansScheduleOfRestrictedStockActivityDetails" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/StockBasedCompensationPlansScheduleOfShareBasedCompensationExpenseDetails" xlink:href="cpix-20161231.xsd#StockBasedCompensationPlansScheduleOfShareBasedCompensationExpenseDetails" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/StockBasedCompensationPlansScheduleOfStockOptionActivityAdditionalDisclosuresDetails" xlink:href="cpix-20161231.xsd#StockBasedCompensationPlansScheduleOfStockOptionActivityAdditionalDisclosuresDetails" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/StockBasedCompensationPlansScheduleOfStockOptionsActivityDetails" xlink:href="cpix-20161231.xsd#StockBasedCompensationPlansScheduleOfStockOptionsActivityDetails" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/StockBasedCompensationPlansTables" xlink:href="cpix-20161231.xsd#StockBasedCompensationPlansTables" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/ValuationAndQualifyingAccounts" xlink:href="cpix-20161231.xsd#ValuationAndQualifyingAccounts" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/ValuationAndQualifyingAccountsDetails" xlink:href="cpix-20161231.xsd#ValuationAndQualifyingAccountsDetails" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/VaprisolOmeclamoxPakEthyolAndMethotrexate" xlink:href="cpix-20161231.xsd#VaprisolOmeclamoxPakEthyolAndMethotrexate" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/VaprisolOmeclamoxPakEthyolAndMethotrexateAssetsAndLiabilitiesAssumedDetails" xlink:href="cpix-20161231.xsd#VaprisolOmeclamoxPakEthyolAndMethotrexateAssetsAndLiabilitiesAssumedDetails" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/VaprisolOmeclamoxPakEthyolAndMethotrexateNarrativeDetails" xlink:href="cpix-20161231.xsd#VaprisolOmeclamoxPakEthyolAndMethotrexateNarrativeDetails" xlink:type="simple" />
  <roleRef roleURI="http://cumberlandpharma.com/role/VaprisolOmeclamoxPakEthyolAndMethotrexateTables" xlink:href="cpix-20161231.xsd#VaprisolOmeclamoxPakEthyolAndMethotrexateTables" xlink:type="simple" />
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <presentationLink xlink:role="http://cumberlandpharma.com/role/CommitmentsAndContingencies" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_97A6C556C2115AEC95E40209F8B18C7A" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_4E065FF8DCA553778A541FF57888E7B2" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_97A6C556C2115AEC95E40209F8B18C7A" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_4E065FF8DCA553778A541FF57888E7B2" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/CommitmentsAndContingenciesLegalMattersNarrativeDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_501CB1B34F535620B5541D306860B496" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="loc_us-gaap_LossContingenciesTable_46AF49C09D2A5C5688F4A508DD7BEADE" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_501CB1B34F535620B5541D306860B496" xlink:to="loc_us-gaap_LossContingenciesTable_46AF49C09D2A5C5688F4A508DD7BEADE" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductOrServiceAxis" xlink:label="loc_us-gaap_ProductOrServiceAxis_D4EFC09A7345544B839A080CDE1EA4EA" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_46AF49C09D2A5C5688F4A508DD7BEADE" xlink:to="loc_us-gaap_ProductOrServiceAxis_D4EFC09A7345544B839A080CDE1EA4EA" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductsAndServicesDomain" xlink:label="loc_us-gaap_ProductsAndServicesDomain_68304EBE3D595748B8FA1A7104173C2E" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductOrServiceAxis_D4EFC09A7345544B839A080CDE1EA4EA" xlink:to="loc_us-gaap_ProductsAndServicesDomain_68304EBE3D595748B8FA1A7104173C2E" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_AcetadoteMember" xlink:label="loc_cpix_AcetadoteMember_213DAE8C0622569EBC7254292AC2BCBB" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductsAndServicesDomain_68304EBE3D595748B8FA1A7104173C2E" xlink:to="loc_cpix_AcetadoteMember_213DAE8C0622569EBC7254292AC2BCBB" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_CEEDF17E00E35DB691CD05CC19B8F2AD" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_46AF49C09D2A5C5688F4A508DD7BEADE" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_CEEDF17E00E35DB691CD05CC19B8F2AD" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LossContingencyNatureDomain" xlink:label="loc_us-gaap_LossContingencyNatureDomain_DC522876668855B5830D8B6B322C4D26" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_CEEDF17E00E35DB691CD05CC19B8F2AD" xlink:to="loc_us-gaap_LossContingencyNatureDomain_DC522876668855B5830D8B6B322C4D26" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_PatentInfringementMember" xlink:label="loc_cpix_PatentInfringementMember_A583C003D83D5DFF90828B353540C073" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_DC522876668855B5830D8B6B322C4D26" xlink:to="loc_cpix_PatentInfringementMember_A583C003D83D5DFF90828B353540C073" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="loc_us-gaap_LossContingenciesLineItems_E203A3D2C6EB522DA469C90BCAE3192B" xlink:type="locator" />
    <presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_46AF49C09D2A5C5688F4A508DD7BEADE" xlink:to="loc_us-gaap_LossContingenciesLineItems_E203A3D2C6EB522DA469C90BCAE3192B" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_NumberOfLawsuitsFiledAsPlaintiff" xlink:label="loc_cpix_NumberOfLawsuitsFiledAsPlaintiff_79E7C0BD81A355E19366851A3F32C7E1" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_E203A3D2C6EB522DA469C90BCAE3192B" xlink:to="loc_cpix_NumberOfLawsuitsFiledAsPlaintiff_79E7C0BD81A355E19366851A3F32C7E1" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_NumberOfCompaniesForWhichLitigationSettlementExists" xlink:label="loc_cpix_NumberOfCompaniesForWhichLitigationSettlementExists_DF0EB4FBA41F5D7093114508831495FF" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_E203A3D2C6EB522DA469C90BCAE3192B" xlink:to="loc_cpix_NumberOfCompaniesForWhichLitigationSettlementExists_DF0EB4FBA41F5D7093114508831495FF" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0CD7F5AF0A770AD4129E8FDD1A53B00E" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_53E1CF103A0FE565D7E28FDD1A54554B" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0CD7F5AF0A770AD4129E8FDD1A53B00E" xlink:to="loc_us-gaap_AssetsAbstract_53E1CF103A0FE565D7E28FDD1A54554B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_B8AC975149392B03081E8FDD1A540CC1" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_53E1CF103A0FE565D7E28FDD1A54554B" xlink:to="loc_us-gaap_AssetsCurrentAbstract_B8AC975149392B03081E8FDD1A540CC1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_C6CCD434C23878D75E408FDD1A54DB17" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_B8AC975149392B03081E8FDD1A540CC1" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_C6CCD434C23878D75E408FDD1A54DB17" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_72B245BDF74FDA15174C8FDD1A546ACF" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_B8AC975149392B03081E8FDD1A540CC1" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_72B245BDF74FDA15174C8FDD1A546ACF" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_0DD20C59CC087C7761778FDD1A549AAB" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_B8AC975149392B03081E8FDD1A540CC1" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_0DD20C59CC087C7761778FDD1A549AAB" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_6860DE7022FB71220EDF8FDD1A546C70" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_B8AC975149392B03081E8FDD1A540CC1" xlink:to="loc_us-gaap_InventoryNet_6860DE7022FB71220EDF8FDD1A546C70" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_7CBFDB0A97EE78BE78198FDD1A54D235" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_B8AC975149392B03081E8FDD1A540CC1" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_7CBFDB0A97EE78BE78198FDD1A54D235" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_907BBCD33E40EA525A2D8FDD1A54BC63" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_B8AC975149392B03081E8FDD1A540CC1" xlink:to="loc_us-gaap_AssetsCurrent_907BBCD33E40EA525A2D8FDD1A54BC63" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_45571CEE7FFB1E12E25E8FDD1A542E57" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_53E1CF103A0FE565D7E28FDD1A54554B" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_45571CEE7FFB1E12E25E8FDD1A542E57" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_93F88133632BF33F91998FDD1A54A2C5" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_53E1CF103A0FE565D7E28FDD1A54554B" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_93F88133632BF33F91998FDD1A54A2C5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNetNoncurrent" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNetNoncurrent_0B87EC4CC258C766DDBF8FDD1A545909" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_53E1CF103A0FE565D7E28FDD1A54554B" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNetNoncurrent_0B87EC4CC258C766DDBF8FDD1A545909" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_8E6180D578C40CDF9DA88FDD1A547A55" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_53E1CF103A0FE565D7E28FDD1A54554B" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_8E6180D578C40CDF9DA88FDD1A547A55" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_453C8E1A0C94A91EC77F8FDD1A54B40D" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_53E1CF103A0FE565D7E28FDD1A54554B" xlink:to="loc_us-gaap_Assets_453C8E1A0C94A91EC77F8FDD1A54B40D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_D30A3FE331DCE417232D8FDD1A5519DB" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0CD7F5AF0A770AD4129E8FDD1A53B00E" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_D30A3FE331DCE417232D8FDD1A5519DB" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_AF4A27D18A3598D9B4438FDD1A55888E" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_D30A3FE331DCE417232D8FDD1A5519DB" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_AF4A27D18A3598D9B4438FDD1A55888E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_F07D95E467F94F9CA3A68FDD1A55CA1E" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_AF4A27D18A3598D9B4438FDD1A55888E" xlink:to="loc_us-gaap_AccountsPayableCurrent_F07D95E467F94F9CA3A68FDD1A55CA1E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_B62F619AE12DB53144EE8FDD1A554D48" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_AF4A27D18A3598D9B4438FDD1A55888E" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_B62F619AE12DB53144EE8FDD1A554D48" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_040A87C49A9CBD272D568FDD1A5565D3" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_AF4A27D18A3598D9B4438FDD1A55888E" xlink:to="loc_us-gaap_LiabilitiesCurrent_040A87C49A9CBD272D568FDD1A5565D3" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermLineOfCredit" xlink:label="loc_us-gaap_LongTermLineOfCredit_1DF0A3236513213B09618FDD1A551566" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_D30A3FE331DCE417232D8FDD1A5519DB" xlink:to="loc_us-gaap_LongTermLineOfCredit_1DF0A3236513213B09618FDD1A551566" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_C72486330709EC57F8418FDD1A550031" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_D30A3FE331DCE417232D8FDD1A5519DB" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_C72486330709EC57F8418FDD1A550031" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_E8DD18B9E84FD5FAC5778FDD1A55B250" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_D30A3FE331DCE417232D8FDD1A5519DB" xlink:to="loc_us-gaap_Liabilities_E8DD18B9E84FD5FAC5778FDD1A55B250" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_4886B32EB2E0771745E78FDD1A553EE2" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_D30A3FE331DCE417232D8FDD1A5519DB" xlink:to="loc_us-gaap_CommitmentsAndContingencies_4886B32EB2E0771745E78FDD1A553EE2" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_B3DBEB300A5FEAE921A38FDD1A5528C3" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_D30A3FE331DCE417232D8FDD1A5519DB" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_B3DBEB300A5FEAE921A38FDD1A5528C3" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_58B4105E8109C0F3AE188FDD1A550D77" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_B3DBEB300A5FEAE921A38FDD1A5528C3" xlink:to="loc_us-gaap_StockholdersEquityAbstract_58B4105E8109C0F3AE188FDD1A550D77" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockValueOutstanding" xlink:label="loc_us-gaap_CommonStockValueOutstanding_39014E9C53B5B0326BDC8FDD1A556B72" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_58B4105E8109C0F3AE188FDD1A550D77" xlink:to="loc_us-gaap_CommonStockValueOutstanding_39014E9C53B5B0326BDC8FDD1A556B72" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_CD0A2F828A1F5E7D90AC8FDD1A5509B4" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_58B4105E8109C0F3AE188FDD1A550D77" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_CD0A2F828A1F5E7D90AC8FDD1A5509B4" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_9A8A5A6A0C5389B865238FDD1A553642" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_58B4105E8109C0F3AE188FDD1A550D77" xlink:to="loc_us-gaap_StockholdersEquity_9A8A5A6A0C5389B865238FDD1A553642" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaap_MinorityInterest_50590678FD4E7EE405CB8FDD1A551EDD" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_B3DBEB300A5FEAE921A38FDD1A5528C3" xlink:to="loc_us-gaap_MinorityInterest_50590678FD4E7EE405CB8FDD1A551EDD" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_EFE3CF7C2501B113887F8FDD1A55624F" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_B3DBEB300A5FEAE921A38FDD1A5528C3" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_EFE3CF7C2501B113887F8FDD1A55624F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_346C4EEA840E5388AD0C8FDD1A565500" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_D30A3FE331DCE417232D8FDD1A5519DB" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_346C4EEA840E5388AD0C8FDD1A565500" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_177B0FC84DBE56659C90E0EF821AA9C5" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockNoParValue" xlink:label="loc_us-gaap_CommonStockNoParValue_E24F3ED69BF4539CBA5EFED70B372DE7" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_177B0FC84DBE56659C90E0EF821AA9C5" xlink:to="loc_us-gaap_CommonStockNoParValue_E24F3ED69BF4539CBA5EFED70B372DE7" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_6511C479819C5EB89537133413D4FE05" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_177B0FC84DBE56659C90E0EF821AA9C5" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_6511C479819C5EB89537133413D4FE05" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_423B9F65005E52B8BD4F072A35114885" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_177B0FC84DBE56659C90E0EF821AA9C5" xlink:to="loc_us-gaap_CommonStockSharesIssued_423B9F65005E52B8BD4F072A35114885" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_57E0CD5B29215420994BF09D2C87FA93" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_177B0FC84DBE56659C90E0EF821AA9C5" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_57E0CD5B29215420994BF09D2C87FA93" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_BEA4E38922E7FA5ED2ECAE90BF7ACEE7" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_081525247B55AED14E79AE90BF7A8A7E" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_BEA4E38922E7FA5ED2ECAE90BF7ACEE7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_081525247B55AED14E79AE90BF7A8A7E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_FC97292B5963673AEC8DAE90BF7A2519" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_081525247B55AED14E79AE90BF7A8A7E" xlink:to="loc_us-gaap_ProfitLoss_FC97292B5963673AEC8DAE90BF7A2519" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1A4D5169C7D850F26864AE90BF7A8677" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_081525247B55AED14E79AE90BF7A8A7E" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1A4D5169C7D850F26864AE90BF7A8677" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_810B5BB9AF878F551435AE90BF7AC088" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1A4D5169C7D850F26864AE90BF7A8677" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_810B5BB9AF878F551435AE90BF7AC088" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_074C02CC93ECDB676451AE90BF7B78AB" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1A4D5169C7D850F26864AE90BF7A8677" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_074C02CC93ECDB676451AE90BF7B78AB" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_D1ACC98138CE13741538AE90BF7B4168" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1A4D5169C7D850F26864AE90BF7A8677" xlink:to="loc_us-gaap_ShareBasedCompensation_D1ACC98138CE13741538AE90BF7B4168" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities" xlink:label="loc_us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities_EA644C935DA276806F6BAE90BF7B88F6" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1A4D5169C7D850F26864AE90BF7A8677" xlink:to="loc_us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities_EA644C935DA276806F6BAE90BF7B88F6" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_1047F22FDE9881FA0B99AE90BF7B0790" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1A4D5169C7D850F26864AE90BF7A8677" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_1047F22FDE9881FA0B99AE90BF7B0790" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherNonoperatingGainsLosses" xlink:label="loc_us-gaap_OtherNonoperatingGainsLosses_37803C1E127DF46E623AAE90BF7B1922" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1A4D5169C7D850F26864AE90BF7A8677" xlink:to="loc_us-gaap_OtherNonoperatingGainsLosses_37803C1E127DF46E623AAE90BF7B1922" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_A7ED5C499BA5670DAC31AE90BF7B78DF" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1A4D5169C7D850F26864AE90BF7A8677" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_A7ED5C499BA5670DAC31AE90BF7B78DF" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_D746C4F421FB854EB3B2AE90BF7BC403" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_A7ED5C499BA5670DAC31AE90BF7B78DF" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_D746C4F421FB854EB3B2AE90BF7BC403" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_79DCFB7A24A414EDB5B8AE90BF7BACCF" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_A7ED5C499BA5670DAC31AE90BF7B78DF" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_79DCFB7A24A414EDB5B8AE90BF7BACCF" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_09D22B6C0DF4C9B04B7DAE90BF7B3AF5" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_A7ED5C499BA5670DAC31AE90BF7B78DF" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_09D22B6C0DF4C9B04B7DAE90BF7B3AF5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_48F11AF68B5C2E91CCD8AE90BF7B4909" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_A7ED5C499BA5670DAC31AE90BF7B78DF" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_48F11AF68B5C2E91CCD8AE90BF7B4909" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_0478295D28A25F26AC6FAE90BF7BFB54" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_A7ED5C499BA5670DAC31AE90BF7B78DF" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_0478295D28A25F26AC6FAE90BF7BFB54" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_05BA04097C398C147BECAE90BF7BF652" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_081525247B55AED14E79AE90BF7A8A7E" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_05BA04097C398C147BECAE90BF7BF652" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_C045AE72E816802A5227AE90BF7B416E" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_BEA4E38922E7FA5ED2ECAE90BF7ACEE7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_C045AE72E816802A5227AE90BF7B416E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0BF96F1FBBF1CCF72CC9AE90BF7C3E61" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_C045AE72E816802A5227AE90BF7B416E" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0BF96F1FBBF1CCF72CC9AE90BF7C3E61" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_05C5C80F3CDE731ADAD6AE90BF7C84DC" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_C045AE72E816802A5227AE90BF7B416E" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_05C5C80F3CDE731ADAD6AE90BF7C84DC" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_283616654860A6184E1BAE90BF7C2709" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_C045AE72E816802A5227AE90BF7B416E" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_283616654860A6184E1BAE90BF7C2709" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_9420D3A2DDABC9B62EC7AE90BF7CD6EA" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_C045AE72E816802A5227AE90BF7B416E" xlink:to="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_9420D3A2DDABC9B62EC7AE90BF7CD6EA" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_BC81D4BADB6E19969F9EAE90BF7CAA1E" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_C045AE72E816802A5227AE90BF7B416E" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_BC81D4BADB6E19969F9EAE90BF7CAA1E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2BB459E79379DA8046F4AE90BF7CE4C1" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_C045AE72E816802A5227AE90BF7B416E" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2BB459E79379DA8046F4AE90BF7CE4C1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_A201CAC0D5BF6EB5AA72AE90BF7CDAC2" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_BEA4E38922E7FA5ED2ECAE90BF7ACEE7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_A201CAC0D5BF6EB5AA72AE90BF7CDAC2" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_3373EA2548C310F8F3E3AE90BF7C3917" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_A201CAC0D5BF6EB5AA72AE90BF7CDAC2" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_3373EA2548C310F8F3E3AE90BF7C3917" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_7DE70ECE11DDA6F80B3EAE90BF7C28E3" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_A201CAC0D5BF6EB5AA72AE90BF7CDAC2" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_7DE70ECE11DDA6F80B3EAE90BF7C28E3" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_298E2FCD0176B321B480AE90BF7C3ED8" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_A201CAC0D5BF6EB5AA72AE90BF7CDAC2" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_298E2FCD0176B321B480AE90BF7C3ED8" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_B61AAAEA6993E7D3EC91AE90BF7C796F" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_A201CAC0D5BF6EB5AA72AE90BF7CDAC2" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_B61AAAEA6993E7D3EC91AE90BF7C796F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders_4B9E522F82C998FAA048AE90BF7C6F29" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_A201CAC0D5BF6EB5AA72AE90BF7CDAC2" xlink:to="loc_us-gaap_ProceedsFromMinorityShareholders_4B9E522F82C998FAA048AE90BF7C6F29" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities" xlink:label="loc_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_BC8C7338BBD5DDF8B411AE90BF7C65AF" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_A201CAC0D5BF6EB5AA72AE90BF7CDAC2" xlink:to="loc_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_BC8C7338BBD5DDF8B411AE90BF7C65AF" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_FD43CD517167241BD978AE90BF7C03AD" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_A201CAC0D5BF6EB5AA72AE90BF7CDAC2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_FD43CD517167241BD978AE90BF7C03AD" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_ACF5AF77783B172F9C99AE90BF7CC23A" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_BEA4E38922E7FA5ED2ECAE90BF7ACEE7" xlink:to="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_ACF5AF77783B172F9C99AE90BF7CC23A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_F2CDB44E673B3CC9B8EAAE90BF7C56D8" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_BEA4E38922E7FA5ED2ECAE90BF7ACEE7" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_F2CDB44E673B3CC9B8EAAE90BF7C56D8" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_DFAD2FF819DBB4611343AE90BF7C60B6" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_BEA4E38922E7FA5ED2ECAE90BF7ACEE7" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_DFAD2FF819DBB4611343AE90BF7C60B6" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_4F89F27EA21D6DC96610AE90BF7D301D" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_BEA4E38922E7FA5ED2ECAE90BF7ACEE7" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_4F89F27EA21D6DC96610AE90BF7D301D" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_CashPaidDuringYearForAbstract" xlink:label="loc_cpix_CashPaidDuringYearForAbstract_0B7287BBDFB69CA6CF98AE90BF7D1171" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_4F89F27EA21D6DC96610AE90BF7D301D" xlink:to="loc_cpix_CashPaidDuringYearForAbstract_0B7287BBDFB69CA6CF98AE90BF7D1171" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestPaid" xlink:label="loc_us-gaap_InterestPaid_3CABD8C4A389417CD14FAE90BF7D8B7A" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_CashPaidDuringYearForAbstract_0B7287BBDFB69CA6CF98AE90BF7D1171" xlink:to="loc_us-gaap_InterestPaid_3CABD8C4A389417CD14FAE90BF7D8B7A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_34049D1CFBE9E2A10150AEC222F4F792" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_CashPaidDuringYearForAbstract_0B7287BBDFB69CA6CF98AE90BF7D1171" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_34049D1CFBE9E2A10150AEC222F4F792" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_C748324F78A527C7E577AE90BF7DC69F" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_4F89F27EA21D6DC96610AE90BF7D301D" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_C748324F78A527C7E577AE90BF7DC69F" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_PurchasesOfIntangibleAssetsIncurredButNotYetPaid" xlink:label="loc_cpix_PurchasesOfIntangibleAssetsIncurredButNotYetPaid_FEAD786E72C2FF45FC9BAE90BF7D0E6C" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_C748324F78A527C7E577AE90BF7DC69F" xlink:to="loc_cpix_PurchasesOfIntangibleAssetsIncurredButNotYetPaid_FEAD786E72C2FF45FC9BAE90BF7D0E6C" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/ConsolidatedStatementsOfEquity" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_B9C781949DE1445F3336902063A0F474" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_DD7D8FBDC0D6738BFABE902063A0C9B8" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_B9C781949DE1445F3336902063A0F474" xlink:to="loc_us-gaap_StatementTable_DD7D8FBDC0D6738BFABE902063A0C9B8" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_BCE9CCB8F8F67D0CD940902063A0A5EF" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_DD7D8FBDC0D6738BFABE902063A0C9B8" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_BCE9CCB8F8F67D0CD940902063A0A5EF" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_841FC3E233A9AD623475902063A07330" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_BCE9CCB8F8F67D0CD940902063A0A5EF" xlink:to="loc_us-gaap_EquityComponentDomain_841FC3E233A9AD623475902063A07330" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_FAFC208EDCD8E7F9392A902063A157E8" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_841FC3E233A9AD623475902063A07330" xlink:to="loc_us-gaap_CommonStockMember_FAFC208EDCD8E7F9392A902063A157E8" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_F48931D93FBAE3906825902063A1770F" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_841FC3E233A9AD623475902063A07330" xlink:to="loc_us-gaap_RetainedEarningsMember_F48931D93FBAE3906825902063A1770F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaap_NoncontrollingInterestMember_BC8D34D0D72CE320B45A902063A1D4EF" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_841FC3E233A9AD623475902063A07330" xlink:to="loc_us-gaap_NoncontrollingInterestMember_BC8D34D0D72CE320B45A902063A1D4EF" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_4024F57207AC4BEB7269902063A173FD" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_DD7D8FBDC0D6738BFABE902063A0C9B8" xlink:to="loc_us-gaap_StatementLineItems_4024F57207AC4BEB7269902063A173FD" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9A027E0214E8A10013AC902063A14AD9" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4024F57207AC4BEB7269902063A173FD" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9A027E0214E8A10013AC902063A14AD9" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_3755AABC8CBB31125D40902063A1E9A0" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9A027E0214E8A10013AC902063A14AD9" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_3755AABC8CBB31125D40902063A1E9A0" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_B1D9578DE9D705DB00CD902063A13E9E" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9A027E0214E8A10013AC902063A14AD9" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_B1D9578DE9D705DB00CD902063A13E9E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_8CAC41C46D872466D1D7902063A11443" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9A027E0214E8A10013AC902063A14AD9" xlink:to="loc_us-gaap_NetIncomeLoss_8CAC41C46D872466D1D7902063A11443" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_7966C1B195FF41AA59C8902063A165DA" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9A027E0214E8A10013AC902063A14AD9" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_7966C1B195FF41AA59C8902063A165DA" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_0BDADA38E4CC20C4153F902063A17C63" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9A027E0214E8A10013AC902063A14AD9" xlink:to="loc_us-gaap_ProfitLoss_0BDADA38E4CC20C4153F902063A17C63" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_96A4240EE240B7719F80902063A166D9" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9A027E0214E8A10013AC902063A14AD9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_96A4240EE240B7719F80902063A166D9" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_202318ED5DFC6DB3B9B2902063A1AAA2" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9A027E0214E8A10013AC902063A14AD9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_202318ED5DFC6DB3B9B2902063A1AAA2" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodNetOfSharesForTaxWithholding" xlink:label="loc_cpix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodNetOfSharesForTaxWithholding_757B50BF452599943C02902063A1D9FC" xlink:type="locator" />
    <presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9A027E0214E8A10013AC902063A14AD9" xlink:to="loc_cpix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodNetOfSharesForTaxWithholding_757B50BF452599943C02902063A1D9FC" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_64BA8F4E8EF239BC74AA902063A12413" xlink:type="locator" />
    <presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9A027E0214E8A10013AC902063A14AD9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_64BA8F4E8EF239BC74AA902063A12413" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_36804AAB2C5CE1C2A927902063A10B5B" xlink:type="locator" />
    <presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9A027E0214E8A10013AC902063A14AD9" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_36804AAB2C5CE1C2A927902063A10B5B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_111C3B811EC73B404598902063A1D67A" xlink:type="locator" />
    <presentationArc order="11" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9A027E0214E8A10013AC902063A14AD9" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_111C3B811EC73B404598902063A1D67A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_562AD750375F869BE180902063A1B0C7" xlink:type="locator" />
    <presentationArc order="12" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9A027E0214E8A10013AC902063A14AD9" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_562AD750375F869BE180902063A1B0C7" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_332DCDB834528FBE3D01902063A281EF" xlink:type="locator" />
    <presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9A027E0214E8A10013AC902063A14AD9" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_332DCDB834528FBE3D01902063A281EF" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_F116948FD1679B8260D9902063A27EFD" xlink:type="locator" />
    <presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9A027E0214E8A10013AC902063A14AD9" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_F116948FD1679B8260D9902063A27EFD" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/ConsolidatedStatementsOfIncomeAndComprehensiveIncomeLoss" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_0DCB67765734B714F5CF8FDD19F9064D" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaap_RevenuesAbstract_0870CC4801D47925DD1B8FDD19F9B097" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0DCB67765734B714F5CF8FDD19F9064D" xlink:to="loc_us-gaap_RevenuesAbstract_0870CC4801D47925DD1B8FDD19F9B097" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesRevenueGoodsNet" xlink:label="loc_us-gaap_SalesRevenueGoodsNet_8EA0C7F6ED4FBA66B6808FDD19F93977" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_0870CC4801D47925DD1B8FDD19F9B097" xlink:to="loc_us-gaap_SalesRevenueGoodsNet_8EA0C7F6ED4FBA66B6808FDD19F93977" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherSalesRevenueNet" xlink:label="loc_us-gaap_OtherSalesRevenueNet_2876609B598CB03920BC8FDD19F91233" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_0870CC4801D47925DD1B8FDD19F9B097" xlink:to="loc_us-gaap_OtherSalesRevenueNet_2876609B598CB03920BC8FDD19F91233" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaap_SalesRevenueNet_EABA47B69A2D2C3BD5068FDD19F92DBB" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_0870CC4801D47925DD1B8FDD19F9B097" xlink:to="loc_us-gaap_SalesRevenueNet_EABA47B69A2D2C3BD5068FDD19F92DBB" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_D5AA84BABA486108477F8FDD19F956EF" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0DCB67765734B714F5CF8FDD19F9064D" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_D5AA84BABA486108477F8FDD19F956EF" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CostOfGoodsSold" xlink:label="loc_us-gaap_CostOfGoodsSold_8545B9F914814DDD8C4C8FDD19FA0B77" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_D5AA84BABA486108477F8FDD19F956EF" xlink:to="loc_us-gaap_CostOfGoodsSold_8545B9F914814DDD8C4C8FDD19FA0B77" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaap_SellingAndMarketingExpense_0352AF6BF5FE07EC48698FDD19FADCF2" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_D5AA84BABA486108477F8FDD19F956EF" xlink:to="loc_us-gaap_SellingAndMarketingExpense_0352AF6BF5FE07EC48698FDD19FADCF2" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_E919E95DAE6FD826ACD28FDD19FAF433" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_D5AA84BABA486108477F8FDD19F956EF" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_E919E95DAE6FD826ACD28FDD19FAF433" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_A0214A952719D46CFAB08FDD19FA7812" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_D5AA84BABA486108477F8FDD19F956EF" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_A0214A952719D46CFAB08FDD19FA7812" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_9BDBCF6D27CC0E3F720F8FDD19FA0BFA" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_D5AA84BABA486108477F8FDD19F956EF" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_9BDBCF6D27CC0E3F720F8FDD19FA0BFA" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaap_CostsAndExpenses_3F4F8B8D5BEB4C2AB8668FDD19FA3D08" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_D5AA84BABA486108477F8FDD19F956EF" xlink:to="loc_us-gaap_CostsAndExpenses_3F4F8B8D5BEB4C2AB8668FDD19FA3D08" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_124ABE8867DB333728C28FDD19FAA2A4" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0DCB67765734B714F5CF8FDD19F9064D" xlink:to="loc_us-gaap_OperatingIncomeLoss_124ABE8867DB333728C28FDD19FAA2A4" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaap_InvestmentIncomeInterest_FEE36FA57988158A8FE28FDD19FA9D41" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0DCB67765734B714F5CF8FDD19F9064D" xlink:to="loc_us-gaap_InvestmentIncomeInterest_FEE36FA57988158A8FE28FDD19FA9D41" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_E9F4895FBC826FF7815A8FDD19FA4280" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0DCB67765734B714F5CF8FDD19F9064D" xlink:to="loc_us-gaap_InterestExpense_E9F4895FBC826FF7815A8FDD19FA4280" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_FE006187AD9BF6B71D968FDD19FA2688" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0DCB67765734B714F5CF8FDD19F9064D" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_FE006187AD9BF6B71D968FDD19FA2688" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_A62B2B3F8C1049D3DC168FDD19FAD115" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0DCB67765734B714F5CF8FDD19F9064D" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_A62B2B3F8C1049D3DC168FDD19FAD115" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_5EDB0B8A22490C7FF0258FDD19FAA22E" xlink:type="locator" />
    <presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0DCB67765734B714F5CF8FDD19F9064D" xlink:to="loc_us-gaap_ProfitLoss_5EDB0B8A22490C7FF0258FDD19FAA22E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_15E86571316762CC453B8FDD19FAAE6E" xlink:type="locator" />
    <presentationArc order="9" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0DCB67765734B714F5CF8FDD19F9064D" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_15E86571316762CC453B8FDD19FAAE6E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_5BE5CBD0C8978470FDD18FDD19FA8B77" xlink:type="locator" />
    <presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0DCB67765734B714F5CF8FDD19F9064D" xlink:to="loc_us-gaap_NetIncomeLoss_5BE5CBD0C8978470FDD18FDD19FA8B77" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_5A5C12957EE77244E3EA8FDD19FABDC7" xlink:type="locator" />
    <presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0DCB67765734B714F5CF8FDD19F9064D" xlink:to="loc_us-gaap_EarningsPerShareAbstract_5A5C12957EE77244E3EA8FDD19FABDC7" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_F189C080572C4B0F55EA8FDD19FA50B1" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5A5C12957EE77244E3EA8FDD19FABDC7" xlink:to="loc_us-gaap_EarningsPerShareBasic_F189C080572C4B0F55EA8FDD19FA50B1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_A1BF42F329341D20EE108FDD19FEF5A2" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5A5C12957EE77244E3EA8FDD19FABDC7" xlink:to="loc_us-gaap_EarningsPerShareDiluted_A1BF42F329341D20EE108FDD19FEF5A2" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_53753A88E80426C05B298FDD19FE444D" xlink:type="locator" />
    <presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0DCB67765734B714F5CF8FDD19F9064D" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_53753A88E80426C05B298FDD19FE444D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_B00007FA37433C4563CC8FDD19FEFB1D" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_53753A88E80426C05B298FDD19FE444D" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_B00007FA37433C4563CC8FDD19FEFB1D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_DE60C5C85B33CAE17F3D8FDD19FE05C8" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_53753A88E80426C05B298FDD19FE444D" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_DE60C5C85B33CAE17F3D8FDD19FE05C8" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_EBA4380B427E2179B06C8FDD19FE739A" xlink:type="locator" />
    <presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0DCB67765734B714F5CF8FDD19F9064D" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_EBA4380B427E2179B06C8FDD19FE739A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_E6EBD3571727DF539BE18FDD19FEB109" xlink:type="locator" />
    <presentationArc order="14" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0DCB67765734B714F5CF8FDD19F9064D" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_E6EBD3571727DF539BE18FDD19FEB109" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_B2F14AEB97613350C3E28FDD19FEA1FD" xlink:type="locator" />
    <presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0DCB67765734B714F5CF8FDD19F9064D" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_B2F14AEB97613350C3E28FDD19FEA1FD" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/Debt" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_F3689844EB4953C99851FBDC8C9AE928" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_9D4168018EE353018B7D0F698CDD3E6E" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_F3689844EB4953C99851FBDC8C9AE928" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_9D4168018EE353018B7D0F698CDD3E6E" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/DebtLineOfCreditDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_24B2DF5E58773DDE5E3A902063203855" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_7EFAA1C47B114964CA6B90206320914C" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_24B2DF5E58773DDE5E3A902063203855" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_7EFAA1C47B114964CA6B90206320914C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_C56333138BF468DD8D959020632043E3" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_7EFAA1C47B114964CA6B90206320914C" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_C56333138BF468DD8D959020632043E3" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_D15D93C069F79D6CD877902063209CED" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_C56333138BF468DD8D959020632043E3" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_D15D93C069F79D6CD877902063209CED" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_SunTrustBankMember" xlink:label="loc_cpix_SunTrustBankMember_05EDC5E185D5FFDBF136902063207E37" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_D15D93C069F79D6CD877902063209CED" xlink:to="loc_cpix_SunTrustBankMember_05EDC5E185D5FFDBF136902063207E37" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_4275D7C7CB2DC8001E5E90206320B89F" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_7EFAA1C47B114964CA6B90206320914C" xlink:to="loc_us-gaap_DebtInstrumentAxis_4275D7C7CB2DC8001E5E90206320B89F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_07840277C8D0D326F39190206320074A" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_4275D7C7CB2DC8001E5E90206320B89F" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_07840277C8D0D326F39190206320074A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LineOfCreditMember" xlink:label="loc_us-gaap_LineOfCreditMember_5E8311949AB2559733A590206320A37F" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_07840277C8D0D326F39190206320074A" xlink:to="loc_us-gaap_LineOfCreditMember_5E8311949AB2559733A590206320A37F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_9796A9B8834EAEFF6A47902063209D5D" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_7EFAA1C47B114964CA6B90206320914C" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_9796A9B8834EAEFF6A47902063209D5D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_62D8E7135FB0B31CB14E90206321B9A5" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_9796A9B8834EAEFF6A47902063209D5D" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_62D8E7135FB0B31CB14E90206321B9A5" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_CreditFacilityFifthAmendedAndRestatedLoanAgreementAgreementAugust2011Member" xlink:label="loc_cpix_CreditFacilityFifthAmendedAndRestatedLoanAgreementAgreementAugust2011Member_CBA082C779DAE34DC4AF90206321DB8E" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_62D8E7135FB0B31CB14E90206321B9A5" xlink:to="loc_cpix_CreditFacilityFifthAmendedAndRestatedLoanAgreementAgreementAugust2011Member_CBA082C779DAE34DC4AF90206321DB8E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_0695A0BDFA17C3119449902063214C09" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_7EFAA1C47B114964CA6B90206320914C" xlink:to="loc_us-gaap_CreditFacilityAxis_0695A0BDFA17C3119449902063214C09" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_B0B0906AB83B33E8D2F290206321FD14" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_0695A0BDFA17C3119449902063214C09" xlink:to="loc_us-gaap_CreditFacilityDomain_B0B0906AB83B33E8D2F290206321FD14" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_EF19F9BEC8B42E46DB0590206321EF1A" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_B0B0906AB83B33E8D2F290206321FD14" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_EF19F9BEC8B42E46DB0590206321EF1A" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_CreditFacilityByAmendmentDateAxis" xlink:label="loc_cpix_CreditFacilityByAmendmentDateAxis_99575FEA22BBCC83522390206321C379" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_7EFAA1C47B114964CA6B90206320914C" xlink:to="loc_cpix_CreditFacilityByAmendmentDateAxis_99575FEA22BBCC83522390206321C379" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_CreditFacilityByAmendmentDateDomain" xlink:label="loc_cpix_CreditFacilityByAmendmentDateDomain_6CBC1E51BA3DE715CA8690206321EDD9" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_CreditFacilityByAmendmentDateAxis_99575FEA22BBCC83522390206321C379" xlink:to="loc_cpix_CreditFacilityByAmendmentDateDomain_6CBC1E51BA3DE715CA8690206321EDD9" xlink:type="arc" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_CreditFacilityByAmendmentDateDomain_6CBC1E51BA3DE715CA8690206321EDD9" xlink:to="loc_cpix_CreditFacilityFifthAmendedAndRestatedLoanAgreementAgreementAugust2011Member_CBA082C779DAE34DC4AF90206321DB8E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_B3D0D9B03E7E96AAE3D5902063212AAD" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_7EFAA1C47B114964CA6B90206320914C" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_B3D0D9B03E7E96AAE3D5902063212AAD" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermLineOfCredit" xlink:label="loc_us-gaap_LongTermLineOfCredit_D0DEDE89F2D065C808C990206321C332" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_B3D0D9B03E7E96AAE3D5902063212AAD" xlink:to="loc_us-gaap_LongTermLineOfCredit_D0DEDE89F2D065C808C990206321C332" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_D36117A2E062C4C5EA7390206321C097" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_B3D0D9B03E7E96AAE3D5902063212AAD" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_D36117A2E062C4C5EA7390206321C097" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_LineOfCreditFacilityMaximumBorrowingCapacityUponSatisfactionOfCertainConditions" xlink:label="loc_cpix_LineOfCreditFacilityMaximumBorrowingCapacityUponSatisfactionOfCertainConditions_B674D4779982CB35EEF590206321C06A" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_B3D0D9B03E7E96AAE3D5902063212AAD" xlink:to="loc_cpix_LineOfCreditFacilityMaximumBorrowingCapacityUponSatisfactionOfCertainConditions_B674D4779982CB35EEF590206321C06A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentageRateRangeMinimum" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentageRateRangeMinimum_8D258FB1C97E1DC06D9A90206321A473" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_B3D0D9B03E7E96AAE3D5902063212AAD" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentageRateRangeMinimum_8D258FB1C97E1DC06D9A90206321A473" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentageRateRangeMaximum" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentageRateRangeMaximum_1730E1CD0272D134A900902063213404" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_B3D0D9B03E7E96AAE3D5902063212AAD" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentageRateRangeMaximum_1730E1CD0272D134A900902063213404" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_E125351311053701062D9020632227A9" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_B3D0D9B03E7E96AAE3D5902063212AAD" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_E125351311053701062D9020632227A9" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_337F3FF07C5038249F0290206322A7BA" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_B3D0D9B03E7E96AAE3D5902063212AAD" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_337F3FF07C5038249F0290206322A7BA" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsNet" xlink:label="loc_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsNet_CCEE1F6006B961E1BB51902063226F91" xlink:type="locator" />
    <presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_B3D0D9B03E7E96AAE3D5902063212AAD" xlink:to="loc_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsNet_CCEE1F6006B961E1BB51902063226F91" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/DocumentAndEntityInformation" xlink:type="extended">
    <loc xlink:href="cpix-20161231.xsd#cpix_DocumentAndEntityInformationAbstract" xlink:label="loc_cpix_DocumentAndEntityInformationAbstract_6BA50656251D5377BF43B3FA4AC1866C" xlink:type="locator" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_508327C5105A5BEEAE6EAC06A0287B4B" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_DocumentAndEntityInformationAbstract_6BA50656251D5377BF43B3FA4AC1866C" xlink:to="loc_dei_EntityRegistrantName_508327C5105A5BEEAE6EAC06A0287B4B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_D06B16EDF2BD51A79CA6D184E681FD5E" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_DocumentAndEntityInformationAbstract_6BA50656251D5377BF43B3FA4AC1866C" xlink:to="loc_dei_EntityCentralIndexKey_D06B16EDF2BD51A79CA6D184E681FD5E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_F5B24F87EEB75FFBAD986045E4594CAA" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_DocumentAndEntityInformationAbstract_6BA50656251D5377BF43B3FA4AC1866C" xlink:to="loc_dei_CurrentFiscalYearEndDate_F5B24F87EEB75FFBAD986045E4594CAA" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_3A918E52A1FC573A8F2EE4A73B5EE99A" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_DocumentAndEntityInformationAbstract_6BA50656251D5377BF43B3FA4AC1866C" xlink:to="loc_dei_EntityFilerCategory_3A918E52A1FC573A8F2EE4A73B5EE99A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_9E955AE8613D5901B11B8FBE0B20EE73" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_DocumentAndEntityInformationAbstract_6BA50656251D5377BF43B3FA4AC1866C" xlink:to="loc_dei_DocumentType_9E955AE8613D5901B11B8FBE0B20EE73" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_40074090994C546F84FF603666A43F93" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_DocumentAndEntityInformationAbstract_6BA50656251D5377BF43B3FA4AC1866C" xlink:to="loc_dei_DocumentPeriodEndDate_40074090994C546F84FF603666A43F93" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_8C0C6A9B0E2D553A8BAAB510C0E1212F" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_DocumentAndEntityInformationAbstract_6BA50656251D5377BF43B3FA4AC1866C" xlink:to="loc_dei_DocumentFiscalYearFocus_8C0C6A9B0E2D553A8BAAB510C0E1212F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_AD5CB091B01A52558763C1ECE056EF24" xlink:type="locator" />
    <presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_DocumentAndEntityInformationAbstract_6BA50656251D5377BF43B3FA4AC1866C" xlink:to="loc_dei_DocumentFiscalPeriodFocus_AD5CB091B01A52558763C1ECE056EF24" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_6B56CDF81F335977BAB2060C290ADB0A" xlink:type="locator" />
    <presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_DocumentAndEntityInformationAbstract_6BA50656251D5377BF43B3FA4AC1866C" xlink:to="loc_dei_AmendmentFlag_6B56CDF81F335977BAB2060C290ADB0A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_4705C37F7B1B5D108B6280C14AE78178" xlink:type="locator" />
    <presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_DocumentAndEntityInformationAbstract_6BA50656251D5377BF43B3FA4AC1866C" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_4705C37F7B1B5D108B6280C14AE78178" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_00C5DB90BB14554EB99276E8F5181049" xlink:type="locator" />
    <presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_DocumentAndEntityInformationAbstract_6BA50656251D5377BF43B3FA4AC1866C" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_00C5DB90BB14554EB99276E8F5181049" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_dei_EntityVoluntaryFilers_AE7EE01A5D7856D7A1E7E5DCE0DB6FFF" xlink:type="locator" />
    <presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_DocumentAndEntityInformationAbstract_6BA50656251D5377BF43B3FA4AC1866C" xlink:to="loc_dei_EntityVoluntaryFilers_AE7EE01A5D7856D7A1E7E5DCE0DB6FFF" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_5859618E51B651629FB598DEE0370ECB" xlink:type="locator" />
    <presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_DocumentAndEntityInformationAbstract_6BA50656251D5377BF43B3FA4AC1866C" xlink:to="loc_dei_EntityCurrentReportingStatus_5859618E51B651629FB598DEE0370ECB" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_dei_EntityPublicFloat_6D25FA31A7ED55F3B54152E575452210" xlink:type="locator" />
    <presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_DocumentAndEntityInformationAbstract_6BA50656251D5377BF43B3FA4AC1866C" xlink:to="loc_dei_EntityPublicFloat_6D25FA31A7ED55F3B54152E575452210" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/EarningsLossPerShare" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_20C0D3454F7DC1214EF7902062CCC156" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_61BE0C3E11B3746E992C902062CC37E7" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_20C0D3454F7DC1214EF7902062CCC156" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_61BE0C3E11B3746E992C902062CC37E7" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/EarningsLossPerShareScheduleOfAntiDilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_A408CC9FD1D547E55769902062B5009E" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_25013ACB8BBF25A75728902062B503DA" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_A408CC9FD1D547E55769902062B5009E" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_25013ACB8BBF25A75728902062B503DA" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/EarningsLossPerShareScheduleOfComputationOfNumeratorAndDenominatorInEarningsPerShareDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_92AAD392590D70784065902062BDFA10" xlink:type="locator" />
    <loc xlink:href="cpix-20161231.xsd#cpix_NumeratorAbstract" xlink:label="loc_cpix_NumeratorAbstract_8927EF5BB6FB01045E3A902062BDA07A" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_92AAD392590D70784065902062BDFA10" xlink:to="loc_cpix_NumeratorAbstract_8927EF5BB6FB01045E3A902062BDA07A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_5EC2D37C6620CD6A840B902062BD54C2" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_NumeratorAbstract_8927EF5BB6FB01045E3A902062BDA07A" xlink:to="loc_us-gaap_NetIncomeLoss_5EC2D37C6620CD6A840B902062BD54C2" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_DenominatorAbstract" xlink:label="loc_cpix_DenominatorAbstract_C17F44F47744FEBFD1E6902062BD2896" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_92AAD392590D70784065902062BDFA10" xlink:to="loc_cpix_DenominatorAbstract_C17F44F47744FEBFD1E6902062BD2896" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2A6049EF7EECA3DE7889902062BD00D1" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_DenominatorAbstract_C17F44F47744FEBFD1E6902062BD2896" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2A6049EF7EECA3DE7889902062BD00D1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_EBB0A64099B13EA97B14902062BDF1AB" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_DenominatorAbstract_C17F44F47744FEBFD1E6902062BD2896" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_EBB0A64099B13EA97B14902062BDF1AB" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5A1C8260397E300C686E902062BD05CA" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_DenominatorAbstract_C17F44F47744FEBFD1E6902062BD2896" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5A1C8260397E300C686E902062BD05CA" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/EarningsLossPerShareTables" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_6F770D66B6DFC65F0A0B902062C42E9E" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_974C97436577BE7CE1DB902062C43D07" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6F770D66B6DFC65F0A0B902062C42E9E" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_974C97436577BE7CE1DB902062C43D07" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_5A7AA1149545D4A96996902062C5479C" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6F770D66B6DFC65F0A0B902062C42E9E" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_5A7AA1149545D4A96996902062C5479C" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/EmployeeBenefitPlans" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_495C5EC08CC95086BB00E344CA40CFB7" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_418BF632EAF75EE39A2B08DD9FFD14B6" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_495C5EC08CC95086BB00E344CA40CFB7" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_418BF632EAF75EE39A2B08DD9FFD14B6" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/EmployeeBenefitPlansNarrativeDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_A0E71AFEF051549E8C002025A51A84E2" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DefinedContributionPensionAndOtherPostretirementPlansDisclosureAbstract" xlink:label="loc_us-gaap_DefinedContributionPensionAndOtherPostretirementPlansDisclosureAbstract_47E4791225475F24BC58383577145615" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_A0E71AFEF051549E8C002025A51A84E2" xlink:to="loc_us-gaap_DefinedContributionPensionAndOtherPostretirementPlansDisclosureAbstract_47E4791225475F24BC58383577145615" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_DefinedContributionPlanEligibilityMinimumEmployeeAge" xlink:label="loc_cpix_DefinedContributionPlanEligibilityMinimumEmployeeAge_43A4BDB2A45B5FC8BED88FEC2EDA4EA5" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedContributionPensionAndOtherPostretirementPlansDisclosureAbstract_47E4791225475F24BC58383577145615" xlink:to="loc_cpix_DefinedContributionPlanEligibilityMinimumEmployeeAge_43A4BDB2A45B5FC8BED88FEC2EDA4EA5" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_DefinedContributionPlanEligibilityMinimumEmployeeServiceTimeForParticipationEligibility" xlink:label="loc_cpix_DefinedContributionPlanEligibilityMinimumEmployeeServiceTimeForParticipationEligibility_C423C02A22F65EFBA2C9F40650383D96" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedContributionPensionAndOtherPostretirementPlansDisclosureAbstract_47E4791225475F24BC58383577145615" xlink:to="loc_cpix_DefinedContributionPlanEligibilityMinimumEmployeeServiceTimeForParticipationEligibility_C423C02A22F65EFBA2C9F40650383D96" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_4CF3A2CC44B4569AB8EA9764EEB5177B" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedContributionPensionAndOtherPostretirementPlansDisclosureAbstract_47E4791225475F24BC58383577145615" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_4CF3A2CC44B4569AB8EA9764EEB5177B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCompensationLiabilityAbstract" xlink:label="loc_us-gaap_DeferredCompensationLiabilityAbstract_E78005646AFF5B70858312BF24068889" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_A0E71AFEF051549E8C002025A51A84E2" xlink:to="loc_us-gaap_DeferredCompensationLiabilityAbstract_E78005646AFF5B70858312BF24068889" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent" xlink:label="loc_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent_66F9019CC5B25EAB8C3E8B5FB4CD88C1" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationLiabilityAbstract_E78005646AFF5B70858312BF24068889" xlink:to="loc_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent_66F9019CC5B25EAB8C3E8B5FB4CD88C1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCompensationPlanAssets" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets_495A6839A6835061951E18D4C92624CB" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationLiabilityAbstract_E78005646AFF5B70858312BF24068889" xlink:to="loc_us-gaap_DeferredCompensationPlanAssets_495A6839A6835061951E18D4C92624CB" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/EmploymentAgreements" xlink:type="extended">
    <loc xlink:href="cpix-20161231.xsd#cpix_EmploymentAgreementsAbstract" xlink:label="loc_cpix_EmploymentAgreementsAbstract_5B3BE82AF4405547AB29B10B46FD2F49" xlink:type="locator" />
    <loc xlink:href="cpix-20161231.xsd#cpix_EmploymentAgreementsTextBlock" xlink:label="loc_cpix_EmploymentAgreementsTextBlock_9919CE8CCAB45E5BA6C97D19D09511B5" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_EmploymentAgreementsAbstract_5B3BE82AF4405547AB29B10B46FD2F49" xlink:to="loc_cpix_EmploymentAgreementsTextBlock_9919CE8CCAB45E5BA6C97D19D09511B5" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/FairValueOfFinancialInstruments" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_BA9AFD2DBEE55E818901B74D4739A84C" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_A6F1D04462E25109981B9AF9B7F63B21" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_BA9AFD2DBEE55E818901B74D4739A84C" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_A6F1D04462E25109981B9AF9B7F63B21" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueOfFinancialInstrumentsByLevelInHierarchyAndNarrativeDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_8481953EE92D37C2DC9BAE9040627C16" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5EB1000D2FAD1B58A31CAE904062E45B" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_8481953EE92D37C2DC9BAE9040627C16" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5EB1000D2FAD1B58A31CAE904062E45B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_3EA60D63D6112FA22325AE9040628818" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5EB1000D2FAD1B58A31CAE904062E45B" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_3EA60D63D6112FA22325AE9040628818" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_7ED67F4B435F390F19C2AE904062F5EE" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_3EA60D63D6112FA22325AE9040628818" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_7ED67F4B435F390F19C2AE904062F5EE" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember_5BF041E128BA630813C3AE904062E522" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_7ED67F4B435F390F19C2AE904062F5EE" xlink:to="loc_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember_5BF041E128BA630813C3AE904062E522" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AgencySecuritiesMember" xlink:label="loc_us-gaap_AgencySecuritiesMember_101ADEE6453968F3B7BDAE9040623E5B" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_7ED67F4B435F390F19C2AE904062F5EE" xlink:to="loc_us-gaap_AgencySecuritiesMember_101ADEE6453968F3B7BDAE9040623E5B" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_LoanPoolsMember" xlink:label="loc_cpix_LoanPoolsMember_0437A84A7D9D1F036960AE904063FE9C" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_7ED67F4B435F390F19C2AE904062F5EE" xlink:to="loc_cpix_LoanPoolsMember_0437A84A7D9D1F036960AE904063FE9C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MunicipalBondsMember" xlink:label="loc_us-gaap_MunicipalBondsMember_83CFF619F09FC224BE82AE904063AFEF" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_7ED67F4B435F390F19C2AE904062F5EE" xlink:to="loc_us-gaap_MunicipalBondsMember_83CFF619F09FC224BE82AE904063AFEF" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1413360F0AD931381ED4AE90406337A7" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5EB1000D2FAD1B58A31CAE904062E45B" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1413360F0AD931381ED4AE90406337A7" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_796E09FC239EE8C26E2BAE904063E756" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1413360F0AD931381ED4AE90406337A7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_796E09FC239EE8C26E2BAE904063E756" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_B574D499FB3B488C7E95AE9040638A3B" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_796E09FC239EE8C26E2BAE904063E756" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_B574D499FB3B488C7E95AE9040638A3B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_80760BBD4F689111C9EEAE904063BBF2" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_796E09FC239EE8C26E2BAE904063E756" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_80760BBD4F689111C9EEAE904063BBF2" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1AAE8D30CFFD90DFCE8FAE904063EFC9" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5EB1000D2FAD1B58A31CAE904062E45B" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1AAE8D30CFFD90DFCE8FAE904063EFC9" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TradingSecurities" xlink:label="loc_us-gaap_TradingSecurities_848769C6656490275B80AE904063EDFF" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1AAE8D30CFFD90DFCE8FAE904063EFC9" xlink:to="loc_us-gaap_TradingSecurities_848769C6656490275B80AE904063EDFF" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/FairValueOfFinancialInstrumentsTables" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_C345E62263BB5A4E89115312F5EA8D64" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_FD372B62502B55069DFA3FEB256109E8" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_C345E62263BB5A4E89115312F5EA8D64" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_FD372B62502B55069DFA3FEB256109E8" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/IncomeTaxes" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0C2600BD15315E2CA10BF56D18EC9BA5" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_90B7ECD0C8785A5DBA05EA7B0CB36471" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0C2600BD15315E2CA10BF56D18EC9BA5" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_90B7ECD0C8785A5DBA05EA7B0CB36471" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/IncomeTaxesOperatingLossCarryforwardsNarrativeDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_83302CF67F667E1F6689AE8BDC5D2E76" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_37D93DD2D42F581DF97EAE8BDC5DE9B6" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_83302CF67F667E1F6689AE8BDC5D2E76" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_37D93DD2D42F581DF97EAE8BDC5DE9B6" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_2489B156601B50463817AEA24C926C6F" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_37D93DD2D42F581DF97EAE8BDC5DE9B6" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_2489B156601B50463817AEA24C926C6F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_3684D977720A66ED70EEAEA24C97AAA5" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_2489B156601B50463817AEA24C926C6F" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_3684D977720A66ED70EEAEA24C97AAA5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_152DE943F860956599CAAEA24CD411D1" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_3684D977720A66ED70EEAEA24C97AAA5" xlink:to="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_152DE943F860956599CAAEA24CD411D1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_F9F7ACFEA0ADF8A1D74CAE8BDC5E159F" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_37D93DD2D42F581DF97EAE8BDC5DE9B6" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_F9F7ACFEA0ADF8A1D74CAE8BDC5E159F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_3AB201D60AF174D6184BAE8BDC5EB87B" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_F9F7ACFEA0ADF8A1D74CAE8BDC5E159F" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_3AB201D60AF174D6184BAE8BDC5EB87B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_AC3E4700B6D7F452867BAE8BDC5EF538" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_3AB201D60AF174D6184BAE8BDC5EB87B" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_AC3E4700B6D7F452867BAE8BDC5EF538" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_4E7C1CB38ABF35E9B261AE8BDC5EA476" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_3AB201D60AF174D6184BAE8BDC5EB87B" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_4E7C1CB38ABF35E9B261AE8BDC5EA476" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_OperatingLossCarryforwardNatureAxis" xlink:label="loc_cpix_OperatingLossCarryforwardNatureAxis_6024834A03C4716B340EAE8BDC5E4425" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_37D93DD2D42F581DF97EAE8BDC5DE9B6" xlink:to="loc_cpix_OperatingLossCarryforwardNatureAxis_6024834A03C4716B340EAE8BDC5E4425" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_OperatingLossCarryforwardNatureDomain" xlink:label="loc_cpix_OperatingLossCarryforwardNatureDomain_7011FCFBA333B472AFD9AE8BDC5E803C" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_OperatingLossCarryforwardNatureAxis_6024834A03C4716B340EAE8BDC5E4425" xlink:to="loc_cpix_OperatingLossCarryforwardNatureDomain_7011FCFBA333B472AFD9AE8BDC5E803C" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_CharitableForeignTaxCreditandAMTCarryforwardMember" xlink:label="loc_cpix_CharitableForeignTaxCreditandAMTCarryforwardMember_39EB05027C850C1D755AAE8BDC5EFA3D" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_OperatingLossCarryforwardNatureDomain_7011FCFBA333B472AFD9AE8BDC5E803C" xlink:to="loc_cpix_CharitableForeignTaxCreditandAMTCarryforwardMember_39EB05027C850C1D755AAE8BDC5EFA3D" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_OrphanDrugandResearchandDevelopmentTaxCreditMember" xlink:label="loc_cpix_OrphanDrugandResearchandDevelopmentTaxCreditMember_038D4C98E37B372D6FE1AE8BDC5E9128" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_OperatingLossCarryforwardNatureDomain_7011FCFBA333B472AFD9AE8BDC5E803C" xlink:to="loc_cpix_OrphanDrugandResearchandDevelopmentTaxCreditMember_038D4C98E37B372D6FE1AE8BDC5E9128" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_ExerciseOfNonqualifiedStockOptionsMember" xlink:label="loc_cpix_ExerciseOfNonqualifiedStockOptionsMember_31BBA84AB43026905202AE8BDC5ECADC" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_OperatingLossCarryforwardNatureDomain_7011FCFBA333B472AFD9AE8BDC5E803C" xlink:to="loc_cpix_ExerciseOfNonqualifiedStockOptionsMember_31BBA84AB43026905202AE8BDC5ECADC" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_73124FDDDFE802189FCDAE8BDC5EF05C" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_37D93DD2D42F581DF97EAE8BDC5DE9B6" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_73124FDDDFE802189FCDAE8BDC5EF05C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_B8B153BA5929D3C85C3AAE8BDC5E4A10" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_73124FDDDFE802189FCDAE8BDC5EF05C" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_B8B153BA5929D3C85C3AAE8BDC5E4A10" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_6991197CC2592F896491AEA2D529289C" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_73124FDDDFE802189FCDAE8BDC5EF05C" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_6991197CC2592F896491AEA2D529289C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaap_OperatingLossCarryforwards_EE8C45166EB5F9CA6684AE8BDC5E3E7E" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_73124FDDDFE802189FCDAE8BDC5EF05C" xlink:to="loc_us-gaap_OperatingLossCarryforwards_EE8C45166EB5F9CA6684AE8BDC5E3E7E" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_OperatingLossCarryforwardsAmountSubjectToFullValuationAllowance" xlink:label="loc_cpix_OperatingLossCarryforwardsAmountSubjectToFullValuationAllowance_A4C016F4AEEC44C8C0E0AE8BDC5E7ED2" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_73124FDDDFE802189FCDAE8BDC5EF05C" xlink:to="loc_cpix_OperatingLossCarryforwardsAmountSubjectToFullValuationAllowance_A4C016F4AEEC44C8C0E0AE8BDC5E7ED2" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/IncomeTaxesScheduleOfComponentsOfDeferredIncomeTaxBenefitExpenseDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_78CE8E6C8230566696211D16054DF84D" xlink:type="locator" />
    <loc xlink:href="cpix-20161231.xsd#cpix_DeferredIncomeTaxExpenseBenefitBeforeReconcilingItems" xlink:label="loc_cpix_DeferredIncomeTaxExpenseBenefitBeforeReconcilingItems_CEC9F6AC06385E6FB8A58DF26E615D8A" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_78CE8E6C8230566696211D16054DF84D" xlink:to="loc_cpix_DeferredIncomeTaxExpenseBenefitBeforeReconcilingItems_CEC9F6AC06385E6FB8A58DF26E615D8A" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_DeferredIncomeTaxExpenseBenefitInventoryWriteDowns" xlink:label="loc_cpix_DeferredIncomeTaxExpenseBenefitInventoryWriteDowns_6D68630701C05C8989909E742880741D" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_78CE8E6C8230566696211D16054DF84D" xlink:to="loc_cpix_DeferredIncomeTaxExpenseBenefitInventoryWriteDowns_6D68630701C05C8989909E742880741D" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_DeferredIncomeTaxExpenseBenefitCreationUtilizationOfOperatingLossCarryforwards" xlink:label="loc_cpix_DeferredIncomeTaxExpenseBenefitCreationUtilizationOfOperatingLossCarryforwards_7260899A7C9E54D0958D64300307477F" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_78CE8E6C8230566696211D16054DF84D" xlink:to="loc_cpix_DeferredIncomeTaxExpenseBenefitCreationUtilizationOfOperatingLossCarryforwards_7260899A7C9E54D0958D64300307477F" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_DeferredIncomeTaxExpenseBenefitCreationUtilizationOfTaxCreditCarryforwards" xlink:label="loc_cpix_DeferredIncomeTaxExpenseBenefitCreationUtilizationOfTaxCreditCarryforwards_BE615E54A42A53D7B789F1AD539BC57C" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_78CE8E6C8230566696211D16054DF84D" xlink:to="loc_cpix_DeferredIncomeTaxExpenseBenefitCreationUtilizationOfTaxCreditCarryforwards_BE615E54A42A53D7B789F1AD539BC57C" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_DeferredIncomeTaxExpenseBenefitChangeInValuationAllowanceDueToChangesInNetDeferredTaxAssetBalances" xlink:label="loc_cpix_DeferredIncomeTaxExpenseBenefitChangeInValuationAllowanceDueToChangesInNetDeferredTaxAssetBalances_CDA3BFAD420C50BE8D190792BAC56830" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_78CE8E6C8230566696211D16054DF84D" xlink:to="loc_cpix_DeferredIncomeTaxExpenseBenefitChangeInValuationAllowanceDueToChangesInNetDeferredTaxAssetBalances_CDA3BFAD420C50BE8D190792BAC56830" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_DeferredIncomeTaxExpenseBenefitCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_cpix_DeferredIncomeTaxExpenseBenefitCompensationAndBenefitsShareBasedCompensationCost_D8B80B7FAD8A5CBFA8F99476AEE162D3" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_78CE8E6C8230566696211D16054DF84D" xlink:to="loc_cpix_DeferredIncomeTaxExpenseBenefitCompensationAndBenefitsShareBasedCompensationCost_D8B80B7FAD8A5CBFA8F99476AEE162D3" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_DeferredIncomeTaxExpenseBenefitAllowanceforAccountsReceivable" xlink:label="loc_cpix_DeferredIncomeTaxExpenseBenefitAllowanceforAccountsReceivable_F78BBD29CA085E309E46DC3C71907B44" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_78CE8E6C8230566696211D16054DF84D" xlink:to="loc_cpix_DeferredIncomeTaxExpenseBenefitAllowanceforAccountsReceivable_F78BBD29CA085E309E46DC3C71907B44" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_DeferredIncomeTaxExpenseBenefitDeferredCharges" xlink:label="loc_cpix_DeferredIncomeTaxExpenseBenefitDeferredCharges_B5C52A2595995FC1B1C1CE8DF113C0EE" xlink:type="locator" />
    <presentationArc order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_78CE8E6C8230566696211D16054DF84D" xlink:to="loc_cpix_DeferredIncomeTaxExpenseBenefitDeferredCharges_B5C52A2595995FC1B1C1CE8DF113C0EE" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_DeferredIncomeTaxExpenseBenefitReserveforExpiredProducts" xlink:label="loc_cpix_DeferredIncomeTaxExpenseBenefitReserveforExpiredProducts_F9423F42E7425A8991CDE8B9B56A94BB" xlink:type="locator" />
    <presentationArc order="9" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_78CE8E6C8230566696211D16054DF84D" xlink:to="loc_cpix_DeferredIncomeTaxExpenseBenefitReserveforExpiredProducts_F9423F42E7425A8991CDE8B9B56A94BB" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_DeferredIncomeTaxExpenseBenefitIntangibleAssets" xlink:label="loc_cpix_DeferredIncomeTaxExpenseBenefitIntangibleAssets_CDFB7EC4D4BF556D9FC6A859DA9FDE6F" xlink:type="locator" />
    <presentationArc order="10" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_78CE8E6C8230566696211D16054DF84D" xlink:to="loc_cpix_DeferredIncomeTaxExpenseBenefitIntangibleAssets_CDFB7EC4D4BF556D9FC6A859DA9FDE6F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredOtherTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredOtherTaxExpenseBenefit_763F37E53B9153D08163E87023602B23" xlink:type="locator" />
    <presentationArc order="11" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_78CE8E6C8230566696211D16054DF84D" xlink:to="loc_us-gaap_DeferredOtherTaxExpenseBenefit_763F37E53B9153D08163E87023602B23" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxBenefitExpenseDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_19C1432CEC98550B8A1BFA1458331BB0" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_FD26C6D4E5975195BD75B00513F2B195" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_19C1432CEC98550B8A1BFA1458331BB0" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_FD26C6D4E5975195BD75B00513F2B195" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_EA598DD90E025A908FC57BDAFB662E1D" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_FD26C6D4E5975195BD75B00513F2B195" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_EA598DD90E025A908FC57BDAFB662E1D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_96E801C666255F8D94EBF8EC8689F683" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_FD26C6D4E5975195BD75B00513F2B195" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_96E801C666255F8D94EBF8EC8689F683" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_66284D06FE98582F93D5A99FFAD0A79D" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_FD26C6D4E5975195BD75B00513F2B195" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_66284D06FE98582F93D5A99FFAD0A79D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_647E70341D6A5EF2A42D8BA3F5CEE6CB" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_19C1432CEC98550B8A1BFA1458331BB0" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_647E70341D6A5EF2A42D8BA3F5CEE6CB" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_91904E9F3C705582AFA5EB7DEFCAAB17" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_647E70341D6A5EF2A42D8BA3F5CEE6CB" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_91904E9F3C705582AFA5EB7DEFCAAB17" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_7CE6AF1C99355D9CB1C219F5A88CB4EA" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_647E70341D6A5EF2A42D8BA3F5CEE6CB" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_7CE6AF1C99355D9CB1C219F5A88CB4EA" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredOtherTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredOtherTaxExpenseBenefit_EB7C0153570A5D589F88D8630DEFE432" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_647E70341D6A5EF2A42D8BA3F5CEE6CB" xlink:to="loc_us-gaap_DeferredOtherTaxExpenseBenefit_EB7C0153570A5D589F88D8630DEFE432" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_517C8D8FAFBA5899B1E245E2E51960AF" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_19C1432CEC98550B8A1BFA1458331BB0" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_517C8D8FAFBA5899B1E245E2E51960AF" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesNetDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_28C6AEFF2C34538581F0D130473F7E46" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsGrossAbstract" xlink:label="loc_us-gaap_DeferredTaxAssetsGrossAbstract_47A590D6A86D56B98C8B2092BF76AE46" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_28C6AEFF2C34538581F0D130473F7E46" xlink:to="loc_us-gaap_DeferredTaxAssetsGrossAbstract_47A590D6A86D56B98C8B2092BF76AE46" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards" xlink:label="loc_cpix_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards_01187266E46555AD881A8FFB207D7AD0" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_47A590D6A86D56B98C8B2092BF76AE46" xlink:to="loc_cpix_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards_01187266E46555AD881A8FFB207D7AD0" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_DeferredTaxAssetsPropertyAndEquipmentAndIntangibles" xlink:label="loc_cpix_DeferredTaxAssetsPropertyAndEquipmentAndIntangibles_A901F707AA9E5BF9B842D09C697B9C16" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_47A590D6A86D56B98C8B2092BF76AE46" xlink:to="loc_cpix_DeferredTaxAssetsPropertyAndEquipmentAndIntangibles_A901F707AA9E5BF9B842D09C697B9C16" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_45E5F48E097D5DA084FCD06FE6338116" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_47A590D6A86D56B98C8B2092BF76AE46" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_45E5F48E097D5DA084FCD06FE6338116" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReservesForExpiredProduct" xlink:label="loc_cpix_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReservesForExpiredProduct_E454622020055196A65708D8C8DB9FB8" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_47A590D6A86D56B98C8B2092BF76AE46" xlink:to="loc_cpix_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReservesForExpiredProduct_E454622020055196A65708D8C8DB9FB8" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_1780E985C71A5E5EBF353833687F1EE2" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_47A590D6A86D56B98C8B2092BF76AE46" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_1780E985C71A5E5EBF353833687F1EE2" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_DeferredTaxAssetsDeferredCharges" xlink:label="loc_cpix_DeferredTaxAssetsDeferredCharges_46A930036F8155AFB78EB18F225EE37E" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_47A590D6A86D56B98C8B2092BF76AE46" xlink:to="loc_cpix_DeferredTaxAssetsDeferredCharges_46A930036F8155AFB78EB18F225EE37E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_E03A05451FE95ED387C59A4248830F2B" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_47A590D6A86D56B98C8B2092BF76AE46" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_E03A05451FE95ED387C59A4248830F2B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_2E03B146FC01595B81B45C57E62FD402" xlink:type="locator" />
    <presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_47A590D6A86D56B98C8B2092BF76AE46" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_2E03B146FC01595B81B45C57E62FD402" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract_608F962FE3CA501E93CD9082DF4CA946" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_28C6AEFF2C34538581F0D130473F7E46" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesAbstract_608F962FE3CA501E93CD9082DF4CA946" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_88375B1632575E94A290363D19018AD4" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_608F962FE3CA501E93CD9082DF4CA946" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_88375B1632575E94A290363D19018AD4" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_NetDeferredTaxAssetsGross" xlink:label="loc_cpix_NetDeferredTaxAssetsGross_DA710A2818345CA599279C64D29B6A38" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_608F962FE3CA501E93CD9082DF4CA946" xlink:to="loc_cpix_NetDeferredTaxAssetsGross_DA710A2818345CA599279C64D29B6A38" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_3CB1DEC61A7C56FB93716930E23EE402" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_608F962FE3CA501E93CD9082DF4CA946" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_3CB1DEC61A7C56FB93716930E23EE402" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_4B5F84C5C3F25205A0249CB51F95FCFA" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_608F962FE3CA501E93CD9082DF4CA946" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_4B5F84C5C3F25205A0249CB51F95FCFA" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_DF921217CA5C68D04735AE8BE013BD0B" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_51D6CE0ACACBB4C6182EAE8BE013BE19" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_DF921217CA5C68D04735AE8BE013BD0B" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_51D6CE0ACACBB4C6182EAE8BE013BE19" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_1722D10D99D8A2328237AE8BE013C01F" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_DF921217CA5C68D04735AE8BE013BD0B" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_1722D10D99D8A2328237AE8BE013C01F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_EBE5064A4D2BDE22E970AE8BE013B60E" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_DF921217CA5C68D04735AE8BE013BD0B" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_EBE5064A4D2BDE22E970AE8BE013B60E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_6C48259EC814282FAE33AE8F09392982" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_DF921217CA5C68D04735AE8BE013BD0B" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_6C48259EC814282FAE33AE8F09392982" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_B7A95DD4D007597E2E39AE8BE01322F8" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_DF921217CA5C68D04735AE8BE013BD0B" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_B7A95DD4D007597E2E39AE8BE01322F8" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_B3C2C4FC0130C0ADEFBBAE8BE013045A" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_DF921217CA5C68D04735AE8BE013BD0B" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_B3C2C4FC0130C0ADEFBBAE8BE013045A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_A0511E8184168E0E1FC8AE8BE0131AC4" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_DF921217CA5C68D04735AE8BE013BD0B" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_A0511E8184168E0E1FC8AE8BE0131AC4" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/IncomeTaxesScheduleOfNetOperatingLossCarryforwardsDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_F9720EC293685BFEB07D2DDC225B48C8" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_336911EB09C0591B8F88AF9DF4423A5F" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_F9720EC293685BFEB07D2DDC225B48C8" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_336911EB09C0591B8F88AF9DF4423A5F" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_ExpirationTimePeriodAxis" xlink:label="loc_cpix_ExpirationTimePeriodAxis_697113F4B8F855C28E0E870DFFD4EF07" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_336911EB09C0591B8F88AF9DF4423A5F" xlink:to="loc_cpix_ExpirationTimePeriodAxis_697113F4B8F855C28E0E870DFFD4EF07" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_ExpirationTimePeriodDomain" xlink:label="loc_cpix_ExpirationTimePeriodDomain_D01568A83A3E5C58BFEC426C22B58923" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_ExpirationTimePeriodAxis_697113F4B8F855C28E0E870DFFD4EF07" xlink:to="loc_cpix_ExpirationTimePeriodDomain_D01568A83A3E5C58BFEC426C22B58923" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_ExpirationTermOneMember" xlink:label="loc_cpix_ExpirationTermOneMember_3158A07920905D73B31081BA8AAF06A4" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_ExpirationTimePeriodDomain_D01568A83A3E5C58BFEC426C22B58923" xlink:to="loc_cpix_ExpirationTermOneMember_3158A07920905D73B31081BA8AAF06A4" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_ExpirationTermTwoMember" xlink:label="loc_cpix_ExpirationTermTwoMember_16FA5769D084587FA6F3B60E5059F5DF" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_ExpirationTimePeriodDomain_D01568A83A3E5C58BFEC426C22B58923" xlink:to="loc_cpix_ExpirationTermTwoMember_16FA5769D084587FA6F3B60E5059F5DF" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_ExpirationTermThreeMember" xlink:label="loc_cpix_ExpirationTermThreeMember_1077B9BD1E325398951063C1E0633E30" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_ExpirationTimePeriodDomain_D01568A83A3E5C58BFEC426C22B58923" xlink:to="loc_cpix_ExpirationTermThreeMember_1077B9BD1E325398951063C1E0633E30" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_ExpirationTermFourMember" xlink:label="loc_cpix_ExpirationTermFourMember_4DF63AA9FACA5DFEAAA6F13B68BA2250" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_ExpirationTimePeriodDomain_D01568A83A3E5C58BFEC426C22B58923" xlink:to="loc_cpix_ExpirationTermFourMember_4DF63AA9FACA5DFEAAA6F13B68BA2250" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_7A62EAA877B05503809CE71716F27322" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_336911EB09C0591B8F88AF9DF4423A5F" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_7A62EAA877B05503809CE71716F27322" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_5D5EDF929CBE5DFB9436A7FDC220B22D" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_7A62EAA877B05503809CE71716F27322" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_5D5EDF929CBE5DFB9436A7FDC220B22D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_BB8281244FFE555689E385B909DE317D" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_5D5EDF929CBE5DFB9436A7FDC220B22D" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_BB8281244FFE555689E385B909DE317D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_6CBDE0711F5B5290B4215D561D781FF7" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_5D5EDF929CBE5DFB9436A7FDC220B22D" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_6CBDE0711F5B5290B4215D561D781FF7" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_D7C95EFAF35F5C949118E7372AED0D2F" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_336911EB09C0591B8F88AF9DF4423A5F" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_D7C95EFAF35F5C949118E7372AED0D2F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaap_OperatingLossCarryforwards_C022681FC1DA55A28E0D2BF1801983C0" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_D7C95EFAF35F5C949118E7372AED0D2F" xlink:to="loc_us-gaap_OperatingLossCarryforwards_C022681FC1DA55A28E0D2BF1801983C0" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/IncomeTaxesTables" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_3C98C445FEF553BEA5D00EED819E78D9" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_77791B50613851838B7B4DAD375403CE" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3C98C445FEF553BEA5D00EED819E78D9" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_77791B50613851838B7B4DAD375403CE" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:label="loc_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_58655DF0BA1D5B1295BCFD9904ED2690" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3C98C445FEF553BEA5D00EED819E78D9" xlink:to="loc_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_58655DF0BA1D5B1295BCFD9904ED2690" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_C50FAC182323539C94B93B90D33198C3" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3C98C445FEF553BEA5D00EED819E78D9" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_C50FAC182323539C94B93B90D33198C3" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_ScheduleOfComponentsOfDeferredTaxExpenseBenefitTableTextBlock" xlink:label="loc_cpix_ScheduleOfComponentsOfDeferredTaxExpenseBenefitTableTextBlock_F009C28F4529580392270D1B282D510D" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3C98C445FEF553BEA5D00EED819E78D9" xlink:to="loc_cpix_ScheduleOfComponentsOfDeferredTaxExpenseBenefitTableTextBlock_F009C28F4529580392270D1B282D510D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_4BCA4461237459D4B55DA2C1824F7927" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3C98C445FEF553BEA5D00EED819E78D9" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_4BCA4461237459D4B55DA2C1824F7927" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/IntangibleAssets" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_B7650D10960E5216AD3C1F8DF2607D71" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_F6B1EC51BB895540BA8DCE960996C2E7" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_B7650D10960E5216AD3C1F8DF2607D71" xlink:to="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_F6B1EC51BB895540BA8DCE960996C2E7" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/IntangibleAssetsFutureAmortizationExpenseDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_BE3FE281AF3B7BAAB6CB90206347B227" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_3C1F3263055260762F5690206347D0FA" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_BE3FE281AF3B7BAAB6CB90206347B227" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_3C1F3263055260762F5690206347D0FA" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_79E852FD5780DC97CF819020634C8B5E" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_BE3FE281AF3B7BAAB6CB90206347B227" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_79E852FD5780DC97CF819020634C8B5E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_E66706E7FE6CC2201F359020634CBD89" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_BE3FE281AF3B7BAAB6CB90206347B227" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_E66706E7FE6CC2201F359020634CBD89" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_7CE24812F6AB98A0C31A9020634C468B" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_BE3FE281AF3B7BAAB6CB90206347B227" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_7CE24812F6AB98A0C31A9020634C468B" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_FiniteLivedIntangibleAssetsAmortizationExpenseYearFiveandAfter" xlink:label="loc_cpix_FiniteLivedIntangibleAssetsAmortizationExpenseYearFiveandAfter_2988805009BCA8CFE0B19020634C08E4" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_BE3FE281AF3B7BAAB6CB90206347B227" xlink:to="loc_cpix_FiniteLivedIntangibleAssetsAmortizationExpenseYearFiveandAfter_2988805009BCA8CFE0B19020634C08E4" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_620D36F6D04B8732F46F9020634DE121" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_BE3FE281AF3B7BAAB6CB90206347B227" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_620D36F6D04B8732F46F9020634DE121" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/IntangibleAssetsNarrativeDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_35C20697738673F6378590206352B6FF" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_5D4977F258A592AA036B9020635280A2" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_35C20697738673F6378590206352B6FF" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_5D4977F258A592AA036B9020635280A2" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_C5845DAE5CF4A5F65B9E90A56612D79A" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_5D4977F258A592AA036B9020635280A2" xlink:to="loc_us-gaap_AwardTypeAxis_C5845DAE5CF4A5F65B9E90A56612D79A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_B307AB47DAE99479736090A566133435" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_C5845DAE5CF4A5F65B9E90A56612D79A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_B307AB47DAE99479736090A566133435" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaap_RestrictedStockMember_2F17B486EC361AD5425D90A56830DB5C" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_B307AB47DAE99479736090A566133435" xlink:to="loc_us-gaap_RestrictedStockMember_2F17B486EC361AD5425D90A56830DB5C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_06549282C68B9C6F114990A5658111A5" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_5D4977F258A592AA036B9020635280A2" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_06549282C68B9C6F114990A5658111A5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_F0C046B181F47FB4858090A5658237FF" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_06549282C68B9C6F114990A5658111A5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_F0C046B181F47FB4858090A5658237FF" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_MethotrexateMember" xlink:label="loc_cpix_MethotrexateMember_6C685F8816780E5A2E0C90A566A668FC" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_F0C046B181F47FB4858090A5658237FF" xlink:to="loc_cpix_MethotrexateMember_6C685F8816780E5A2E0C90A566A668FC" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_31DEE9196C9E4A7B84FF9020635233C3" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_5D4977F258A592AA036B9020635280A2" xlink:to="loc_dei_LegalEntityAxis_31DEE9196C9E4A7B84FF9020635233C3" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_58D02B8458C01753853B902063520369" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_31DEE9196C9E4A7B84FF9020635233C3" xlink:to="loc_dei_EntityDomain_58D02B8458C01753853B902063520369" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_VaprisolMember" xlink:label="loc_cpix_VaprisolMember_2641B2CAD78A837E18649020635218EB" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_58D02B8458C01753853B902063520369" xlink:to="loc_cpix_VaprisolMember_2641B2CAD78A837E18649020635218EB" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_PernixTherapeuticsMember" xlink:label="loc_cpix_PernixTherapeuticsMember_7AAA54F1E9963A96CB06902063522482" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_58D02B8458C01753853B902063520369" xlink:to="loc_cpix_PernixTherapeuticsMember_7AAA54F1E9963A96CB06902063522482" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaap_TypeOfArrangementAxis_1C9426BD7BCAA726716F90206352A321" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_5D4977F258A592AA036B9020635280A2" xlink:to="loc_us-gaap_TypeOfArrangementAxis_1C9426BD7BCAA726716F90206352A321" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_3BA4C052758F7E3566C890206352E8AB" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_1C9426BD7BCAA726716F90206352A321" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_3BA4C052758F7E3566C890206352E8AB" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_AmendedInternationalAgreementMember" xlink:label="loc_cpix_AmendedInternationalAgreementMember_82F06B83D60FEC0ED6D590206352FD8B" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_3BA4C052758F7E3566C890206352E8AB" xlink:to="loc_cpix_AmendedInternationalAgreementMember_82F06B83D60FEC0ED6D590206352FD8B" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_ProductRightsAgreementUSCommercializationRightsForKristaloseFromInalcoBiochemicalsIncAndInalcoSPAMember" xlink:label="loc_cpix_ProductRightsAgreementUSCommercializationRightsForKristaloseFromInalcoBiochemicalsIncAndInalcoSPAMember_107F6E11CD12B931C41990206352C5A9" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_3BA4C052758F7E3566C890206352E8AB" xlink:to="loc_cpix_ProductRightsAgreementUSCommercializationRightsForKristaloseFromInalcoBiochemicalsIncAndInalcoSPAMember_107F6E11CD12B931C41990206352C5A9" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductOrServiceAxis" xlink:label="loc_us-gaap_ProductOrServiceAxis_5C411B38D6208D6BB4BD902063522CBD" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_5D4977F258A592AA036B9020635280A2" xlink:to="loc_us-gaap_ProductOrServiceAxis_5C411B38D6208D6BB4BD902063522CBD" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductsAndServicesDomain" xlink:label="loc_us-gaap_ProductsAndServicesDomain_348BC0616AE15D2850C990206352E626" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductOrServiceAxis_5C411B38D6208D6BB4BD902063522CBD" xlink:to="loc_us-gaap_ProductsAndServicesDomain_348BC0616AE15D2850C990206352E626" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_KristaloseMember" xlink:label="loc_cpix_KristaloseMember_EDF3ED0D5706B35D8C5F9020635261BD" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductsAndServicesDomain_348BC0616AE15D2850C990206352E626" xlink:to="loc_cpix_KristaloseMember_EDF3ED0D5706B35D8C5F9020635261BD" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_FFA6FD42F16328C1199F902063529D93" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_5D4977F258A592AA036B9020635280A2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_FFA6FD42F16328C1199F902063529D93" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5237C00C6005353E86AD90206352A988" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_FFA6FD42F16328C1199F902063529D93" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5237C00C6005353E86AD90206352A988" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_ProductAndLicenseRightsMember" xlink:label="loc_cpix_ProductAndLicenseRightsMember_0FB0CB2B00F420FFA7329020635396BC" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5237C00C6005353E86AD90206352A988" xlink:to="loc_cpix_ProductAndLicenseRightsMember_0FB0CB2B00F420FFA7329020635396BC" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaap_PatentsMember_CA401079BCABAAFEB8A790206353F5BA" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5237C00C6005353E86AD90206352A988" xlink:to="loc_us-gaap_PatentsMember_CA401079BCABAAFEB8A790206353F5BA" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_CD6440BC9B1A6C7879ED90206353855C" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_5D4977F258A592AA036B9020635280A2" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_CD6440BC9B1A6C7879ED90206353855C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_B6FC59D4D5D34D75664590206353D943" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_CD6440BC9B1A6C7879ED90206353855C" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_B6FC59D4D5D34D75664590206353D943" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_RevenueRecognitionPotentialUpfrontPaymentRelatedtoProductSales" xlink:label="loc_cpix_RevenueRecognitionPotentialUpfrontPaymentRelatedtoProductSales_14838EBA1A7DC99860B79020635387FE" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_CD6440BC9B1A6C7879ED90206353855C" xlink:to="loc_cpix_RevenueRecognitionPotentialUpfrontPaymentRelatedtoProductSales_14838EBA1A7DC99860B79020635387FE" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_ProductRightsAgreementQuarterlyPaymentsExpirationDate" xlink:label="loc_cpix_ProductRightsAgreementQuarterlyPaymentsExpirationDate_033B87DDD717F3988FA7902063538CB6" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_CD6440BC9B1A6C7879ED90206353855C" xlink:to="loc_cpix_ProductRightsAgreementQuarterlyPaymentsExpirationDate_033B87DDD717F3988FA7902063538CB6" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_ProductRightsAgreementQuarterlyPaymentsMade" xlink:label="loc_cpix_ProductRightsAgreementQuarterlyPaymentsMade_E5C4E0049472891E904A90206353E312" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_CD6440BC9B1A6C7879ED90206353855C" xlink:to="loc_cpix_ProductRightsAgreementQuarterlyPaymentsMade_E5C4E0049472891E904A90206353E312" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_EBA36557570B0DE1758C902063539830" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_CD6440BC9B1A6C7879ED90206353855C" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_EBA36557570B0DE1758C902063539830" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_55825A69D6032FC0D35490206353C2E9" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_CD6440BC9B1A6C7879ED90206353855C" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_55825A69D6032FC0D35490206353C2E9" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_0A2191EC187097B470BE90A563F8F643" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_CD6440BC9B1A6C7879ED90206353855C" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_0A2191EC187097B470BE90A563F8F643" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_9CD96AEBACAF8D9BD08190A56437D4B7" xlink:type="locator" />
    <presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_CD6440BC9B1A6C7879ED90206353855C" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_9CD96AEBACAF8D9BD08190A56437D4B7" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_7D0D8057F854188E4C2690A5649D787C" xlink:type="locator" />
    <presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_CD6440BC9B1A6C7879ED90206353855C" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_7D0D8057F854188E4C2690A5649D787C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_FE9EDD55AC35CE98F94290A564F73DFD" xlink:type="locator" />
    <presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_CD6440BC9B1A6C7879ED90206353855C" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_FE9EDD55AC35CE98F94290A564F73DFD" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/IntangibleAssetsScheduleOfIntangibleAssetsDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3D4AF688472F51F3840D50B1FDB8896D" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_6C5DF98FA6955A3E9BF952CC3C93B4EB" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3D4AF688472F51F3840D50B1FDB8896D" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_6C5DF98FA6955A3E9BF952CC3C93B4EB" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7ACD5A347A575A4FA7F5EE9C2345AD0D" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_6C5DF98FA6955A3E9BF952CC3C93B4EB" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7ACD5A347A575A4FA7F5EE9C2345AD0D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_E3E082DAC996525B92F7430451CE6622" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7ACD5A347A575A4FA7F5EE9C2345AD0D" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_E3E082DAC996525B92F7430451CE6622" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_ProductAndLicenseRightsMember" xlink:label="loc_cpix_ProductAndLicenseRightsMember_05B58FBD84CD5D59B8FC98AC561CD699" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_E3E082DAC996525B92F7430451CE6622" xlink:to="loc_cpix_ProductAndLicenseRightsMember_05B58FBD84CD5D59B8FC98AC561CD699" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaap_PatentsMember_02796CB0C89D501BA923A7C70E65827A" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_E3E082DAC996525B92F7430451CE6622" xlink:to="loc_us-gaap_PatentsMember_02796CB0C89D501BA923A7C70E65827A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TrademarksMember" xlink:label="loc_us-gaap_TrademarksMember_6EBD77DB292F5920AB044D9CF1A6A239" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_E3E082DAC996525B92F7430451CE6622" xlink:to="loc_us-gaap_TrademarksMember_6EBD77DB292F5920AB044D9CF1A6A239" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_263067FC1904585D85F2CCDCF93E04B8" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_6C5DF98FA6955A3E9BF952CC3C93B4EB" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_263067FC1904585D85F2CCDCF93E04B8" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_3A4411C65034540BBE28F902D5D6FF67" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_263067FC1904585D85F2CCDCF93E04B8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_3A4411C65034540BBE28F902D5D6FF67" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_043CD4011FB950ABA37254D52B52CBD9" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_263067FC1904585D85F2CCDCF93E04B8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_043CD4011FB950ABA37254D52B52CBD9" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_205FCCFF8A8B5F83836931108852CBCE" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_263067FC1904585D85F2CCDCF93E04B8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_205FCCFF8A8B5F83836931108852CBCE" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/IntangibleAssetsTables" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_EE89BD89273D5B15ACDE4DA1FABB0EEF" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_E39B50D0309A53E5A1412E25CB828972" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_EE89BD89273D5B15ACDE4DA1FABB0EEF" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_E39B50D0309A53E5A1412E25CB828972" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_8F734541C057543EA97AA3F1CA337BBD" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_EE89BD89273D5B15ACDE4DA1FABB0EEF" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_8F734541C057543EA97AA3F1CA337BBD" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/Inventories" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_6886662AF1D15436BAB50F4A65BE8DE1" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_6F7CF954AAEA5B5395AAEB707CEDD1CA" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_6886662AF1D15436BAB50F4A65BE8DE1" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_6F7CF954AAEA5B5395AAEB707CEDD1CA" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/InventoriesNarrativeDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_2A672F4E7CD75942993AADADF78BEE17" xlink:type="locator" />
    <loc xlink:href="cpix-20161231.xsd#cpix_InventoryShelfLife" xlink:label="loc_cpix_InventoryShelfLife_03C93A70700C580D9AE70F3CA26AB747" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_2A672F4E7CD75942993AADADF78BEE17" xlink:to="loc_cpix_InventoryShelfLife_03C93A70700C580D9AE70F3CA26AB747" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_InventoryExtendedShelfLife" xlink:label="loc_cpix_InventoryExtendedShelfLife_E0C0E39A0E4A550DA10205801D2C6483" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_2A672F4E7CD75942993AADADF78BEE17" xlink:to="loc_cpix_InventoryExtendedShelfLife_E0C0E39A0E4A550DA10205801D2C6483" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryValuationReserves" xlink:label="loc_us-gaap_InventoryValuationReserves_AEB66B52F6C15E70AE0CE9C45D69D3DC" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_2A672F4E7CD75942993AADADF78BEE17" xlink:to="loc_us-gaap_InventoryValuationReserves_AEB66B52F6C15E70AE0CE9C45D69D3DC" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/InventoriesScheduleOfInventoriesCurrentDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_8B40261F53B8B2FC6103902063686EDF" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_428CC53913510A1E0CC390206368669C" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_8B40261F53B8B2FC6103902063686EDF" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_428CC53913510A1E0CC390206368669C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" xlink:label="loc_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment_F87891C0DFFB0D8D824D90542F9E6815" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_8B40261F53B8B2FC6103902063686EDF" xlink:to="loc_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment_F87891C0DFFB0D8D824D90542F9E6815" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_D4AB85E7CFEBFF686D5390206368499D" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_8B40261F53B8B2FC6103902063686EDF" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_D4AB85E7CFEBFF686D5390206368499D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_AFFE15F2941E877223C1902063682FF2" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_8B40261F53B8B2FC6103902063686EDF" xlink:to="loc_us-gaap_InventoryNet_AFFE15F2941E877223C1902063682FF2" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/InventoriesTables" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_7147AEA16E365A82BC6C3BEDE5564E82" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_B3D7DCCE9E6853BA8108BC9B0ED01C85" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_7147AEA16E365A82BC6C3BEDE5564E82" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_B3D7DCCE9E6853BA8108BC9B0ED01C85" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/Leases" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_DB5335198AB157C88B529E383C327EB8" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LeasesOfLesseeDisclosureTextBlock" xlink:label="loc_us-gaap_LeasesOfLesseeDisclosureTextBlock_EF7E42407E59524AAB2DD1D82A13C0C2" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_DB5335198AB157C88B529E383C327EB8" xlink:to="loc_us-gaap_LeasesOfLesseeDisclosureTextBlock_EF7E42407E59524AAB2DD1D82A13C0C2" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_BD954346BB3B5B30BA7EC988AACC00EF" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="loc_us-gaap_LeaseAndRentalExpense_FA40EF66A7B15F9F882497FD34B664DE" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_BD954346BB3B5B30BA7EC988AACC00EF" xlink:to="loc_us-gaap_LeaseAndRentalExpense_FA40EF66A7B15F9F882497FD34B664DE" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLeasesRentExpenseSubleaseRentals1" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1_2CCE20338D2D5F388D26AF7C915465A2" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_BD954346BB3B5B30BA7EC988AACC00EF" xlink:to="loc_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1_2CCE20338D2D5F388D26AF7C915465A2" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals_D2595A453360582FBB79D9620E754C88" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_BD954346BB3B5B30BA7EC988AACC00EF" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals_D2595A453360582FBB79D9620E754C88" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/LeasesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_1D765A8EC280A5FFCF24902061A7689A" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_20696C0E390484E59B8A902061A72F08" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1D765A8EC280A5FFCF24902061A7689A" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_20696C0E390484E59B8A902061A72F08" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_9DC76CD350A8ABA4D456902061A74146" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1D765A8EC280A5FFCF24902061A7689A" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_9DC76CD350A8ABA4D456902061A74146" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_8C5F5332483CB69ECE2E902061A72CCC" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1D765A8EC280A5FFCF24902061A7689A" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_8C5F5332483CB69ECE2E902061A72CCC" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_3973A7ECA15A524E587D902061A7DE9B" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1D765A8EC280A5FFCF24902061A7689A" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_3973A7ECA15A524E587D902061A7DE9B" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_OperatingLeasesFutureMinimumPaymentsDueInFiveYearsAndThereafter" xlink:label="loc_cpix_OperatingLeasesFutureMinimumPaymentsDueInFiveYearsAndThereafter_454ABA12FD908F014051902061A86B51" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1D765A8EC280A5FFCF24902061A7689A" xlink:to="loc_cpix_OperatingLeasesFutureMinimumPaymentsDueInFiveYearsAndThereafter_454ABA12FD908F014051902061A86B51" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_C5EC27B6E7EF5BDBF370902061A8A2D3" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1D765A8EC280A5FFCF24902061A7689A" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_C5EC27B6E7EF5BDBF370902061A8A2D3" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/LeasesTables" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_F9F59C205918574689B8DF8100330403" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_8ADC766C50195A639F30EF85DC8639B6" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_F9F59C205918574689B8DF8100330403" xlink:to="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_8ADC766C50195A639F30EF85DC8639B6" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/ManufacturingAndSupplyAgreements" xlink:type="extended">
    <loc xlink:href="cpix-20161231.xsd#cpix_ManufacturingAndSupplyAgreementsAbstract" xlink:label="loc_cpix_ManufacturingAndSupplyAgreementsAbstract_F4AB7CC941B352F6A76FE04A07007CEF" xlink:type="locator" />
    <loc xlink:href="cpix-20161231.xsd#cpix_ManufacturingAndSupplyAgreementsTextBlock" xlink:label="loc_cpix_ManufacturingAndSupplyAgreementsTextBlock_77FB193B6BA45269A6B14734B08E23B4" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_ManufacturingAndSupplyAgreementsAbstract_F4AB7CC941B352F6A76FE04A07007CEF" xlink:to="loc_cpix_ManufacturingAndSupplyAgreementsTextBlock_77FB193B6BA45269A6B14734B08E23B4" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/ManufacturingAndSupplyAgreementsManufacturingAndSupplyAgreementsNarrativeDetails" xlink:type="extended">
    <loc xlink:href="cpix-20161231.xsd#cpix_ManufacturingAndSupplyAgreementsAbstract" xlink:label="loc_cpix_ManufacturingAndSupplyAgreementsAbstract_837E023A8EA0F94F5C97AF88D183477C" xlink:type="locator" />
    <loc xlink:href="cpix-20161231.xsd#cpix_ManufacturingandSupplyAgreementTable" xlink:label="loc_cpix_ManufacturingandSupplyAgreementTable_0F23D6D7C83D05DF469CAF89CBBFD259" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_ManufacturingAndSupplyAgreementsAbstract_837E023A8EA0F94F5C97AF88D183477C" xlink:to="loc_cpix_ManufacturingandSupplyAgreementTable_0F23D6D7C83D05DF469CAF89CBBFD259" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_37CE60E2CC311AFA7C43AF89E80E5FAD" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_ManufacturingandSupplyAgreementTable_0F23D6D7C83D05DF469CAF89CBBFD259" xlink:to="loc_us-gaap_RangeAxis_37CE60E2CC311AFA7C43AF89E80E5FAD" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_C14A913C0501CC219192AF89E9E71EDD" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis_37CE60E2CC311AFA7C43AF89E80E5FAD" xlink:to="loc_us-gaap_RangeMember_C14A913C0501CC219192AF89E9E71EDD" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_FF7A6A1351A2AB2811A4AF8A0B7EB46E" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_C14A913C0501CC219192AF89E9E71EDD" xlink:to="loc_us-gaap_MinimumMember_FF7A6A1351A2AB2811A4AF8A0B7EB46E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_29DD1C83FE701E86E8FAAF8A2F113F1E" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_C14A913C0501CC219192AF89E9E71EDD" xlink:to="loc_us-gaap_MaximumMember_29DD1C83FE701E86E8FAAF8A2F113F1E" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_ManufacturingandSupplyAgreementLineItems" xlink:label="loc_cpix_ManufacturingandSupplyAgreementLineItems_9ED7A668D07754B6069FAF89CBC5B02A" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_ManufacturingandSupplyAgreementTable_0F23D6D7C83D05DF469CAF89CBBFD259" xlink:to="loc_cpix_ManufacturingandSupplyAgreementLineItems_9ED7A668D07754B6069FAF89CBC5B02A" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_ManufacturingAgreementsNumberOfPrimarySuppliersForEachProduct" xlink:label="loc_cpix_ManufacturingAgreementsNumberOfPrimarySuppliersForEachProduct_FB79930DCA9362F79481AF88D18566F5" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_ManufacturingandSupplyAgreementLineItems_9ED7A668D07754B6069FAF89CBC5B02A" xlink:to="loc_cpix_ManufacturingAgreementsNumberOfPrimarySuppliersForEachProduct_FB79930DCA9362F79481AF88D18566F5" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/MarketConcentrations" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_DE6AC3E28ED5582EBACE02E6C28FA22F" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="loc_us-gaap_ConcentrationRiskDisclosureTextBlock_AC8CDB3677785B489CA8E09F089AB7D8" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_DE6AC3E28ED5582EBACE02E6C28FA22F" xlink:to="loc_us-gaap_ConcentrationRiskDisclosureTextBlock_AC8CDB3677785B489CA8E09F089AB7D8" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/MarketConcentrationsScheduleOfRevenuesConcentrationFromMajorCustomersAndNarrativeDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_898C1019703257EE9712CF5DD8DA7922" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaap_ConcentrationRiskTable_3A801527A96E5E4193ED648693776F22" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_898C1019703257EE9712CF5DD8DA7922" xlink:to="loc_us-gaap_ConcentrationRiskTable_3A801527A96E5E4193ED648693776F22" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_F1BB2258E74058DAB9A70D4611487CD1" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_3A801527A96E5E4193ED648693776F22" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_F1BB2258E74058DAB9A70D4611487CD1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_91703C0D67DF5135B9D6ACBDF3C75C0C" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_F1BB2258E74058DAB9A70D4611487CD1" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_91703C0D67DF5135B9D6ACBDF3C75C0C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_37687793578A5A67AFC16C269A5547D0" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_91703C0D67DF5135B9D6ACBDF3C75C0C" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_37687793578A5A67AFC16C269A5547D0" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_04C79C1855715E9E8753161CA35E1F95" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_3A801527A96E5E4193ED648693776F22" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_04C79C1855715E9E8753161CA35E1F95" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_751754216ACF5FEBA23FB664DF83C013" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_04C79C1855715E9E8753161CA35E1F95" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_751754216ACF5FEBA23FB664DF83C013" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_SalesRevenueGoodsGrossMember" xlink:label="loc_cpix_SalesRevenueGoodsGrossMember_CEC90EE2C1AA5DFD8F911952959AB4E3" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_751754216ACF5FEBA23FB664DF83C013" xlink:to="loc_cpix_SalesRevenueGoodsGrossMember_CEC90EE2C1AA5DFD8F911952959AB4E3" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaap_AccountsReceivableMember_D9AB8CB402E951359534AF928E579E00" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_751754216ACF5FEBA23FB664DF83C013" xlink:to="loc_us-gaap_AccountsReceivableMember_D9AB8CB402E951359534AF928E579E00" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MajorCustomersAxis" xlink:label="loc_us-gaap_MajorCustomersAxis_9ACC1B70513F5E718580954B93B918AE" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_3A801527A96E5E4193ED648693776F22" xlink:to="loc_us-gaap_MajorCustomersAxis_9ACC1B70513F5E718580954B93B918AE" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NameOfMajorCustomerDomain" xlink:label="loc_us-gaap_NameOfMajorCustomerDomain_884DBA88E16D5AC0972927CD8C9379C9" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MajorCustomersAxis_9ACC1B70513F5E718580954B93B918AE" xlink:to="loc_us-gaap_NameOfMajorCustomerDomain_884DBA88E16D5AC0972927CD8C9379C9" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_CustomerOneMember" xlink:label="loc_cpix_CustomerOneMember_E84BBBD453D65DFAA7E2CF8241595CB7" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NameOfMajorCustomerDomain_884DBA88E16D5AC0972927CD8C9379C9" xlink:to="loc_cpix_CustomerOneMember_E84BBBD453D65DFAA7E2CF8241595CB7" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_CustomerTwoMember" xlink:label="loc_cpix_CustomerTwoMember_50C1FF24612F500C93712D464C472FA6" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NameOfMajorCustomerDomain_884DBA88E16D5AC0972927CD8C9379C9" xlink:to="loc_cpix_CustomerTwoMember_50C1FF24612F500C93712D464C472FA6" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_CustomerThreeMember" xlink:label="loc_cpix_CustomerThreeMember_A20F03A7486A56C9B40031266F094BBA" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NameOfMajorCustomerDomain_884DBA88E16D5AC0972927CD8C9379C9" xlink:to="loc_cpix_CustomerThreeMember_A20F03A7486A56C9B40031266F094BBA" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_CustomerFourMember" xlink:label="loc_cpix_CustomerFourMember_BAE2D3E896F55AEE804CB64E2FCF4AC6" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NameOfMajorCustomerDomain_884DBA88E16D5AC0972927CD8C9379C9" xlink:to="loc_cpix_CustomerFourMember_BAE2D3E896F55AEE804CB64E2FCF4AC6" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_6EBFAD276D4B593F80EEF149AF017F4F" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_3A801527A96E5E4193ED648693776F22" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_6EBFAD276D4B593F80EEF149AF017F4F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_118DFA77A3645D21B63A534C21C7F238" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6EBFAD276D4B593F80EEF149AF017F4F" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_118DFA77A3645D21B63A534C21C7F238" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_ConcentrationRiskNumberOfMajorCustomersExceeding10PercentThreshhold" xlink:label="loc_cpix_ConcentrationRiskNumberOfMajorCustomersExceeding10PercentThreshhold_C513D14025B853F3B6389678B1A74437" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6EBFAD276D4B593F80EEF149AF017F4F" xlink:to="loc_cpix_ConcentrationRiskNumberOfMajorCustomersExceeding10PercentThreshhold_C513D14025B853F3B6389678B1A74437" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/MarketConcentrationsTables" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_5032004A75F25B69B30213A4C04DE546" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:label="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_A5C2FA2C8F8B529C8496D387DA0C37D1" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_5032004A75F25B69B30213A4C04DE546" xlink:to="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_A5C2FA2C8F8B529C8496D387DA0C37D1" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/Organization" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_CB57839C43FD54BBAD91CD1CCCA2250E" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_6C47A2396B46544FA1B50F7C69E32464" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_CB57839C43FD54BBAD91CD1CCCA2250E" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_6C47A2396B46544FA1B50F7C69E32464" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/OrganizationNarrativeDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7BC59850A692A425C46190206399FAD1" xlink:type="locator" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntitiesTable" xlink:label="loc_dei_EntitiesTable_A96B597C4450116851EB9020639AB4FC" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7BC59850A692A425C46190206399FAD1" xlink:to="loc_dei_EntitiesTable_A96B597C4450116851EB9020639AB4FC" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_2747E055658AF68945779020639A9A5C" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_A96B597C4450116851EB9020639AB4FC" xlink:to="loc_dei_LegalEntityAxis_2747E055658AF68945779020639A9A5C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_E4B745A1CDCF8625C2309020639A220E" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_2747E055658AF68945779020639A9A5C" xlink:to="loc_dei_EntityDomain_E4B745A1CDCF8625C2309020639A220E" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_CumberlandEmergingTechnologiesIncMember" xlink:label="loc_cpix_CumberlandEmergingTechnologiesIncMember_E5D36B10706272F04A779020639AEAC8" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_E4B745A1CDCF8625C2309020639A220E" xlink:to="loc_cpix_CumberlandEmergingTechnologiesIncMember_E5D36B10706272F04A779020639AEAC8" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CounterpartyNameAxis" xlink:label="loc_us-gaap_CounterpartyNameAxis_24491E6E83CBC2B1F2749020639A595C" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_A96B597C4450116851EB9020639AB4FC" xlink:to="loc_us-gaap_CounterpartyNameAxis_24491E6E83CBC2B1F2749020639A595C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain_78C04F170FA20B0D36E09020639A5D0A" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CounterpartyNameAxis_24491E6E83CBC2B1F2749020639A595C" xlink:to="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain_78C04F170FA20B0D36E09020639A5D0A" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_HarbinGloriaPharmaceuticalsCoMember" xlink:label="loc_cpix_HarbinGloriaPharmaceuticalsCoMember_EFD692E5D52E5C8702239020639A3A89" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain_78C04F170FA20B0D36E09020639A5D0A" xlink:to="loc_cpix_HarbinGloriaPharmaceuticalsCoMember_EFD692E5D52E5C8702239020639A3A89" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityInformationLineItems" xlink:label="loc_dei_EntityInformationLineItems_A1208289976B8C3AA2AD9020639A02E4" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_A96B597C4450116851EB9020639AB4FC" xlink:to="loc_dei_EntityInformationLineItems_A1208289976B8C3AA2AD9020639A02E4" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_7CC112D80A719CD01BDB9020639A169A" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_A1208289976B8C3AA2AD9020639A02E4" xlink:to="loc_us-gaap_NoncontrollingInterestAbstract_7CC112D80A719CD01BDB9020639A169A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_6007CC81DE30E69EFC0D9020639AD1DC" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_7CC112D80A719CD01BDB9020639A169A" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_6007CC81DE30E69EFC0D9020639AD1DC" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_22F597CBB817410FE1009020639AABD0" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_7CC112D80A719CD01BDB9020639A169A" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_22F597CBB817410FE1009020639AABD0" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_F9394A56C7BF1B25912C9020639A7E65" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_7CC112D80A719CD01BDB9020639A169A" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_F9394A56C7BF1B25912C9020639A7E65" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/OtherCurrentLiabilities" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherLiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_OtherLiabilitiesCurrentAbstract_19FB027BBD7B572183308CA3A9B9D4DF" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock_8FFB740229BF579E83AAA7A7CC12423A" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_19FB027BBD7B572183308CA3A9B9D4DF" xlink:to="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock_8FFB740229BF579E83AAA7A7CC12423A" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/OtherCurrentLiabilitiesScheduleOfAccruedLiabilitiesDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherLiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_OtherLiabilitiesCurrentAbstract_709CF507D58E6B7AB42C902063312FF4" xlink:type="locator" />
    <loc xlink:href="cpix-20161231.xsd#cpix_ProductSalesRelatedLiabilitiesCurrent" xlink:label="loc_cpix_ProductSalesRelatedLiabilitiesCurrent_3439A44C7B34789BF99A90206331F400" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_709CF507D58E6B7AB42C902063312FF4" xlink:to="loc_cpix_ProductSalesRelatedLiabilitiesCurrent_3439A44C7B34789BF99A90206331F400" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_099815118462B895575A90206331BFF6" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_709CF507D58E6B7AB42C902063312FF4" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_099815118462B895575A90206331BFF6" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_BE7CF2D0A972394A6540902063368CEE" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_709CF507D58E6B7AB42C902063312FF4" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_BE7CF2D0A972394A6540902063368CEE" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_BCFA0D13C2207DA3A42790206337E3B8" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_709CF507D58E6B7AB42C902063312FF4" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_BCFA0D13C2207DA3A42790206337E3B8" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/OtherCurrentLiabilitiesTables" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherLiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_OtherLiabilitiesCurrentAbstract_9A31FCF713D954A79AC17E9DBE9ECFC1" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_52D7EB42BBAE57EE9AC4F280CA86F644" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_9A31FCF713D954A79AC17E9DBE9ECFC1" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_52D7EB42BBAE57EE9AC4F280CA86F644" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/PropertyAndEquipment" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_6F1D5D974C1F5373B9FA642F72246DC1" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_9DE8A1FBE11752DE84C39A86BFCFB9D5" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_6F1D5D974C1F5373B9FA642F72246DC1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_9DE8A1FBE11752DE84C39A86BFCFB9D5" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/PropertyAndEquipmentNarrativeDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_14D41DC33672856815159020635CF094" xlink:type="locator" />
    <loc xlink:href="cpix-20161231.xsd#cpix_DepreciationIncludingAmortizationRelatedToLeaseholdImprovements" xlink:label="loc_cpix_DepreciationIncludingAmortizationRelatedToLeaseholdImprovements_AD9389E58F607913A29E9020635C6AFE" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_14D41DC33672856815159020635CF094" xlink:to="loc_cpix_DepreciationIncludingAmortizationRelatedToLeaseholdImprovements_AD9389E58F607913A29E9020635C6AFE" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/PropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_2A7991AD27EA5BF1AC8288A9FBF9BD50" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4E8557F8A9675856A9E1F4B60D23D6AE" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_2A7991AD27EA5BF1AC8288A9FBF9BD50" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4E8557F8A9675856A9E1F4B60D23D6AE" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_D867EE91558257F1810D2A160A6FE927" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4E8557F8A9675856A9E1F4B60D23D6AE" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_D867EE91558257F1810D2A160A6FE927" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_C475A12AE49A5396B31BA8D7CAE68DFA" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_D867EE91558257F1810D2A160A6FE927" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_C475A12AE49A5396B31BA8D7CAE68DFA" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaap_ComputerEquipmentMember_4FE19E2A651B50659BD12BF66022FAB1" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_C475A12AE49A5396B31BA8D7CAE68DFA" xlink:to="loc_us-gaap_ComputerEquipmentMember_4FE19E2A651B50659BD12BF66022FAB1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OfficeEquipmentMember" xlink:label="loc_us-gaap_OfficeEquipmentMember_9C378327348C53F5BED5D2003C733868" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_C475A12AE49A5396B31BA8D7CAE68DFA" xlink:to="loc_us-gaap_OfficeEquipmentMember_9C378327348C53F5BED5D2003C733868" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_52FA61E2DFBD59948DDF8D9554C03C03" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_C475A12AE49A5396B31BA8D7CAE68DFA" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_52FA61E2DFBD59948DDF8D9554C03C03" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_638907B3894553D08109F7376987921F" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_C475A12AE49A5396B31BA8D7CAE68DFA" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_638907B3894553D08109F7376987921F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_04DC8A9E2E73584EA5C681E18EAF0C23" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4E8557F8A9675856A9E1F4B60D23D6AE" xlink:to="loc_us-gaap_RangeAxis_04DC8A9E2E73584EA5C681E18EAF0C23" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_5601D7CEF90C57DDAE1CD6067382A437" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis_04DC8A9E2E73584EA5C681E18EAF0C23" xlink:to="loc_us-gaap_RangeMember_5601D7CEF90C57DDAE1CD6067382A437" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_1417B5DDF17A57A2B9F5559F250FFD06" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_5601D7CEF90C57DDAE1CD6067382A437" xlink:to="loc_us-gaap_MinimumMember_1417B5DDF17A57A2B9F5559F250FFD06" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_12BA4EB72CC653A89B64B8CC9E30ABAD" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_5601D7CEF90C57DDAE1CD6067382A437" xlink:to="loc_us-gaap_MaximumMember_12BA4EB72CC653A89B64B8CC9E30ABAD" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7F6FA39A42D45A43BE8B770F971AB7C5" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4E8557F8A9675856A9E1F4B60D23D6AE" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7F6FA39A42D45A43BE8B770F971AB7C5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_2D7901F047105E318B4C397EC2356511" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7F6FA39A42D45A43BE8B770F971AB7C5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_2D7901F047105E318B4C397EC2356511" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_A9F6EBAC15C75EBBBFA149312C468D26" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7F6FA39A42D45A43BE8B770F971AB7C5" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_A9F6EBAC15C75EBBBFA149312C468D26" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_B6CC526F5CB3546E90448F35EDF63FB2" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7F6FA39A42D45A43BE8B770F971AB7C5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_B6CC526F5CB3546E90448F35EDF63FB2" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_0BE9CBD45DBC5915A321F72F849A5AB4" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7F6FA39A42D45A43BE8B770F971AB7C5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_0BE9CBD45DBC5915A321F72F849A5AB4" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_PropertyAndEquipmentUsefulLifeTextual" xlink:label="loc_cpix_PropertyAndEquipmentUsefulLifeTextual_EF4FC9E106855B56A61151CAE261DAE8" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7F6FA39A42D45A43BE8B770F971AB7C5" xlink:to="loc_cpix_PropertyAndEquipmentUsefulLifeTextual_EF4FC9E106855B56A61151CAE261DAE8" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/PropertyAndEquipmentTables" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_5000DD1797105054B7CDDFA4C55CA985" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_59DAD58061A25460A5DF105E4A046672" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_5000DD1797105054B7CDDFA4C55CA985" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_59DAD58061A25460A5DF105E4A046672" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/QuarterlyFinancialInformationScheduleOfQuarterlyFinancialInformationUnauditedDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_3CC0B165395054E6A4009E09964F1088" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaap_SalesRevenueNet_E01C1948DB0A58E6AAC7E3EEEAFCC28C" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_3CC0B165395054E6A4009E09964F1088" xlink:to="loc_us-gaap_SalesRevenueNet_E01C1948DB0A58E6AAC7E3EEEAFCC28C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_5DD46950FF0B5687A96D12F5960940B7" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_3CC0B165395054E6A4009E09964F1088" xlink:to="loc_us-gaap_OperatingIncomeLoss_5DD46950FF0B5687A96D12F5960940B7" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_68479B4C474A554D9F7135CFC6225316" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_3CC0B165395054E6A4009E09964F1088" xlink:to="loc_us-gaap_NetIncomeLoss_68479B4C474A554D9F7135CFC6225316" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_6FEE2C67013A5A698C1E459ADF197FAD" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_3CC0B165395054E6A4009E09964F1088" xlink:to="loc_us-gaap_EarningsPerShareAbstract_6FEE2C67013A5A698C1E459ADF197FAD" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_84DC8ACC4A6E58DEA75E6E9057A9011C" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6FEE2C67013A5A698C1E459ADF197FAD" xlink:to="loc_us-gaap_EarningsPerShareBasic_84DC8ACC4A6E58DEA75E6E9057A9011C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_C04515FFC533554CA8EBDCBB06049B1A" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6FEE2C67013A5A698C1E459ADF197FAD" xlink:to="loc_us-gaap_EarningsPerShareDiluted_C04515FFC533554CA8EBDCBB06049B1A" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/QuarterlyFinancialInformationUnaudited" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_FF25B08811BB50F8A40774E4E45F0F5C" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock" xlink:label="loc_us-gaap_QuarterlyFinancialInformationTextBlock_A2135A15F2A45E4AA363BC5B8D04C66A" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_FF25B08811BB50F8A40774E4E45F0F5C" xlink:to="loc_us-gaap_QuarterlyFinancialInformationTextBlock_A2135A15F2A45E4AA363BC5B8D04C66A" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/QuarterlyFinancialInformationUnauditedTables" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_425E33D467B05911A7CE82BD8537D14B" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_CBE7BE8BF20150A1A1A0A510E00465F2" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_425E33D467B05911A7CE82BD8537D14B" xlink:to="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_CBE7BE8BF20150A1A1A0A510E00465F2" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/Revenues" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaap_RevenuesAbstract_69C365FFBC765D9BB69880AE5AA2C3FB" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:label="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_9C3C7EF181CC5FEBA351A0E7DF0B6041" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_69C365FFBC765D9BB69880AE5AA2C3FB" xlink:to="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_9C3C7EF181CC5FEBA351A0E7DF0B6041" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/RevenuesNarrativeDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaap_RevenuesAbstract_497EC94BC78749639C999020637122DE" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AirlineProductsAndServicesTable" xlink:label="loc_us-gaap_AirlineProductsAndServicesTable_F8DB506121A99463C8F4902063718F63" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_497EC94BC78749639C999020637122DE" xlink:to="loc_us-gaap_AirlineProductsAndServicesTable_F8DB506121A99463C8F4902063718F63" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="loc_us-gaap_StatementGeographicalAxis_BA222EB71ABCFF8448A3902063718CBB" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AirlineProductsAndServicesTable_F8DB506121A99463C8F4902063718F63" xlink:to="loc_us-gaap_StatementGeographicalAxis_BA222EB71ABCFF8448A3902063718CBB" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="loc_us-gaap_SegmentGeographicalDomain_93BD76E560B35128F922902063714267" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementGeographicalAxis_BA222EB71ABCFF8448A3902063718CBB" xlink:to="loc_us-gaap_SegmentGeographicalDomain_93BD76E560B35128F922902063714267" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_OutsideUnitedStatesMember" xlink:label="loc_cpix_OutsideUnitedStatesMember_CCA30DD2019D5DFFCB1F902063716263" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentGeographicalDomain_93BD76E560B35128F922902063714267" xlink:to="loc_cpix_OutsideUnitedStatesMember_CCA30DD2019D5DFFCB1F902063716263" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaap_TypeOfArrangementAxis_5691EE7B71C92B0148B4902063718F14" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AirlineProductsAndServicesTable_F8DB506121A99463C8F4902063718F63" xlink:to="loc_us-gaap_TypeOfArrangementAxis_5691EE7B71C92B0148B4902063718F14" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_29B8B065702877DD5106902063710893" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_5691EE7B71C92B0148B4902063718F14" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_29B8B065702877DD5106902063710893" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_CollaborativeArrangementFederalSmallBusinessGrantProgramsMember" xlink:label="loc_cpix_CollaborativeArrangementFederalSmallBusinessGrantProgramsMember_97392A7A5A856699B622902063712D24" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_29B8B065702877DD5106902063710893" xlink:to="loc_cpix_CollaborativeArrangementFederalSmallBusinessGrantProgramsMember_97392A7A5A856699B622902063712D24" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_AccountsReceivableAllowancesByComponentAxis" xlink:label="loc_cpix_AccountsReceivableAllowancesByComponentAxis_D6E43E7D05936747AFC890206371470A" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AirlineProductsAndServicesTable_F8DB506121A99463C8F4902063718F63" xlink:to="loc_cpix_AccountsReceivableAllowancesByComponentAxis_D6E43E7D05936747AFC890206371470A" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_AccountsReceivableAllowancesByComponentDomain" xlink:label="loc_cpix_AccountsReceivableAllowancesByComponentDomain_AEF8771C360EB3C49A2890206371BADC" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_AccountsReceivableAllowancesByComponentAxis_D6E43E7D05936747AFC890206371470A" xlink:to="loc_cpix_AccountsReceivableAllowancesByComponentDomain_AEF8771C360EB3C49A2890206371BADC" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_ChargebacksCashDiscountsAndDamagedGoodsMember" xlink:label="loc_cpix_ChargebacksCashDiscountsAndDamagedGoodsMember_09ABF1BE432A2F343D0F90206371CBF6" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_AccountsReceivableAllowancesByComponentDomain_AEF8771C360EB3C49A2890206371BADC" xlink:to="loc_cpix_ChargebacksCashDiscountsAndDamagedGoodsMember_09ABF1BE432A2F343D0F90206371CBF6" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductOrServiceAxis" xlink:label="loc_us-gaap_ProductOrServiceAxis_3CD39148C1FBD9B28BB890206371FFE6" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AirlineProductsAndServicesTable_F8DB506121A99463C8F4902063718F63" xlink:to="loc_us-gaap_ProductOrServiceAxis_3CD39148C1FBD9B28BB890206371FFE6" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductsAndServicesDomain" xlink:label="loc_us-gaap_ProductsAndServicesDomain_19A2346BB75D4429954690206371D773" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductOrServiceAxis_3CD39148C1FBD9B28BB890206371FFE6" xlink:to="loc_us-gaap_ProductsAndServicesDomain_19A2346BB75D4429954690206371D773" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_CaldolorMember" xlink:label="loc_cpix_CaldolorMember_3629319F23868B9EF20090206372718B" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductsAndServicesDomain_19A2346BB75D4429954690206371D773" xlink:to="loc_cpix_CaldolorMember_3629319F23868B9EF20090206372718B" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_ProductAcetadoteGenericMember" xlink:label="loc_cpix_ProductAcetadoteGenericMember_F661478F738026F082BE90206372E468" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductsAndServicesDomain_19A2346BB75D4429954690206371D773" xlink:to="loc_cpix_ProductAcetadoteGenericMember_F661478F738026F082BE90206372E468" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_ProductEthyolMember" xlink:label="loc_cpix_ProductEthyolMember_43C4081504E199EBE78590397FA24366" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductsAndServicesDomain_19A2346BB75D4429954690206371D773" xlink:to="loc_cpix_ProductEthyolMember_43C4081504E199EBE78590397FA24366" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_AccruedLiabilitiesCurrentByComponentAxis" xlink:label="loc_cpix_AccruedLiabilitiesCurrentByComponentAxis_1B05BFA0256F93A423BE90206372E11F" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AirlineProductsAndServicesTable_F8DB506121A99463C8F4902063718F63" xlink:to="loc_cpix_AccruedLiabilitiesCurrentByComponentAxis_1B05BFA0256F93A423BE90206372E11F" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_AccruedLiabilitiesCurrentByComponentDomain" xlink:label="loc_cpix_AccruedLiabilitiesCurrentByComponentDomain_0A39A205FF978FFC2FC1902063724926" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_AccruedLiabilitiesCurrentByComponentAxis_1B05BFA0256F93A423BE90206372E11F" xlink:to="loc_cpix_AccruedLiabilitiesCurrentByComponentDomain_0A39A205FF978FFC2FC1902063724926" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_ProductSalesRelatedAccrualsRebatesProductReturnsAdministrativeFeesAndServiceFeesMember" xlink:label="loc_cpix_ProductSalesRelatedAccrualsRebatesProductReturnsAdministrativeFeesAndServiceFeesMember_1D9F67343C237DB1C751902063723A10" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_AccruedLiabilitiesCurrentByComponentDomain_0A39A205FF978FFC2FC1902063724926" xlink:to="loc_cpix_ProductSalesRelatedAccrualsRebatesProductReturnsAdministrativeFeesAndServiceFeesMember_1D9F67343C237DB1C751902063723A10" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_EC40867B9CFA689A4A0F90206372B87A" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AirlineProductsAndServicesTable_F8DB506121A99463C8F4902063718F63" xlink:to="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_EC40867B9CFA689A4A0F90206372B87A" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_ProductRevenuesAbstract" xlink:label="loc_cpix_ProductRevenuesAbstract_00CEA2DCBE01B1BEAC0B9020637278B5" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_EC40867B9CFA689A4A0F90206372B87A" xlink:to="loc_cpix_ProductRevenuesAbstract_00CEA2DCBE01B1BEAC0B9020637278B5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesRevenueGoodsNet" xlink:label="loc_us-gaap_SalesRevenueGoodsNet_906D626767C3702C75F6902063726A33" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_ProductRevenuesAbstract_00CEA2DCBE01B1BEAC0B9020637278B5" xlink:to="loc_us-gaap_SalesRevenueGoodsNet_906D626767C3702C75F6902063726A33" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_BB67C2827EC52703561B902063727620" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_ProductRevenuesAbstract_00CEA2DCBE01B1BEAC0B9020637278B5" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_BB67C2827EC52703561B902063727620" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_C2F3A49C8CC0853D2798902063727173" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_ProductRevenuesAbstract_00CEA2DCBE01B1BEAC0B9020637278B5" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_C2F3A49C8CC0853D2798902063727173" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_OtherRevenuesAbstract" xlink:label="loc_cpix_OtherRevenuesAbstract_F6D20610DD4498438A61902063723277" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_EC40867B9CFA689A4A0F90206372B87A" xlink:to="loc_cpix_OtherRevenuesAbstract_F6D20610DD4498438A61902063723277" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_RevenueRecognitionUpfrontPayment" xlink:label="loc_cpix_RevenueRecognitionUpfrontPayment_69C849B9B27E0FE14FD9902063723869" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_OtherRevenuesAbstract_F6D20610DD4498438A61902063723277" xlink:to="loc_cpix_RevenueRecognitionUpfrontPayment_69C849B9B27E0FE14FD9902063723869" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_RevenueRecognitionPotentialUpfrontPaymentsRelatedtoRegulatoryApproval" xlink:label="loc_cpix_RevenueRecognitionPotentialUpfrontPaymentsRelatedtoRegulatoryApproval_FC934A250C3D7E3D3137902063721FE6" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_OtherRevenuesAbstract_F6D20610DD4498438A61902063723277" xlink:to="loc_cpix_RevenueRecognitionPotentialUpfrontPaymentsRelatedtoRegulatoryApproval_FC934A250C3D7E3D3137902063721FE6" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_RevenueRecognitionPotentialUpfrontPaymentRelatedtoProductSales" xlink:label="loc_cpix_RevenueRecognitionPotentialUpfrontPaymentRelatedtoProductSales_81DBD5371CE5058636B8902063729355" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_OtherRevenuesAbstract_F6D20610DD4498438A61902063723277" xlink:to="loc_cpix_RevenueRecognitionPotentialUpfrontPaymentRelatedtoProductSales_81DBD5371CE5058636B8902063729355" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_RevenueRecognitionCumulativeUpfrontPayment" xlink:label="loc_cpix_RevenueRecognitionCumulativeUpfrontPayment_92A90C2B0B06057DD9A89020637220CD" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_OtherRevenuesAbstract_F6D20610DD4498438A61902063723277" xlink:to="loc_cpix_RevenueRecognitionCumulativeUpfrontPayment_92A90C2B0B06057DD9A89020637220CD" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_RevenueRecognitionRelatedtoMilestonePayments" xlink:label="loc_cpix_RevenueRecognitionRelatedtoMilestonePayments_AF802EF42F5863D277DB905175FD5EF1" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_OtherRevenuesAbstract_F6D20610DD4498438A61902063723277" xlink:to="loc_cpix_RevenueRecognitionRelatedtoMilestonePayments_AF802EF42F5863D277DB905175FD5EF1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RevenueFromGrants" xlink:label="loc_us-gaap_RevenueFromGrants_09324FA798BDEB1B613B90206372AB73" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_OtherRevenuesAbstract_F6D20610DD4498438A61902063723277" xlink:to="loc_us-gaap_RevenueFromGrants_09324FA798BDEB1B613B90206372AB73" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/RevenuesScheduleOfNetProductRevenuesByProductDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaap_RevenuesAbstract_B9DD3E39D157C80080CDAE90BF45D861" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_FF0C79EB4456688E9685AE90BF45F687" xlink:type="locator" />
    <presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_B9DD3E39D157C80080CDAE90BF45D861" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_FF0C79EB4456688E9685AE90BF45F687" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductOrServiceAxis" xlink:label="loc_us-gaap_ProductOrServiceAxis_FEB008C3AE4FFDE4FF22AE90BF462D48" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_FF0C79EB4456688E9685AE90BF45F687" xlink:to="loc_us-gaap_ProductOrServiceAxis_FEB008C3AE4FFDE4FF22AE90BF462D48" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductsAndServicesDomain" xlink:label="loc_us-gaap_ProductsAndServicesDomain_74E2ACE9F6683CB06B2EAE90BF462670" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductOrServiceAxis_FEB008C3AE4FFDE4FF22AE90BF462D48" xlink:to="loc_us-gaap_ProductsAndServicesDomain_74E2ACE9F6683CB06B2EAE90BF462670" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_AcetadoteMember" xlink:label="loc_cpix_AcetadoteMember_D0FD1C5AB99ACB5FA594AE90BF4620E9" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductsAndServicesDomain_74E2ACE9F6683CB06B2EAE90BF462670" xlink:to="loc_cpix_AcetadoteMember_D0FD1C5AB99ACB5FA594AE90BF4620E9" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_OmeclamoxPakMember" xlink:label="loc_cpix_OmeclamoxPakMember_D917B5BDA4AE1A0E4ED0AE90BF465826" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductsAndServicesDomain_74E2ACE9F6683CB06B2EAE90BF462670" xlink:to="loc_cpix_OmeclamoxPakMember_D917B5BDA4AE1A0E4ED0AE90BF465826" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_KristaloseMember" xlink:label="loc_cpix_KristaloseMember_5E3053969EBA73369103AE90BF46B2C1" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductsAndServicesDomain_74E2ACE9F6683CB06B2EAE90BF462670" xlink:to="loc_cpix_KristaloseMember_5E3053969EBA73369103AE90BF46B2C1" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_VaprisolMember" xlink:label="loc_cpix_VaprisolMember_070411E30D9473E4D746AE90BF46DE0D" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductsAndServicesDomain_74E2ACE9F6683CB06B2EAE90BF462670" xlink:to="loc_cpix_VaprisolMember_070411E30D9473E4D746AE90BF46DE0D" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_CaldolorMember" xlink:label="loc_cpix_CaldolorMember_2B6BC0CF86F3905FCAD2AE90BF46F6F3" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductsAndServicesDomain_74E2ACE9F6683CB06B2EAE90BF462670" xlink:to="loc_cpix_CaldolorMember_2B6BC0CF86F3905FCAD2AE90BF46F6F3" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_ProductEthyolMember" xlink:label="loc_cpix_ProductEthyolMember_4376B0AE11380BD24062AE90BF468B69" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductsAndServicesDomain_74E2ACE9F6683CB06B2EAE90BF462670" xlink:to="loc_cpix_ProductEthyolMember_4376B0AE11380BD24062AE90BF468B69" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_E3F311E42014945CD55CAE90BF467347" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_FF0C79EB4456688E9685AE90BF45F687" xlink:to="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_E3F311E42014945CD55CAE90BF467347" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesRevenueGoodsNet" xlink:label="loc_us-gaap_SalesRevenueGoodsNet_E7B0AC24502B522B8852AE90BF46D818" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_E3F311E42014945CD55CAE90BF467347" xlink:to="loc_us-gaap_SalesRevenueGoodsNet_E7B0AC24502B522B8852AE90BF46D818" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/RevenuesTables" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaap_RevenuesAbstract_986D8A30F44550ECA6C965DE0A1020D0" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_80EC22E1A5EB500D9606BD81CCF41BDE" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_986D8A30F44550ECA6C965DE0A1020D0" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_80EC22E1A5EB500D9606BD81CCF41BDE" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/ShareholdersEquity" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_D5C21EB19A2956189B46F3AC2CE19C27" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_D9FB0670B9545E1EBF5732EB6F251632" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_D5C21EB19A2956189B46F3AC2CE19C27" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_D9FB0670B9545E1EBF5732EB6F251632" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/ShareholdersEquityInitialPublicOfferingPreferredStockAndCommonStockNarrativeDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_E57D96CF38A4564E7F9D90C04BE9DCF9" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_AFF0E0E3200E0235965490C04BE91BEB" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_E57D96CF38A4564E7F9D90C04BE9DCF9" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_AFF0E0E3200E0235965490C04BE91BEB" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_EA0EAA353BF4DBB523C090C04BE9E6E0" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_AFF0E0E3200E0235965490C04BE91BEB" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_EA0EAA353BF4DBB523C090C04BE9E6E0" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_B4AB57FC53AD8500E20F90C04BEAB518" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_EA0EAA353BF4DBB523C090C04BE9E6E0" xlink:to="loc_us-gaap_EquityComponentDomain_B4AB57FC53AD8500E20F90C04BEAB518" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_31EE5622A20279FFB8ED90C04BEA1D05" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_B4AB57FC53AD8500E20F90C04BEAB518" xlink:to="loc_us-gaap_CommonStockMember_31EE5622A20279FFB8ED90C04BEA1D05" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_A3660D48F776CE3BB73390C04BEA1345" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_AFF0E0E3200E0235965490C04BE91BEB" xlink:to="loc_us-gaap_StatementClassOfStockAxis_A3660D48F776CE3BB73390C04BEA1345" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_34E12E5FDBC3F179B2D990C04BEAEB29" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_A3660D48F776CE3BB73390C04BEA1345" xlink:to="loc_us-gaap_ClassOfStockDomain_34E12E5FDBC3F179B2D990C04BEAEB29" xlink:type="arc" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_34E12E5FDBC3F179B2D990C04BEAEB29" xlink:to="loc_us-gaap_CommonStockMember_31EE5622A20279FFB8ED90C04BEA1D05" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems_4386794BC9734A2A3B4D90C04BEBFB53" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_AFF0E0E3200E0235965490C04BE91BEB" xlink:to="loc_us-gaap_ClassOfStockLineItems_4386794BC9734A2A3B4D90C04BEBFB53" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_InitialPublicOfferingAbstract" xlink:label="loc_cpix_InitialPublicOfferingAbstract_47F89C6F9134B77E60FC90C04BEB5D15" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_4386794BC9734A2A3B4D90C04BEBFB53" xlink:to="loc_cpix_InitialPublicOfferingAbstract_47F89C6F9134B77E60FC90C04BEB5D15" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SaleOfStockTransactionDate" xlink:label="loc_us-gaap_SaleOfStockTransactionDate_4613C355023860160A2E90C04BEC22C8" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_InitialPublicOfferingAbstract_47F89C6F9134B77E60FC90C04BEB5D15" xlink:to="loc_us-gaap_SaleOfStockTransactionDate_4613C355023860160A2E90C04BEC22C8" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_F4EA778DE1152D9A973090C04BECA3FF" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_InitialPublicOfferingAbstract_47F89C6F9134B77E60FC90C04BEB5D15" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_F4EA778DE1152D9A973090C04BECA3FF" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_StockIssuedDuringPeriodPricePerShareNewIssues" xlink:label="loc_cpix_StockIssuedDuringPeriodPricePerShareNewIssues_4CDFAA0C89CB7DE3C67690C04BF1B64B" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_InitialPublicOfferingAbstract_47F89C6F9134B77E60FC90C04BEB5D15" xlink:to="loc_cpix_StockIssuedDuringPeriodPricePerShareNewIssues_4CDFAA0C89CB7DE3C67690C04BF1B64B" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_StockIssuedDuringPeriodGrossProceedsFromInitialPublicOffering" xlink:label="loc_cpix_StockIssuedDuringPeriodGrossProceedsFromInitialPublicOffering_B7426C193FB8137FABF890C04BF1BC4C" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_InitialPublicOfferingAbstract_47F89C6F9134B77E60FC90C04BEB5D15" xlink:to="loc_cpix_StockIssuedDuringPeriodGrossProceedsFromInitialPublicOffering_B7426C193FB8137FABF890C04BF1BC4C" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_StockIssuedDuringPeriodNewSharesUnderwritingDiscounts" xlink:label="loc_cpix_StockIssuedDuringPeriodNewSharesUnderwritingDiscounts_CC576E7D7AFF102DB62290C04BF12428" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_InitialPublicOfferingAbstract_47F89C6F9134B77E60FC90C04BEB5D15" xlink:to="loc_cpix_StockIssuedDuringPeriodNewSharesUnderwritingDiscounts_CC576E7D7AFF102DB62290C04BF12428" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_AF0142E3673316A3011490C04BF139BD" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_InitialPublicOfferingAbstract_47F89C6F9134B77E60FC90C04BEB5D15" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_AF0142E3673316A3011490C04BF139BD" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_5DE19B9ED3D2B77D267D90C04BF18D98" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_InitialPublicOfferingAbstract_47F89C6F9134B77E60FC90C04BEB5D15" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_5DE19B9ED3D2B77D267D90C04BF18D98" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_StockIssuedInInitialPublicOfferingNumberOfSharesCommonStockReceivedForPreferredStockContemporareousWithOffering" xlink:label="loc_cpix_StockIssuedInInitialPublicOfferingNumberOfSharesCommonStockReceivedForPreferredStockContemporareousWithOffering_0D85E5F114EB6B0DF99390C04BF288BF" xlink:type="locator" />
    <presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_InitialPublicOfferingAbstract_47F89C6F9134B77E60FC90C04BEB5D15" xlink:to="loc_cpix_StockIssuedInInitialPublicOfferingNumberOfSharesCommonStockReceivedForPreferredStockContemporareousWithOffering_0D85E5F114EB6B0DF99390C04BF288BF" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_PreferredStockAbstract" xlink:label="loc_cpix_PreferredStockAbstract_BC0719F9B6C9E5D069C890C04BF24124" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_4386794BC9734A2A3B4D90C04BEBFB53" xlink:to="loc_cpix_PreferredStockAbstract_BC0719F9B6C9E5D069C890C04BF24124" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_764BDA07D882E21F987790C04BF26BE9" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_PreferredStockAbstract_BC0719F9B6C9E5D069C890C04BF24124" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_764BDA07D882E21F987790C04BF26BE9" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_CommonStockAbstract" xlink:label="loc_cpix_CommonStockAbstract_6DA20E8151FCB4B410C090C04BF2D1D6" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_4386794BC9734A2A3B4D90C04BEBFB53" xlink:to="loc_cpix_CommonStockAbstract_6DA20E8151FCB4B410C090C04BF2D1D6" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_559BDC905EB936339A4090C04BF2DD57" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_CommonStockAbstract_6DA20E8151FCB4B410C090C04BF2D1D6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_559BDC905EB936339A4090C04BF2DD57" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodNetOfSharesForTaxWithholding" xlink:label="loc_cpix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodNetOfSharesForTaxWithholding_16982A51CE947F0F783490C04BF223DE" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_CommonStockAbstract_6DA20E8151FCB4B410C090C04BF2D1D6" xlink:to="loc_cpix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodNetOfSharesForTaxWithholding_16982A51CE947F0F783490C04BF223DE" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/ShareholdersEquityShareRepurchasesCumberlandEmergingTechnologiesNarrativeDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_05887651DFB4451D97FD90F60C0C2EF4" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfTreasuryStockTable" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_921EF9A79EC440618DEA90F60C0D4875" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_05887651DFB4451D97FD90F60C0C2EF4" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_921EF9A79EC440618DEA90F60C0D4875" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_ACABB96996BEB65BC25B90F60C0DE1CB" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_921EF9A79EC440618DEA90F60C0D4875" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_ACABB96996BEB65BC25B90F60C0DE1CB" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_AF7102A903F0A58014C490F60C0D8A0D" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_ACABB96996BEB65BC25B90F60C0DE1CB" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_AF7102A903F0A58014C490F60C0D8A0D" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_ShareRepurchaseProgramAuthorizedIn2010Member" xlink:label="loc_cpix_ShareRepurchaseProgramAuthorizedIn2010Member_F135818D5F85B3682A7A90F60C0DDD1F" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_AF7102A903F0A58014C490F60C0D8A0D" xlink:to="loc_cpix_ShareRepurchaseProgramAuthorizedIn2010Member_F135818D5F85B3682A7A90F60C0DDD1F" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_SharesRepurchaseActivityTypeAxis" xlink:label="loc_cpix_SharesRepurchaseActivityTypeAxis_0EFA4084BB4FE21C51CC90F60C0DC687" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_921EF9A79EC440618DEA90F60C0D4875" xlink:to="loc_cpix_SharesRepurchaseActivityTypeAxis_0EFA4084BB4FE21C51CC90F60C0DC687" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_SharesRepurchaseActivityTypeDomain" xlink:label="loc_cpix_SharesRepurchaseActivityTypeDomain_B569963D148C881CB03090F60C0E9A93" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_SharesRepurchaseActivityTypeAxis_0EFA4084BB4FE21C51CC90F60C0DC687" xlink:to="loc_cpix_SharesRepurchaseActivityTypeDomain_B569963D148C881CB03090F60C0E9A93" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_SharesRepurchaseAllExceptSettlementOfTaxLiabilitiesRelatedToExerciseOfStockOptionsMember" xlink:label="loc_cpix_SharesRepurchaseAllExceptSettlementOfTaxLiabilitiesRelatedToExerciseOfStockOptionsMember_4BF4676D64F2EE9A383E90F60C0E9158" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_SharesRepurchaseActivityTypeDomain_B569963D148C881CB03090F60C0E9A93" xlink:to="loc_cpix_SharesRepurchaseAllExceptSettlementOfTaxLiabilitiesRelatedToExerciseOfStockOptionsMember_4BF4676D64F2EE9A383E90F60C0E9158" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_E60A86352915539D64D890F60C0EC340" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_921EF9A79EC440618DEA90F60C0D4875" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_E60A86352915539D64D890F60C0EC340" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_3CE723DF6080331B11C690F60C0E938C" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_E60A86352915539D64D890F60C0EC340" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_3CE723DF6080331B11C690F60C0E938C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_2C75FF77D44B422221DA90F60C0EBBB6" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_E60A86352915539D64D890F60C0EC340" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_2C75FF77D44B422221DA90F60C0EBBB6" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_26B937F35B7AB45CA81C90F60C0EA12F" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_E60A86352915539D64D890F60C0EC340" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_26B937F35B7AB45CA81C90F60C0EA12F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_BE9A5C6A52430769B17D90F60C0E5921" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_E60A86352915539D64D890F60C0EC340" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_BE9A5C6A52430769B17D90F60C0E5921" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_0CFC79943C51619C2C8A90F60C0E70EF" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_E60A86352915539D64D890F60C0EC340" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_0CFC79943C51619C2C8A90F60C0E70EF" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_625B84164D3D385AACA090F60C0E709C" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_E60A86352915539D64D890F60C0EC340" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_625B84164D3D385AACA090F60C0E709C" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_LoansForgiveninExchangeForShareIssuedAmount" xlink:label="loc_cpix_LoansForgiveninExchangeForShareIssuedAmount_6F7E9DB55B4168E088A990F60C0E2BBA" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_E60A86352915539D64D890F60C0EC340" xlink:to="loc_cpix_LoansForgiveninExchangeForShareIssuedAmount_6F7E9DB55B4168E088A990F60C0E2BBA" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/ShareholdersEquityWarrantsNarrativeDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_EB9EB3AFB620502DA94504DCA25B58EE" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_ED0C9FE4E1775CDD819FDB43C4AFADA2" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_EB9EB3AFB620502DA94504DCA25B58EE" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_ED0C9FE4E1775CDD819FDB43C4AFADA2" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_13431047CBA451538B29D256738307EC" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_ED0C9FE4E1775CDD819FDB43C4AFADA2" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_13431047CBA451538B29D256738307EC" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_B8F9D4DAD75E53E5A50EEB028C6AA027" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_13431047CBA451538B29D256738307EC" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_B8F9D4DAD75E53E5A50EEB028C6AA027" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_WarrantsIssuedInConsiderationOf2006CreditFacilityAmendmentMember" xlink:label="loc_cpix_WarrantsIssuedInConsiderationOf2006CreditFacilityAmendmentMember_34695AECC2AE589683A66F9D98E8957A" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_B8F9D4DAD75E53E5A50EEB028C6AA027" xlink:to="loc_cpix_WarrantsIssuedInConsiderationOf2006CreditFacilityAmendmentMember_34695AECC2AE589683A66F9D98E8957A" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_WarrantsIssuedInConsiderationOf2009CreditFacilityAmendmentMember" xlink:label="loc_cpix_WarrantsIssuedInConsiderationOf2009CreditFacilityAmendmentMember_3581E2E46226529DB5ECB2B79371A295" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_B8F9D4DAD75E53E5A50EEB028C6AA027" xlink:to="loc_cpix_WarrantsIssuedInConsiderationOf2009CreditFacilityAmendmentMember_3581E2E46226529DB5ECB2B79371A295" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_DEE9B8B3FA8F5447ADF3540F26251CDE" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_ED0C9FE4E1775CDD819FDB43C4AFADA2" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_DEE9B8B3FA8F5447ADF3540F26251CDE" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_2B84DA6298FA5EE48EEA029E5B5F3AB6" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_DEE9B8B3FA8F5447ADF3540F26251CDE" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_2B84DA6298FA5EE48EEA029E5B5F3AB6" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_E4CB6188E5C75E4BB57B7564432562A1" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_DEE9B8B3FA8F5447ADF3540F26251CDE" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_E4CB6188E5C75E4BB57B7564432562A1" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_ClassOfWarrantOrRightExpirationDate" xlink:label="loc_cpix_ClassOfWarrantOrRightExpirationDate_1F8260170C715AD6A7DD6D2CA2368804" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_DEE9B8B3FA8F5447ADF3540F26251CDE" xlink:to="loc_cpix_ClassOfWarrantOrRightExpirationDate_1F8260170C715AD6A7DD6D2CA2368804" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/SignificantAccountingPolicies" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_89D7F5A1CF805636B9710AA2494CC534" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_3E58ADAF1CC65A6FA173F79B926C6C95" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_89D7F5A1CF805636B9710AA2494CC534" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_3E58ADAF1CC65A6FA173F79B926C6C95" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_379C8AC11AC14673C487AE90BF5F75FB" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_23027DFD8D2BFCDC2C12AEB4BD0238FD" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_379C8AC11AC14673C487AE90BF5F75FB" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_23027DFD8D2BFCDC2C12AEB4BD0238FD" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:label="loc_us-gaap_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_6CE921D9B0ACB8961141AEB57AA9D835" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_23027DFD8D2BFCDC2C12AEB4BD0238FD" xlink:to="loc_us-gaap_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_6CE921D9B0ACB8961141AEB57AA9D835" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:label="loc_us-gaap_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_FDF7962A1F6C3D67B554AEC3B2C14B80" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_6CE921D9B0ACB8961141AEB57AA9D835" xlink:to="loc_us-gaap_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_FDF7962A1F6C3D67B554AEC3B2C14B80" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_CorporateHeadquartersMember" xlink:label="loc_cpix_CorporateHeadquartersMember_8D2A8106E28336EF6CF3AEB606B51672" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_FDF7962A1F6C3D67B554AEC3B2C14B80" xlink:to="loc_cpix_CorporateHeadquartersMember_8D2A8106E28336EF6CF3AEB606B51672" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_CETLifeSciencesCenterMember" xlink:label="loc_cpix_CETLifeSciencesCenterMember_1791C33F7352A4BDFFB4AEB757A79E62" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_FDF7962A1F6C3D67B554AEC3B2C14B80" xlink:to="loc_cpix_CETLifeSciencesCenterMember_1791C33F7352A4BDFFB4AEB757A79E62" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_45D990AD07E8DE3CC192AEB4BD020C8D" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_23027DFD8D2BFCDC2C12AEB4BD0238FD" xlink:to="loc_us-gaap_OperatingLeasedAssetsLineItems_45D990AD07E8DE3CC192AEB4BD020C8D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="loc_us-gaap_AreaOfRealEstateProperty_6A71D7EEEF000948D395AEAF9856CF69" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_45D990AD07E8DE3CC192AEB4BD020C8D" xlink:to="loc_us-gaap_AreaOfRealEstateProperty_6A71D7EEEF000948D395AEAF9856CF69" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_E35BADE718C4BF54DFDFAE90BF5F7547" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_379C8AC11AC14673C487AE90BF5F75FB" xlink:to="loc_us-gaap_SegmentReportingAbstract_E35BADE718C4BF54DFDFAE90BF5F7547" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="loc_us-gaap_NumberOfOperatingSegments_ABBD8308D21FAF15BFCDAE90BF5F5B19" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_E35BADE718C4BF54DFDFAE90BF5F7547" xlink:to="loc_us-gaap_NumberOfOperatingSegments_ABBD8308D21FAF15BFCDAE90BF5F5B19" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_70BD2B0E5DFC966312ADAE90BF5F64B3" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_E35BADE718C4BF54DFDFAE90BF5F7547" xlink:to="loc_us-gaap_Revenues_70BD2B0E5DFC966312ADAE90BF5F64B3" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShippingHandlingAndTransportationCosts" xlink:label="loc_us-gaap_ShippingHandlingAndTransportationCosts_0831204352693E24B6A7AE90BF5F1B63" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_379C8AC11AC14673C487AE90BF5F75FB" xlink:to="loc_us-gaap_ShippingHandlingAndTransportationCosts_0831204352693E24B6A7AE90BF5F1B63" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaap_AdvertisingExpense_6D62F785910718653188AE90BF5F6103" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_379C8AC11AC14673C487AE90BF5F75FB" xlink:to="loc_us-gaap_AdvertisingExpense_6D62F785910718653188AE90BF5F6103" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaap_OperatingLossCarryforwards_525AE417E05480BFBBECAEB4C2F9B56C" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_379C8AC11AC14673C487AE90BF5F75FB" xlink:to="loc_us-gaap_OperatingLossCarryforwards_525AE417E05480BFBBECAEB4C2F9B56C" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_40C697ED31BC5ED194CFBFD7F1E66C3F" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_B87A0B73F2CC596188FC3FD5D317F5DB" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_40C697ED31BC5ED194CFBFD7F1E66C3F" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_B87A0B73F2CC596188FC3FD5D317F5DB" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates_A15788D7571B5B7793B4FBEA492BA2C5" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_40C697ED31BC5ED194CFBFD7F1E66C3F" xlink:to="loc_us-gaap_UseOfEstimates_A15788D7571B5B7793B4FBEA492BA2C5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_DB67FEC15CD05813A70BEEAAC6B3339A" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_40C697ED31BC5ED194CFBFD7F1E66C3F" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_DB67FEC15CD05813A70BEEAAC6B3339A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_7FFF418B3A7F52708812B926B0F16ECB" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_40C697ED31BC5ED194CFBFD7F1E66C3F" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_7FFF418B3A7F52708812B926B0F16ECB" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_8A19D8AF367D5B52BA02014840524E60" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_40C697ED31BC5ED194CFBFD7F1E66C3F" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_8A19D8AF367D5B52BA02014840524E60" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy_DD393768A2D7538386AE7BE9B1B30C13" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_40C697ED31BC5ED194CFBFD7F1E66C3F" xlink:to="loc_us-gaap_MarketableSecuritiesPolicy_DD393768A2D7538386AE7BE9B1B30C13" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_F5688AD05BBC5EE4B8DD6EA11600429B" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_40C697ED31BC5ED194CFBFD7F1E66C3F" xlink:to="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_F5688AD05BBC5EE4B8DD6EA11600429B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_5494FBA51C4259C78A7966404A787EB5" xlink:type="locator" />
    <presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_40C697ED31BC5ED194CFBFD7F1E66C3F" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_5494FBA51C4259C78A7966404A787EB5" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_PrepaidsAndOtherCurrentAssetsPolicyPolicyTextBlock" xlink:label="loc_cpix_PrepaidsAndOtherCurrentAssetsPolicyPolicyTextBlock_1F7F53AF6B545D4E96E051561B7AE88B" xlink:type="locator" />
    <presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_40C697ED31BC5ED194CFBFD7F1E66C3F" xlink:to="loc_cpix_PrepaidsAndOtherCurrentAssetsPolicyPolicyTextBlock_1F7F53AF6B545D4E96E051561B7AE88B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_962A3B2988395272B5E2A3FA38DB5F5B" xlink:type="locator" />
    <presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_40C697ED31BC5ED194CFBFD7F1E66C3F" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_962A3B2988395272B5E2A3FA38DB5F5B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy_C932ED4F3AC655A98B66F4450A0BF9D1" xlink:type="locator" />
    <presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_40C697ED31BC5ED194CFBFD7F1E66C3F" xlink:to="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy_C932ED4F3AC655A98B66F4450A0BF9D1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_6FC47E17BCEF57F49FDFFC6D53F71815" xlink:type="locator" />
    <presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_40C697ED31BC5ED194CFBFD7F1E66C3F" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_6FC47E17BCEF57F49FDFFC6D53F71815" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_8A1C916ACC6A599C99CC6B242FFD3548" xlink:type="locator" />
    <presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_40C697ED31BC5ED194CFBFD7F1E66C3F" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_8A1C916ACC6A599C99CC6B242FFD3548" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock_0882E900DCC15D89A4D026DB8B920AD6" xlink:type="locator" />
    <presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_40C697ED31BC5ED194CFBFD7F1E66C3F" xlink:to="loc_us-gaap_CostOfSalesPolicyTextBlock_0882E900DCC15D89A4D026DB8B920AD6" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_SellingAndMarketingExpensePolicyPolicyTextBlock" xlink:label="loc_cpix_SellingAndMarketingExpensePolicyPolicyTextBlock_2E17644B3DB558418AEDB419D8B815E3" xlink:type="locator" />
    <presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_40C697ED31BC5ED194CFBFD7F1E66C3F" xlink:to="loc_cpix_SellingAndMarketingExpensePolicyPolicyTextBlock_2E17644B3DB558418AEDB419D8B815E3" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShippingAndHandlingCostPolicyTextBlock" xlink:label="loc_us-gaap_ShippingAndHandlingCostPolicyTextBlock_411C1D30C504545F9015D3009F50F47A" xlink:type="locator" />
    <presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_40C697ED31BC5ED194CFBFD7F1E66C3F" xlink:to="loc_us-gaap_ShippingAndHandlingCostPolicyTextBlock_411C1D30C504545F9015D3009F50F47A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock_99641C675FC054E598356EF9785BD42E" xlink:type="locator" />
    <presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_40C697ED31BC5ED194CFBFD7F1E66C3F" xlink:to="loc_us-gaap_AdvertisingCostsPolicyTextBlock_99641C675FC054E598356EF9785BD42E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_B710C8E9E26B53988D0362B4BF11193C" xlink:type="locator" />
    <presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_40C697ED31BC5ED194CFBFD7F1E66C3F" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_B710C8E9E26B53988D0362B4BF11193C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_CCA2EB89C008595BACCDD31A6510D06E" xlink:type="locator" />
    <presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_40C697ED31BC5ED194CFBFD7F1E66C3F" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_CCA2EB89C008595BACCDD31A6510D06E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_8A61A7FAB21D57B4BD460CB23228273F" xlink:type="locator" />
    <presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_40C697ED31BC5ED194CFBFD7F1E66C3F" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_8A61A7FAB21D57B4BD460CB23228273F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_A8F442A5A99D595E8F94908F09E47221" xlink:type="locator" />
    <presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_40C697ED31BC5ED194CFBFD7F1E66C3F" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_A8F442A5A99D595E8F94908F09E47221" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_8ECD0B5C288559D48F0A93CAEA284A29" xlink:type="locator" />
    <presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_40C697ED31BC5ED194CFBFD7F1E66C3F" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_8ECD0B5C288559D48F0A93CAEA284A29" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CollaborativeArrangementAccountingPolicy" xlink:label="loc_us-gaap_CollaborativeArrangementAccountingPolicy_19FDED468C905913A3297C3EC80CC621" xlink:type="locator" />
    <presentationArc order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_40C697ED31BC5ED194CFBFD7F1E66C3F" xlink:to="loc_us-gaap_CollaborativeArrangementAccountingPolicy_19FDED468C905913A3297C3EC80CC621" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_E92F9AAEE11A53888CD487A606773685" xlink:type="locator" />
    <presentationArc order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_40C697ED31BC5ED194CFBFD7F1E66C3F" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_E92F9AAEE11A53888CD487A606773685" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/SignificantAccountingPoliciesScheduleOfIntangibleAssetsUsefulLivesDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_8747161AB2B059A598B6CF8104743E6F" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8A151023F25458C8A61FE020956CB74A" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8747161AB2B059A598B6CF8104743E6F" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8A151023F25458C8A61FE020956CB74A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_10A6B3E88DB953C28DDDA9EC0B424882" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8A151023F25458C8A61FE020956CB74A" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_10A6B3E88DB953C28DDDA9EC0B424882" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_91FE3AF99A2F5328832E5DBF9FFC7981" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_10A6B3E88DB953C28DDDA9EC0B424882" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_91FE3AF99A2F5328832E5DBF9FFC7981" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_ProductRightsMember" xlink:label="loc_cpix_ProductRightsMember_5EE2DCF4309350A693C00B1F1C0D8986" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_91FE3AF99A2F5328832E5DBF9FFC7981" xlink:to="loc_cpix_ProductRightsMember_5EE2DCF4309350A693C00B1F1C0D8986" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LicensingAgreementsMember" xlink:label="loc_us-gaap_LicensingAgreementsMember_7FB4F43B0C755B7593D7337AFF9F0A1A" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_91FE3AF99A2F5328832E5DBF9FFC7981" xlink:to="loc_us-gaap_LicensingAgreementsMember_7FB4F43B0C755B7593D7337AFF9F0A1A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaap_PatentsMember_6F17D6DFB8F85509A1DEC72E647C932C" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_91FE3AF99A2F5328832E5DBF9FFC7981" xlink:to="loc_us-gaap_PatentsMember_6F17D6DFB8F85509A1DEC72E647C932C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_99917A679EEE50EDA01892400ADEF4F0" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8A151023F25458C8A61FE020956CB74A" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_99917A679EEE50EDA01892400ADEF4F0" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_FiniteLivedIntangibleAssetsUsefulLivesTextual" xlink:label="loc_cpix_FiniteLivedIntangibleAssetsUsefulLivesTextual_D8220EF6793755C6B10F228BE3CE53A5" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_99917A679EEE50EDA01892400ADEF4F0" xlink:to="loc_cpix_FiniteLivedIntangibleAssetsUsefulLivesTextual_D8220EF6793755C6B10F228BE3CE53A5" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/SignificantAccountingPoliciesTables" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_77CD7E8166125276AF1C95A102FDB250" xlink:type="locator" />
    <loc xlink:href="cpix-20161231.xsd#cpix_ScheduleOfFiniteLivedIntangibleAssetsUsefulLivesTableTextBlock" xlink:label="loc_cpix_ScheduleOfFiniteLivedIntangibleAssetsUsefulLivesTableTextBlock_94118842AB0C5EEFB1919FDABDC8FA02" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_77CD7E8166125276AF1C95A102FDB250" xlink:to="loc_cpix_ScheduleOfFiniteLivedIntangibleAssetsUsefulLivesTableTextBlock_94118842AB0C5EEFB1919FDABDC8FA02" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/StockBasedCompensationPlans" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_C5A82DF7F30358E0955659D88615A8A1" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_E46A00E7266250ACB10AB65D2D1DAF5D" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_C5A82DF7F30358E0955659D88615A8A1" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_E46A00E7266250ACB10AB65D2D1DAF5D" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/StockBasedCompensationPlansNarrativeDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_B0C111AAAB2E284632D8902062233B2D" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D3140B7C71C702B79F1390206223D776" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_B0C111AAAB2E284632D8902062233B2D" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D3140B7C71C702B79F1390206223D776" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_A5A34A56DF1A0B265F85902062230F07" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D3140B7C71C702B79F1390206223D776" xlink:to="loc_us-gaap_AwardTypeAxis_A5A34A56DF1A0B265F85902062230F07" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_DE26A5017CB7CF4CADBB9020622325F5" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_A5A34A56DF1A0B265F85902062230F07" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_DE26A5017CB7CF4CADBB9020622325F5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_C4DB115D059932782AD290206223B9B5" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_DE26A5017CB7CF4CADBB9020622325F5" xlink:to="loc_us-gaap_EmployeeStockOptionMember_C4DB115D059932782AD290206223B9B5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaap_RestrictedStockMember_D609DCA19C81FD7919B3902062231D2E" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_DE26A5017CB7CF4CADBB9020622325F5" xlink:to="loc_us-gaap_RestrictedStockMember_D609DCA19C81FD7919B3902062231D2E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_E6526D7B42923A11D8CE90206223DE06" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D3140B7C71C702B79F1390206223D776" xlink:to="loc_us-gaap_PlanNameAxis_E6526D7B42923A11D8CE90206223DE06" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_35D351790A31A1CB8EFB902062235E8C" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_E6526D7B42923A11D8CE90206223DE06" xlink:to="loc_us-gaap_PlanNameDomain_35D351790A31A1CB8EFB902062235E8C" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_LongTermIncentiveCompensationPlan2007Member" xlink:label="loc_cpix_LongTermIncentiveCompensationPlan2007Member_38E014BBC8FE7C5702CD9020622326B3" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_35D351790A31A1CB8EFB902062235E8C" xlink:to="loc_cpix_LongTermIncentiveCompensationPlan2007Member_38E014BBC8FE7C5702CD9020622326B3" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_DirectorsIncentivePlan2007Member" xlink:label="loc_cpix_DirectorsIncentivePlan2007Member_A72BFC8B711E3431F955902062247046" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_35D351790A31A1CB8EFB902062235E8C" xlink:to="loc_cpix_DirectorsIncentivePlan2007Member_A72BFC8B711E3431F955902062247046" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaap_TitleOfIndividualAxis_FCD8BCCF553592F2C77790206224C88F" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D3140B7C71C702B79F1390206223D776" xlink:to="loc_us-gaap_TitleOfIndividualAxis_FCD8BCCF553592F2C77790206224C88F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_1F8CD1EFEB16D004D1CA902062246DC2" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualAxis_FCD8BCCF553592F2C77790206224C88F" xlink:to="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_1F8CD1EFEB16D004D1CA902062246DC2" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_EmployeeMember" xlink:label="loc_cpix_EmployeeMember_5CEFF010F5939026FDEE902062245190" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_1F8CD1EFEB16D004D1CA902062246DC2" xlink:to="loc_cpix_EmployeeMember_5CEFF010F5939026FDEE902062245190" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrincipalOwnerMember" xlink:label="loc_us-gaap_PrincipalOwnerMember_FA3A1EAFC10375B14DF9902062244E79" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_1F8CD1EFEB16D004D1CA902062246DC2" xlink:to="loc_us-gaap_PrincipalOwnerMember_FA3A1EAFC10375B14DF9902062244E79" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_NonprincipalOwnerMember" xlink:label="loc_cpix_NonprincipalOwnerMember_64CEF652A36192575BA89020622438E6" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_1F8CD1EFEB16D004D1CA902062246DC2" xlink:to="loc_cpix_NonprincipalOwnerMember_64CEF652A36192575BA89020622438E6" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DirectorMember" xlink:label="loc_us-gaap_DirectorMember_90C175BF67AC8FCDC8BE902062245643" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_1F8CD1EFEB16D004D1CA902062246DC2" xlink:to="loc_us-gaap_DirectorMember_90C175BF67AC8FCDC8BE902062245643" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_85D97D70FBB780DDE04890206224F536" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D3140B7C71C702B79F1390206223D776" xlink:to="loc_us-gaap_RangeAxis_85D97D70FBB780DDE04890206224F536" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_5AC1A5488C4755085FA5902062257719" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis_85D97D70FBB780DDE04890206224F536" xlink:to="loc_us-gaap_RangeMember_5AC1A5488C4755085FA5902062257719" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_392D2CDF4577177B21B0902062253616" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_5AC1A5488C4755085FA5902062257719" xlink:to="loc_us-gaap_MinimumMember_392D2CDF4577177B21B0902062253616" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_62D241DB8DA301FD55F7902062255392" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_5AC1A5488C4755085FA5902062257719" xlink:to="loc_us-gaap_MaximumMember_62D241DB8DA301FD55F7902062255392" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5376393CC45E3C89F4539020622A8FA1" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D3140B7C71C702B79F1390206223D776" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5376393CC45E3C89F4539020622A8FA1" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" xlink:label="loc_cpix_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_19B110FBE15EBE1621879020622AB9D1" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5376393CC45E3C89F4539020622A8FA1" xlink:to="loc_cpix_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_19B110FBE15EBE1621879020622AB9D1" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlansAvailableForFutureGrants" xlink:label="loc_cpix_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlansAvailableForFutureGrants_AB8399B4B988322B00AF9020622A06D3" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5376393CC45E3C89F4539020622A8FA1" xlink:to="loc_cpix_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlansAvailableForFutureGrants_AB8399B4B988322B00AF9020622A06D3" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_3EEDDDBDEF931D67103F9020622A8EEB" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5376393CC45E3C89F4539020622A8FA1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_3EEDDDBDEF931D67103F9020622A8EEB" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePriceAsPercentOfWeightedAverageGrantDateFairValue" xlink:label="loc_cpix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePriceAsPercentOfWeightedAverageGrantDateFairValue_978AA0D016F1A85ECCFD9020622ACA31" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5376393CC45E3C89F4539020622A8FA1" xlink:to="loc_cpix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePriceAsPercentOfWeightedAverageGrantDateFairValue_978AA0D016F1A85ECCFD9020622ACA31" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_0E01EC41A0CC026489F59020622B4EAD" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5376393CC45E3C89F4539020622A8FA1" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_0E01EC41A0CC026489F59020622B4EAD" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_3ED964275700084937909020622B8668" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5376393CC45E3C89F4539020622A8FA1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_3ED964275700084937909020622B8668" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_5AD5BE300EE69DE3CF9F9020622B68A6" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5376393CC45E3C89F4539020622A8FA1" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_5AD5BE300EE69DE3CF9F9020622B68A6" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_BDBC213A2285D46D8E759020622B9EB6" xlink:type="locator" />
    <presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5376393CC45E3C89F4539020622A8FA1" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_BDBC213A2285D46D8E759020622B9EB6" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/StockBasedCompensationPlansScheduleOfRestrictedStockActivityDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0FAF3A5F14D8A7B40326902061E079CC" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_C42E98785776A65BB85E902061E02BCD" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0FAF3A5F14D8A7B40326902061E079CC" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_C42E98785776A65BB85E902061E02BCD" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_CC6BEA419A61C05C614B902061E063E6" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_C42E98785776A65BB85E902061E02BCD" xlink:to="loc_us-gaap_AwardTypeAxis_CC6BEA419A61C05C614B902061E063E6" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_125239A7F5FFC5486811902061E02801" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_CC6BEA419A61C05C614B902061E063E6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_125239A7F5FFC5486811902061E02801" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaap_RestrictedStockMember_AFC29A4A6799EC012B06902061E0095A" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_125239A7F5FFC5486811902061E02801" xlink:to="loc_us-gaap_RestrictedStockMember_AFC29A4A6799EC012B06902061E0095A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BD1A37B6AE170657EE62902061E0D8B2" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_C42E98785776A65BB85E902061E02BCD" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BD1A37B6AE170657EE62902061E0D8B2" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_81E2E799C2BFF2503647902061E0E7C9" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BD1A37B6AE170657EE62902061E0D8B2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_81E2E799C2BFF2503647902061E0E7C9" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_F9680F05836ABC3D5ED2902061E0D7DE" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_81E2E799C2BFF2503647902061E0E7C9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_F9680F05836ABC3D5ED2902061E0D7DE" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_CDB9BB29ADAD6827526B902061E0B3C4" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_81E2E799C2BFF2503647902061E0E7C9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_CDB9BB29ADAD6827526B902061E0B3C4" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2E9B69C54F2A310C96D4902061E0D239" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_81E2E799C2BFF2503647902061E0E7C9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2E9B69C54F2A310C96D4902061E0D239" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1B0B67E4D8A3CFD2791B902061E0FD7E" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_81E2E799C2BFF2503647902061E0E7C9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1B0B67E4D8A3CFD2791B902061E0FD7E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0A54F1B8430645B4C210902061E0FCCF" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_81E2E799C2BFF2503647902061E0E7C9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0A54F1B8430645B4C210902061E0FCCF" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_D6BD06A384695DADB6C1902061E05748" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BD1A37B6AE170657EE62902061E0D8B2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_D6BD06A384695DADB6C1902061E05748" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_45A2C7DCBD97D934718E902061E12734" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_D6BD06A384695DADB6C1902061E05748" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_45A2C7DCBD97D934718E902061E12734" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_02A18F6638255E91B54A902061E61D3A" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_D6BD06A384695DADB6C1902061E05748" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_02A18F6638255E91B54A902061E61D3A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_C0681901F5840EF2612C902061E6B937" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_D6BD06A384695DADB6C1902061E05748" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_C0681901F5840EF2612C902061E6B937" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_7FC2117393849D631D7F902061E6B389" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_D6BD06A384695DADB6C1902061E05748" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_7FC2117393849D631D7F902061E6B389" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_DB675EA769F9168BB953902061E62E47" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_D6BD06A384695DADB6C1902061E05748" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_DB675EA769F9168BB953902061E62E47" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/StockBasedCompensationPlansScheduleOfShareBasedCompensationExpenseDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2E6C0F36B0CF58EF90582A1D1D4CE45A" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_CCFDE847D78F5B6CB4D0CC4A6D47D922" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2E6C0F36B0CF58EF90582A1D1D4CE45A" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_CCFDE847D78F5B6CB4D0CC4A6D47D922" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaap_TitleOfIndividualAxis_B58FE821B03650F0B7CDC10196B63D50" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_CCFDE847D78F5B6CB4D0CC4A6D47D922" xlink:to="loc_us-gaap_TitleOfIndividualAxis_B58FE821B03650F0B7CDC10196B63D50" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_6CF16079AED954F3A2668A89A0071EAD" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualAxis_B58FE821B03650F0B7CDC10196B63D50" xlink:to="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_6CF16079AED954F3A2668A89A0071EAD" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_EmployeeMember" xlink:label="loc_cpix_EmployeeMember_7D402519EAC5512BB8168D0E192BBFE1" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_6CF16079AED954F3A2668A89A0071EAD" xlink:to="loc_cpix_EmployeeMember_7D402519EAC5512BB8168D0E192BBFE1" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_NonemployeeMember" xlink:label="loc_cpix_NonemployeeMember_6BF76671473858AC8E85D59046178664" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_6CF16079AED954F3A2668A89A0071EAD" xlink:to="loc_cpix_NonemployeeMember_6BF76671473858AC8E85D59046178664" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5C3E0986B2DB52F0B58427621E0D9A75" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_CCFDE847D78F5B6CB4D0CC4A6D47D922" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5C3E0986B2DB52F0B58427621E0D9A75" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_A2D667521FB056ADB73EB149B5C1A986" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5C3E0986B2DB52F0B58427621E0D9A75" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_A2D667521FB056ADB73EB149B5C1A986" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/StockBasedCompensationPlansScheduleOfStockOptionActivityAdditionalDisclosuresDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_31A84809D7775E37B67730942D5F90B5" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_54F7E95AB0905E33AE63E3865FCFADA1" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_31A84809D7775E37B67730942D5F90B5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_54F7E95AB0905E33AE63E3865FCFADA1" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_cpix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGrantDateFairValue_1C908414186457B790D153F8C7185C94" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_31A84809D7775E37B67730942D5F90B5" xlink:to="loc_cpix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGrantDateFairValue_1C908414186457B790D153F8C7185C94" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/StockBasedCompensationPlansScheduleOfStockOptionsActivityDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_A582F6C8324156479CA3E6B50E4E67E7" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7B2828F2F1BF5F6EA7E0964214D5DAF0" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_A582F6C8324156479CA3E6B50E4E67E7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7B2828F2F1BF5F6EA7E0964214D5DAF0" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_7148F5F9D43C59A2B1432B233B72C4E0" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7B2828F2F1BF5F6EA7E0964214D5DAF0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_7148F5F9D43C59A2B1432B233B72C4E0" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_B8275AA459165B95B912F8A991C3BC67" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7B2828F2F1BF5F6EA7E0964214D5DAF0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_B8275AA459165B95B912F8A991C3BC67" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_A94E2DCD17615E16B1F7D41137D465B2" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7B2828F2F1BF5F6EA7E0964214D5DAF0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_A94E2DCD17615E16B1F7D41137D465B2" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_AE249755FB405896A33106ADA4A7A05E" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7B2828F2F1BF5F6EA7E0964214D5DAF0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_AE249755FB405896A33106ADA4A7A05E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0EA8225FDF8A5D7B986E7B9663854830" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7B2828F2F1BF5F6EA7E0964214D5DAF0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0EA8225FDF8A5D7B986E7B9663854830" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_3F89355B3DB75CA9B2AEFB6D0007870B" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_A582F6C8324156479CA3E6B50E4E67E7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_3F89355B3DB75CA9B2AEFB6D0007870B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7762F9F0010D5BF49E990B9B48C1D87C" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_A582F6C8324156479CA3E6B50E4E67E7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7762F9F0010D5BF49E990B9B48C1D87C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_C2F2B070AC6B576E83934C150CB5EAF6" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7762F9F0010D5BF49E990B9B48C1D87C" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_C2F2B070AC6B576E83934C150CB5EAF6" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_4EB3F9E000295F5B9AAF30E9ED196F6A" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7762F9F0010D5BF49E990B9B48C1D87C" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_4EB3F9E000295F5B9AAF30E9ED196F6A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_64B55078438A5901A28C87FCEEA6246D" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7762F9F0010D5BF49E990B9B48C1D87C" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_64B55078438A5901A28C87FCEEA6246D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_09C2BB891EFA5AEE82C1FAB9C7C3395A" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7762F9F0010D5BF49E990B9B48C1D87C" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_09C2BB891EFA5AEE82C1FAB9C7C3395A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_FD62FA8DA58654BDA4751428EA34A53C" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7762F9F0010D5BF49E990B9B48C1D87C" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_FD62FA8DA58654BDA4751428EA34A53C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_F330B4BA759A52A9839D093AD2D9A5DC" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_A582F6C8324156479CA3E6B50E4E67E7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_F330B4BA759A52A9839D093AD2D9A5DC" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_BB147737A73956FF8D21482396455476" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_A582F6C8324156479CA3E6B50E4E67E7" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_BB147737A73956FF8D21482396455476" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_DC95AE496E685A62984784167A8DBC4A" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_A582F6C8324156479CA3E6B50E4E67E7" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_DC95AE496E685A62984784167A8DBC4A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_8F0140327E5E53E0944DA1D5710B0F65" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_A582F6C8324156479CA3E6B50E4E67E7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_8F0140327E5E53E0944DA1D5710B0F65" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_9152CEDA679B53F78BA9E2C1B0664001" xlink:type="locator" />
    <presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_A582F6C8324156479CA3E6B50E4E67E7" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_9152CEDA679B53F78BA9E2C1B0664001" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/StockBasedCompensationPlansTables" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_86B87ED3D758557CB4758F29463A05E7" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_937E08A4781050B8BB3FB260224B6A18" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_86B87ED3D758557CB4758F29463A05E7" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_937E08A4781050B8BB3FB260224B6A18" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_91398E5C5D58502FBD413AAA36A9EBC0" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_86B87ED3D758557CB4758F29463A05E7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_91398E5C5D58502FBD413AAA36A9EBC0" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_ScheduleOfStockOptionActivityAdditionalDisclosuresTableTextBlock" xlink:label="loc_cpix_ScheduleOfStockOptionActivityAdditionalDisclosuresTableTextBlock_8444216F82DC567BA95F5FC270F5A122" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_86B87ED3D758557CB4758F29463A05E7" xlink:to="loc_cpix_ScheduleOfStockOptionActivityAdditionalDisclosuresTableTextBlock_8444216F82DC567BA95F5FC270F5A122" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_E5261E085CBE566098A72A589D8E1491" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_86B87ED3D758557CB4758F29463A05E7" xlink:to="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_E5261E085CBE566098A72A589D8E1491" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/ValuationAndQualifyingAccounts" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationAndQualifyingAccountsAbstract" xlink:label="loc_us-gaap_ValuationAndQualifyingAccountsAbstract_AECCC1ADEBA45837BDA8330147822113" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:label="loc_us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_0ECEEA519EA15958A77F9C2EAA2D863F" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAndQualifyingAccountsAbstract_AECCC1ADEBA45837BDA8330147822113" xlink:to="loc_us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_0ECEEA519EA15958A77F9C2EAA2D863F" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/ValuationAndQualifyingAccountsDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationAndQualifyingAccountsAbstract" xlink:label="loc_us-gaap_ValuationAndQualifyingAccountsAbstract_C9A1C55CF927F4D6302FAE90BEA3CCAD" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationAndQualifyingAccountsDisclosureTable" xlink:label="loc_us-gaap_ValuationAndQualifyingAccountsDisclosureTable_EEF1392D3E3CAF5F0673AE90BEA3416D" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAndQualifyingAccountsAbstract_C9A1C55CF927F4D6302FAE90BEA3CCAD" xlink:to="loc_us-gaap_ValuationAndQualifyingAccountsDisclosureTable_EEF1392D3E3CAF5F0673AE90BEA3416D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_699F3366048B68AB4128AE90BEA3AF73" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAndQualifyingAccountsDisclosureTable_EEF1392D3E3CAF5F0673AE90BEA3416D" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_699F3366048B68AB4128AE90BEA3AF73" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_376DC62462EDB67BDA65AE90BEA39DBE" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_699F3366048B68AB4128AE90BEA3AF73" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_376DC62462EDB67BDA65AE90BEA39DBE" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsCurrentMember" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsCurrentMember_6C36B8F4FCAE509017C3AE90BEA39D13" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_376DC62462EDB67BDA65AE90BEA39DBE" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsCurrentMember_6C36B8F4FCAE509017C3AE90BEA39D13" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_7A637952E9CA9A3FB282AE90BEA38CEF" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_376DC62462EDB67BDA65AE90BEA39DBE" xlink:to="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_7A637952E9CA9A3FB282AE90BEA38CEF" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:label="loc_us-gaap_ValuationAndQualifyingAccountsDisclosureLineItems_9694FD5A620DE92B294FAE90BEA3F17B" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAndQualifyingAccountsDisclosureTable_EEF1392D3E3CAF5F0673AE90BEA3416D" xlink:to="loc_us-gaap_ValuationAndQualifyingAccountsDisclosureLineItems_9694FD5A620DE92B294FAE90BEA3F17B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_9449E7CE6C1206381CBFAE90BEA32F1D" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAndQualifyingAccountsDisclosureLineItems_9694FD5A620DE92B294FAE90BEA3F17B" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_9449E7CE6C1206381CBFAE90BEA32F1D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_1FA8EC990BDF0C54E6CDAE90BEA3D6FA" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_9449E7CE6C1206381CBFAE90BEA32F1D" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_1FA8EC990BDF0C54E6CDAE90BEA3D6FA" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_AFC9CE5FB4B38204CAC3AE90BEA317D1" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_9449E7CE6C1206381CBFAE90BEA32F1D" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_AFC9CE5FB4B38204CAC3AE90BEA317D1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_6A1063980A94519E437FAE90BEA34671" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_9449E7CE6C1206381CBFAE90BEA32F1D" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_6A1063980A94519E437FAE90BEA34671" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_1D5B51D006E57406767CAE90BEA32374" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_9449E7CE6C1206381CBFAE90BEA32F1D" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_1D5B51D006E57406767CAE90BEA32374" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_7E31B6D4B3EF447CE3A3AE90BEA3AF88" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_9449E7CE6C1206381CBFAE90BEA32F1D" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_7E31B6D4B3EF447CE3A3AE90BEA3AF88" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/VaprisolOmeclamoxPakEthyolAndMethotrexate" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_A4E55A979F29AB037B7E8FDD19CC5621" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_6DA162A967A3A488C7078FDD19CC536F" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_A4E55A979F29AB037B7E8FDD19CC5621" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_6DA162A967A3A488C7078FDD19CC536F" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/VaprisolOmeclamoxPakEthyolAndMethotrexateAssetsAndLiabilitiesAssumedDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_6C815199D96055802AEB8FDD19BD1A33" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_29A798325BB8451CAB3D8FDD19BDDAAB" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_6C815199D96055802AEB8FDD19BD1A33" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_29A798325BB8451CAB3D8FDD19BDDAAB" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3A13094F8E2C2E5CA5E18FDD19BD3582" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_29A798325BB8451CAB3D8FDD19BDDAAB" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3A13094F8E2C2E5CA5E18FDD19BD3582" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_308119F983E73F5A26C18FDD19BDAE7F" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3A13094F8E2C2E5CA5E18FDD19BD3582" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_308119F983E73F5A26C18FDD19BDAE7F" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_VaprisolMember" xlink:label="loc_cpix_VaprisolMember_02AE1F3A861C0E9099D68FDD19BD5598" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_308119F983E73F5A26C18FDD19BDAE7F" xlink:to="loc_cpix_VaprisolMember_02AE1F3A861C0E9099D68FDD19BD5598" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_D04B63A218626F75471C8FDD19BDE916" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_29A798325BB8451CAB3D8FDD19BDDAAB" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_D04B63A218626F75471C8FDD19BDE916" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_834FD553B614FFE803EC8FDD19BD990E" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_D04B63A218626F75471C8FDD19BDE916" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_834FD553B614FFE803EC8FDD19BD990E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_076F5514517CF213C4848FDD19BD1401" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_D04B63A218626F75471C8FDD19BDE916" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_076F5514517CF213C4848FDD19BD1401" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_08FEF3525070A37782488FDD19BE07B1" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_D04B63A218626F75471C8FDD19BDE916" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_08FEF3525070A37782488FDD19BE07B1" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedContingentConsiderationObligations" xlink:label="loc_cpix_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedContingentConsiderationObligations_0F3F768C0BCD8618A8878FDD19BE87B0" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_D04B63A218626F75471C8FDD19BDE916" xlink:to="loc_cpix_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedContingentConsiderationObligations_0F3F768C0BCD8618A8878FDD19BE87B0" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_4C6C8295B78776FD8A168FDD19BE5DC8" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_D04B63A218626F75471C8FDD19BDE916" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_4C6C8295B78776FD8A168FDD19BE5DC8" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/VaprisolOmeclamoxPakEthyolAndMethotrexateNarrativeDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_7BC73CE153C5E926A30E95A0A2A8BE07" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_45E375704109567335C895A0A2A84C6D" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_7BC73CE153C5E926A30E95A0A2A8BE07" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_45E375704109567335C895A0A2A84C6D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_5A8FC9324488F2E2817095A0A2A86619" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_45E375704109567335C895A0A2A84C6D" xlink:to="loc_us-gaap_AwardTypeAxis_5A8FC9324488F2E2817095A0A2A86619" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5D19C5BC2BF72C3DBBE195A0A2A8DA0E" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_5A8FC9324488F2E2817095A0A2A86619" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5D19C5BC2BF72C3DBBE195A0A2A8DA0E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaap_RestrictedStockMember_7FA11E90A4368817D6F195A0A2A8EEC9" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5D19C5BC2BF72C3DBBE195A0A2A8DA0E" xlink:to="loc_us-gaap_RestrictedStockMember_7FA11E90A4368817D6F195A0A2A8EEC9" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductOrServiceAxis" xlink:label="loc_us-gaap_ProductOrServiceAxis_A21A429D5E8E22EF34A195A0A2A8BF65" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_45E375704109567335C895A0A2A84C6D" xlink:to="loc_us-gaap_ProductOrServiceAxis_A21A429D5E8E22EF34A195A0A2A8BF65" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductsAndServicesDomain" xlink:label="loc_us-gaap_ProductsAndServicesDomain_F0C6BF09A61FA50EDA2795A0A2A84099" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductOrServiceAxis_A21A429D5E8E22EF34A195A0A2A8BF65" xlink:to="loc_us-gaap_ProductsAndServicesDomain_F0C6BF09A61FA50EDA2795A0A2A84099" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_VaprisolMember" xlink:label="loc_cpix_VaprisolMember_4B61B58F7C21B013ED2E95A0A2A8A526" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductsAndServicesDomain_F0C6BF09A61FA50EDA2795A0A2A84099" xlink:to="loc_cpix_VaprisolMember_4B61B58F7C21B013ED2E95A0A2A8A526" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_ProductEthyolMember" xlink:label="loc_cpix_ProductEthyolMember_29F78A9854FF9D94C85D95A0A2A8B772" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductsAndServicesDomain_F0C6BF09A61FA50EDA2795A0A2A84099" xlink:to="loc_cpix_ProductEthyolMember_29F78A9854FF9D94C85D95A0A2A8B772" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_01EA697A46E2CEB8C56095A0A2A8062D" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_45E375704109567335C895A0A2A84C6D" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_01EA697A46E2CEB8C56095A0A2A8062D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_86FF08877BC5E07C17F795A0A2A823B9" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_01EA697A46E2CEB8C56095A0A2A8062D" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_86FF08877BC5E07C17F795A0A2A823B9" xlink:type="arc" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_86FF08877BC5E07C17F795A0A2A823B9" xlink:to="loc_cpix_VaprisolMember_4B61B58F7C21B013ED2E95A0A2A8A526" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_OmeclamoxPakMember" xlink:label="loc_cpix_OmeclamoxPakMember_E74CD9C0EE7C02C19A4195A0A2A814CE" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_86FF08877BC5E07C17F795A0A2A823B9" xlink:to="loc_cpix_OmeclamoxPakMember_E74CD9C0EE7C02C19A4195A0A2A814CE" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_EthyolMember" xlink:label="loc_cpix_EthyolMember_CEA3C7661908E5FC863395A0A2A89061" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_86FF08877BC5E07C17F795A0A2A823B9" xlink:to="loc_cpix_EthyolMember_CEA3C7661908E5FC863395A0A2A89061" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_MethotrexateMember" xlink:label="loc_cpix_MethotrexateMember_16D580CEAD2283F05E6995A0A2A803E9" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_86FF08877BC5E07C17F795A0A2A823B9" xlink:to="loc_cpix_MethotrexateMember_16D580CEAD2283F05E6995A0A2A803E9" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaap_TypeOfArrangementAxis_622FD063DCBB34470CD795A0A2A86025" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_45E375704109567335C895A0A2A84C6D" xlink:to="loc_us-gaap_TypeOfArrangementAxis_622FD063DCBB34470CD795A0A2A86025" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_082FA5606593F26FF71195A0A2A87FF4" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_622FD063DCBB34470CD795A0A2A86025" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_082FA5606593F26FF71195A0A2A87FF4" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_AmendedInternationalAgreementMember" xlink:label="loc_cpix_AmendedInternationalAgreementMember_334EB20425FFF5A2BCD595A0A2A88931" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_082FA5606593F26FF71195A0A2A87FF4" xlink:to="loc_cpix_AmendedInternationalAgreementMember_334EB20425FFF5A2BCD595A0A2A88931" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_0C9D6BD8054F812D490D95A0A2A853AA" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_45E375704109567335C895A0A2A84C6D" xlink:to="loc_dei_LegalEntityAxis_0C9D6BD8054F812D490D95A0A2A853AA" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_F1C89D9BCEC18D0FC10995A0A2A8286F" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_0C9D6BD8054F812D490D95A0A2A853AA" xlink:to="loc_dei_EntityDomain_F1C89D9BCEC18D0FC10995A0A2A8286F" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_PernixTherapeuticsMember" xlink:label="loc_cpix_PernixTherapeuticsMember_ECCC1276F5A3B06AF3F895A0A2A8843A" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_F1C89D9BCEC18D0FC10995A0A2A8286F" xlink:to="loc_cpix_PernixTherapeuticsMember_ECCC1276F5A3B06AF3F895A0A2A8843A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_5438EA0D869BD3D579BB95A0A2A8EF19" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_45E375704109567335C895A0A2A84C6D" xlink:to="loc_us-gaap_RangeAxis_5438EA0D869BD3D579BB95A0A2A8EF19" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_39CE4B12137DF6CC0E3C95A0A2A8AA49" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis_5438EA0D869BD3D579BB95A0A2A8EF19" xlink:to="loc_us-gaap_RangeMember_39CE4B12137DF6CC0E3C95A0A2A8AA49" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_4624B65E96B28C5E044695A0A2A8AC5D" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_39CE4B12137DF6CC0E3C95A0A2A8AA49" xlink:to="loc_us-gaap_MinimumMember_4624B65E96B28C5E044695A0A2A8AC5D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_DD499AC0A086B49FF30595A0A2A85972" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_39CE4B12137DF6CC0E3C95A0A2A8AA49" xlink:to="loc_us-gaap_MaximumMember_DD499AC0A086B49FF30595A0A2A85972" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_28B609F49DD893AADBD195A0A2A81264" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_45E375704109567335C895A0A2A84C6D" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_28B609F49DD893AADBD195A0A2A81264" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_BusinessCombinationUpfrontPayment" xlink:label="loc_cpix_BusinessCombinationUpfrontPayment_BBCEB144029AE18C84CE95A0A2A8CDEF" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_28B609F49DD893AADBD195A0A2A81264" xlink:to="loc_cpix_BusinessCombinationUpfrontPayment_BBCEB144029AE18C84CE95A0A2A8CDEF" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_BusinessCombinationAggregateUpfrontPayments" xlink:label="loc_cpix_BusinessCombinationAggregateUpfrontPayments_049E82C64B1047DB4D0E95A0A2A8AD79" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_28B609F49DD893AADBD195A0A2A81264" xlink:to="loc_cpix_BusinessCombinationAggregateUpfrontPayments_049E82C64B1047DB4D0E95A0A2A8AD79" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_PaymentsforContingentConsideration" xlink:label="loc_cpix_PaymentsforContingentConsideration_CFF9CDD2A1829B59A01F95A0A2A86925" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_28B609F49DD893AADBD195A0A2A81264" xlink:to="loc_cpix_PaymentsforContingentConsideration_CFF9CDD2A1829B59A01F95A0A2A86925" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_RecognizedGainLossonContingentConsideration" xlink:label="loc_cpix_RecognizedGainLossonContingentConsideration_960A4326B917495335CC95A0A2A88E00" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_28B609F49DD893AADBD195A0A2A81264" xlink:to="loc_cpix_RecognizedGainLossonContingentConsideration_960A4326B917495335CC95A0A2A88E00" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_E03B6A3E3F938B343D9B95A0A2A81B8C" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_28B609F49DD893AADBD195A0A2A81264" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_E03B6A3E3F938B343D9B95A0A2A81B8C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesRevenueGoodsNet" xlink:label="loc_us-gaap_SalesRevenueGoodsNet_E0088CDD01D53AB566A995A0A2A892CC" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_28B609F49DD893AADBD195A0A2A81264" xlink:to="loc_us-gaap_SalesRevenueGoodsNet_E0088CDD01D53AB566A995A0A2A892CC" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaap_SalesRevenueNet_3DB2F68F2F8F42B544B595A0A2A8A6DA" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_28B609F49DD893AADBD195A0A2A81264" xlink:to="loc_us-gaap_SalesRevenueNet_3DB2F68F2F8F42B544B595A0A2A8A6DA" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_BusinessCombinationRoyaltiesRangeofPaymentOverGrossProfitsPercentage" xlink:label="loc_cpix_BusinessCombinationRoyaltiesRangeofPaymentOverGrossProfitsPercentage_527E383420AFC03B2A7D95A0A2A87823" xlink:type="locator" />
    <presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_28B609F49DD893AADBD195A0A2A81264" xlink:to="loc_cpix_BusinessCombinationRoyaltiesRangeofPaymentOverGrossProfitsPercentage_527E383420AFC03B2A7D95A0A2A87823" xlink:type="arc" />
    <loc xlink:href="cpix-20161231.xsd#cpix_RevenueRecognitionPotentialUpfrontPaymentRelatedtoProductSales" xlink:label="loc_cpix_RevenueRecognitionPotentialUpfrontPaymentRelatedtoProductSales_D0BDFFA12D8C08CFF5F695A0A2A8FEF3" xlink:type="locator" />
    <presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_28B609F49DD893AADBD195A0A2A81264" xlink:to="loc_cpix_RevenueRecognitionPotentialUpfrontPaymentRelatedtoProductSales_D0BDFFA12D8C08CFF5F695A0A2A8FEF3" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_6D355F3980F1708D2CF895A0A2A80242" xlink:type="locator" />
    <presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_28B609F49DD893AADBD195A0A2A81264" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_6D355F3980F1708D2CF895A0A2A80242" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_F71FAB8300547A0F1EC795A0A2A81179" xlink:type="locator" />
    <presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_28B609F49DD893AADBD195A0A2A81264" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_F71FAB8300547A0F1EC795A0A2A81179" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_480AA8EB149885D9130095A0A2A8CD50" xlink:type="locator" />
    <presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_28B609F49DD893AADBD195A0A2A81264" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_480AA8EB149885D9130095A0A2A8CD50" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_F1ACC4F3A064935E7DDC95A0A2A8E83E" xlink:type="locator" />
    <presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_28B609F49DD893AADBD195A0A2A81264" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_F1ACC4F3A064935E7DDC95A0A2A8E83E" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://cumberlandpharma.com/role/VaprisolOmeclamoxPakEthyolAndMethotrexateTables" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_BE45671DE5E726DFD4868FDD19C95121" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_2343F07B1079E192789A8FDD19C9B5E8" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_BE45671DE5E726DFD4868FDD19C95121" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_2343F07B1079E192789A8FDD19C9B5E8" xlink:type="arc" />
  </presentationLink>
</linkbase>
